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ABSTRACT
The membrane attack complex (MAC: C5blC61C71C81C9n) is the terminal complex of
the mammalian complement cascade. Its principal function is to form a self-assembling,
potentially cytolytic pore spanning the membrane of a foreign cell. However,
inappropriate complement activation and subsequent aberrant MAC action is responsible
for tissue damage in several human pathologies.1 The C-terminal domains or modules
that are exclusive to the C6 and C7 components of the MAC, form a putative molecular
arm. These modules consist of two complement control protein modules (CCPs)
followed by a pair of Factor I-like Modules (FIMs). The C-terminal molecular arms of
C6 and C7 are important for linking the complement activation cascade with MAC
assembly and thereby ensuring MAC assembly occurs only when needed. They interact
with the C345C domain of C5 and C5b. Currently there are no high-resolution structural
data for any of the MAC components but efforts are underway to solve the structures of
the individual domains. For instance, the structure of the central MAC/perforin domain
of C8 has been determined, so has the structure of C5 and the FIM domains ofC7.
However , the lack of structural information for the MAC is being balanced by an
increased understanding of mechanism, and eventually towards the rational design of
therapies designed to supress MAC formation.
This report describes the preparation from bacterial and yeast cells of 13C,15N-labelled
samples of the C7 CCP-pair and of a triple module consisting of the second CCP
followed by the FIM-pair, as well as other constructs from the C6 and C7 C-terminal
arms. The NMR samples were used to solve 3D solutions of structures, thus allowing
for reconstruction of the four-module C-terminus ofC7. Efforts were aimed at obtaining
additional structural information for C7. This included SAXS analysis as well as the
development of a novel approach using chemical cross-linking followed by tryptic
digestion and mass spectrometry-based identification of cross-linked peptides.
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1.1 The complement system1
1.1.1 An overview
The complement system is both a key molecular component of innate immunity and
provides one of the main effector mechanisms of antibody-mediated immunity.
Phylogenetic analysis has traced the genetic origins of the complement system to the
deuterozome lineage of metazoans that emerged more than 900 million years ago.2
Many primitive multicellular organisms have relatively simple complement systems
while expansion of complement genes by gene duplications has given rise to the more
complex complement systems found in higher vertebrates.3
The human complement system is composed of over 30 serum and cell-surface proteins.
It is required for host defense against invading pathogens, clearance of immune
complexes and disposal of apoptotic cell debris and other waste products. It has opsonic,
cytolytic and inflammatory role and has been implicated in the pathogenesis of several
autoimmune, ischemic and vascular diseases.1 Furthermore, specific complement
components provide an essential link between the innate and acquired immune systems
acting as molecular adjuvants, augmenting antigen-specific immune responses.4 More
recently, accumulating evidence suggests that the complement system has many more
novel, non-inflammatory roles in the promotion of cell differentiation, tissue remodeling
and regeneration, in a variety of biological processes such as animal reproduction and
organ regeneration.5 The multi-functionality of some complement components is
governed by their ability to interact with a large number of complement factors,
including complement regulators and receptors, as well as non-complement proteins.
Whilst the various biological pathways in which complement participates are currently
under investigation, the activation events, the central proteolytic cascade (Fig. 1) and the
terminal steps leading to assembly of the membrane-attack complex are well established.
2
CHAPTER 1: INTRODUCTION
These are key to the role of complement in inflammation and host defense against
pathogens. These processes are less understood at the level of atomic resolution of
structures. An emerging theme is the exposure of distinct interaction sites on protein
molecules occurring as a result of conformational changes induced by limited proteolysis
and /or formation of complexes.
1.1.2 The complement cascade 1
The human complement cascade (Fig. 1) is activated via the three canonical activation
pathways: the classical, lectin and alternative pathways. Two novel routes to activation -
the C2 bypass6 and extrinsic protease pathway7 - are also potentially important. All of
these pathways entail successive cleavage events, prominent amongst which is
conversion of C3 to C3b, which instigates the central amplification cascade, and of C5 to
C5b that nucleates assembly of the membrane-attack complex in the so-called terminal
pathway.
The classical pathway is initiated by the recognition of immune complexes containing
IgG or IgM, and by C-reactive protein, as well as various danger-associated and
pathogen-associated molecular patterns (DAMPs and PAMPs).1 Recognition is achieved
via the globular domains of Clq, which is part of a heteroligomeric complex CI that also
includes two copies, each of proteins Clr and Cls. The lectin pathway also occurs
through the recognition of PAMPs, via mannose-binding lectin (MBL) or ficolin proteins
in conjunction with MBL-associated serine proteases (MASPs).1 In both the classical
and lectin pathways, target binding activates the proteolytic components (Clr/Cls and
MASP-1 or MASP-2, respectively) of the recognition complexes, resulting in the
cleavage of C4 to C4b (and C4a) and then in cleavage of C4b-associated C2 to C2a (and
C2b) to generate the classical pathway C3 convertase, C4bC2a (Fig. 1). Recently, the C2
bypass pathway was described whereby MASP-2 of the lectin pathway seems to directly
3
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attack and cleave C3 without formation of the corresponding C3 convertase.6
Activation via the alternative pathway however, occurs constitutively by spontaneous
hydrolysis at a slow 'tick over' rate of a thioester bond in C3, forming C3u (also called
C3(H20)). This form of the protein can bind factor B, which is one of numerous proteins
within the complement system that contain CCP modules (see below). Binding of factor
B to C3(H20) renders factor B susceptible to cleavage by factor D. This generates the
initiation convertase C3(H20)Bb, which cleaves C3 to generating the activated C3b
molecule and an anaphylatoxin, C3a. C3b is central to the complement system. It's
nascently activated thioester interacts with any nearby nucleophile allowing it to
covalently attach itself to surfaces. C3b also interacts, non-covalently, with factor B
yielding (after factor B cleavage by factor D) the important alternative-pathway C3
convertase, C3bBb.
The C3 convertases of both the classical/lectin and the alternative pathways create a
positive-feedback loop by generating more C3b molecules that contribute to formation
of further C3bBb (alternative pathway convertase) complexes. Additional molecules of
C3b may bind to either C3bBb or C4b2a to generate the C5 convertases (i.e. C4b3b3b
(CP) or C3b3bBb (AP)) that have a catalytic preference for C5 over C3, generating C5b
and the potent anaphylatoxin, C5a. As with the C3a generated as a result of proteolytic
cleavage of C3, C5a is a potent inflammatory mediator that triggers a plethora of
processes, which culminate in the stimulation of immune cells and the elimination of the
pathogen. However, extrinsic proteases such as thrombin and kallikrein have C5
convertase activity and have been reported to cleave C5 to C5b, in the description of a
fourth potential complement actvation pathway.7 C5b is the primary protein in the
formation of the terminal complex of complement, the membrane attack complex
(MAC), which is the focal point of the work in this report.
4
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Fig. 1 Activation Pathways of the Complement Cascade' All three pathways (lectin, classical and
alternative) involve sequential cleavage reactions resulting in the formation of a C3 convertase. The lectin
and classical pathway are initiated by molecular recognition of carbohydrates and antigen-antibody
complexes on the pathogen surface, respectively. This results in sequential cleavage reactions and the
formation of the C4bC2b C3 convertase. The alternative pathway is initiated by spontaneous activation and
attachment of C3b to the cell surface, initiating cleavage reactions that result in C3bBb C3 convertase
formation. Both converatses cleave C3 forming the activate C3b, which feeds the amplification loop and has
a variety of effector actions, including contributing to cleavage of C5 and activation of the terminal pathway.
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1.2 The terminal pathway
1.2.1 MAC formation
The MAC is a large (555->1000kDa) heteropolymeric protein complex formed by the
sequential addition of four complement proteins (C6, C7, C8 and multiple C9 molecules;
Fig. 2) to C5b. The presence of multiple copies of the MAC on a cell mediates one of the
principal functions of complement, the lysis of pathogenic cells. Thus the cleavage of C5
to C5b is the final enzymatic event in the complement pathway and subsequent steps
involve domain reorganizations rather than cleavage events. C5 is a two-chain plasma
protein (190 kDa), which is structurally and genetically related to C3 and C4, belonging
to the a2-macroglobulin (a2M) 'superfamily'.79 As with C3 and C4, C5 cleavage and
activation occurs at a specific single site on the a-chain, resulting in a structural
transition to the transiently activated C5b* form. Unlike C3 and C4, C5 does not contain
a thioester, and therefore upon activation C5b cannot directly bind to cell surfaces.
Instead, whilst reportedly8 remaining attached to C3b within a membrane-tethered C5
convertase complex, the conformational changes that accompany C5 cleavage expose,
transiently, a hydrophobic binding surface for C6.1 If binding does not occur, the C6
binding site exposed in C5b* irreversibly decays to C5b with a half-life of ~2 min at 37
°C.8 The C5b6 complex, on the other hand, has the capacity to disassociate from the C5
convertase, although it may remain attached.8 The C5bC6 complex ionically interacts
with the membrane surface9 prior to the attachment of C7 and formation of C5bC6C7.
Conformational changes promote release of any C5b-7 complex still attached to the
convertase. Simultaneously, the C7 is presumed to undergo a conformational change that
induces a hydrophilic to amphiphilic transition, allowing for membrane insertion by part
of the C7 molecule. Most evidence suggests that C7 primarily provides the
phospholipid-binding site,10 although C5b has also been proposed to contribute to
membrane association.11 Due to the short half-life of the fluid-phase C5b-7 membrane
binding site (10-100ms),12 and the tendency of the complex to form protein micelles at
6
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physiologic ionic strength and pH13 attachment of the complex is selectively restricted to
nearby membranes that will normally be those of the pathogen. Whilst this is a tight
association, the integrity of the lipid bilayer as monitored by XYZ is undisturbed.(REFs)
Perturbation of the membrane only occurs following addition of the C8 complex,
composed of C8(3 and its close homologue C8a that is disulfide linked to C8y, a protein
that shares no homology to the other MAC proteins. At this point the C5b-8 complex
becomes more deeply buried in the membrane and forms small perturbations of the
membrane, causing the cell to become slightly leaky. The mature pore is completed by
addition of multiple C9 molecules (as many as 18). These functional pores spanning the
cell membrane allow for the passage of ions and small molecules into the cell, ultimately
leading to osmotic lysis and cell death.
Fig. 2 MAC assembly: C5b*, possibly still bound to C5 convertase, binds C6 and C7 sequentially creating a
stable C5b-7 complex that associates with the membrane. Membrane binding allows for addition of C8,
which inserts into the membrane, followed by multiple additions of C9, which form a pore, completing
MAC assembly.
1.2.2 The MAC in physiology, health and disease
The physiological extent of MAC action, and the ability of MACs to lyse cells, depends





nucleated cells can endocytose the MAC and repair the damage unless multiple MACs
are present.12 Gram-negative bacteria, with their exposed outer membrane, and
enveloped viruses are generally susceptible to complement-mediated lysis. Gram-
positive bacteria on the other hand have a thicker peptidoglycan layer protecting the
membrane and making them less susceptible to MAC-mediated lysis.13 Lytic cell death
induced by the MAC is thought to be a multi-hit process akin to necrotic cell death; a
rapid increase in [Ca2+], followed by loss of mitochondrial membrane polarity, a total
loss of adenosine triphosphate (ATP), adenosine diphosphate (ADP) and adenosine
monophosphate (AMP) and finally cell death.14 Furthermore studies on various
Escherichia coli strains have indicated that the completion of MAC formation
(specifically the incorporation of C9) was necessary for lipopolysacharide (LPS) release
from the outer membrane. The release of these molecules stimulates activation of the
complement system, both through their binding to antibodies and via their direct
interaction with complement proteins.15 At sub-lytic levels, however, the MAC can
trigger diverse intracellular signalling responses, affecting pathways of the cell cycle,
proliferation, differentiation and rescue from cell apoptosis.16,17 These sub-lytic functions
are thought to contribute to focal tissue repair or cell proliferation at sites of complement
activation.17
As with complement activation, the terminal or membrane-attack pathway requires strict
regulatory control in order to prevent complement-mediated destruction of the host's
own tissue. This is achieved through inhibitors present in the fluid-phase and on
membranes. Solution-phase inhibition prevents the binding of C5b-7 to membranes and
has been attributed to several plasma proteins such as S-protein and clusterin.1 The
accumulation of soluble C5b-7 in haemolytic inhibition assays suggests that this is
achieved via the elusive C5b-7 membrane-binding site.18 Host cells also express
membrane proteins that protect them from MAC action such as the major MAC inhibitor
8
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CD59, that binds to C8, preventing C9 incorporation and expansion of the pore.1
Expression of CD59 in cancer-cells is one of the many routes of resistance of tumour
cells to complement-mediated lysis, which depend on both extracellular and intracellular
factors.19
Despite the myriad of proteins involved in complement regulation, inappropriate
complement activity can result in MAC-induced tissue damage in several pathologies.
Thus prospective drugs inhibiting the MAC could serve a variety of therapeutic uses. In
many inflammatory diseases, such as systemic lupus erythematosus, tissue damage has
been attributed to host membrane attack.20 Similarly, in ischemic incidences, such as
myocardial infarctions and strokes, the MAC has been associated with tissue necrosis.21
Furthermore it is suggested that MAC-induced release of growth factors is responsible
for several pathologies including choroidal angiogenesis, diabetic retinopathy and
nephropathy.22 Another potential use of MAC inhibition is to increase the success rate of
xenotransplantations and organ transplants by preventing rejection of the transplanted
organ.23 Chronic complement activation and MAC formation has been indicated to have
a significant role in many neuropathological conditions, including multiple sclerosis,
neurodegenerative disorders and various epilepsies.24 However complement activation
and membrane assembly of C5b-9, depending on the pathophysiological context, can
play a role in neuroprotection as well as injury.24 Therefore drugs directing the
complement system rather than inhibiting it may provide a better therapeutic rationale.
MAC primary immunodeficiency diseases (PIDs) are the converse of conditions linked
with aberrant MAC action. In these conditions about three-dozen mutations, including
deletions, single nucleotide polymorphisms and intron-exon boundary mutations lead to
complete deficiencies in C525, C626, C727, C8a- y28, C8(329 and C9.30 Subtotal deficiencies
have also been described for C6, C7, C8 and C9, with the protein present in plasma at
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approximately 1-5% of the normal concentration levels.3132 Terminal complement
deficiencies are associated with recurring meningococcal and gonococcal infections and
an increased prevalence of autoimmune diseases such as rheumatoid arthritis, systemic
lupus erythematosus, pyoderma gangrenosum and scleroderma. The effective treatment
of complement deficiencies would require replacing the missing component of the
cascade, either through direct infusion of the protein or through gene therapy. However,
neither of these options are currently very feasible and therefore treatment with
prophylactic antibiotics and fresh frozen plasma is presently used in emerging therapies
aimed at replacement of complement components.31
Currently, there are drugs targeting the complement system in the therapeutic pipeline,33'
34 however, there is only one complement-specific drug approved by the FDA, an
antibody targeting C5 and preventing its proteolytic activation for MAC nucleation and
release of its pro-inflammatory anaphylatoxin.35 Presently, the humanised monoclonal
antibody Eculizumab (Soliris, Alexion Pharmaceuticals, Cheshire, CT, USA) is marketed
as a therapy for paroxysmal nocturnal hemoglobinuria, described by an inability to
prevent MAC-mediated lysis of red cells that occurs due to lack on the cells of the GPI-
linked regulators CD59 and CD55.34 However, Eculizumab has potential for treatment of
numerous conditions and is currently in clinical trials for treatment of chronic
autoimmune indications, including rheumatoid arthritis, atypical haemolytic uremic
syndrome, membranous glomerulonephritis, dermatomyositis and lupus.34 Furthermore,
novel C5 antibodies are in development, one of which has shown efficacy in the
treatment of myasthenia gravis.36 Anti-C5 antibodies as well as anti-C8 antibodies
(which block C5b-9 formation without interfering with C5 cleavage) were found to
reduce tissue damage in rat hearts perfused with human serum highlighting a putative
future roll in the prevention of organ rejection in xenotransplantations.37 Recent results
regarding the successful prevention of organ rejection in a hamster-to-rat heart transplant
10
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model using anti-C6 antibodies suggest that the MAC is the only product of complement
that needs to be suppressed to permit induction of accommodation.23
With the future development of therapeutics specifically targeting the terminal pathway,
only terminal complement components will be affected, allowing the beneficial
immunoprotective and immunoregulatory effects mediated by 'upstream' complement
components to be maintained.33 Furthermore targeting early MAC formation would
prevent C5b-7 docking to the membrane in addition to the prevention of pore-formation.
1.2.3 Early MAC molecular interactions
1.2.3.1 MAC protein domain organization
As drugs directed towards the MAC provide an attractive therapeutic option, structural
and functional insights regarding MAC formation, and any putative pre-initiation
complexes, would be of invaluable aid to rational drug design. The MAC protein family;
C6, C7, C8 (C8a and C8(3) and C9, are structurally and genetically related proteins with
a similar modular structural organization (Fig. 3) and highly conserved sequences.38
These proteins share two main distinctive features; the large central domain of the
MAC/perforin superfamily (MACPF, ~300-370 aa) and the tandemly arranged, small,
disulfide-rich modules located at their N and C termini (~40-80 aa). All MAC proteins
have thrombospondin type 1 repeats (TSP) at the N terminus. Exceptionally, C6 has two
TSP domains at the N-terminus (TSPN and TSPN2). The TSP-1 domain, or domains, are
followed by a low-density lipoprotein receptor class-A domain (LDLRA) that precedes
the MACPF. An epidermal growth factor-like domain (EGF) comes after the MACPF
and is followed by another TSP (TSPC), which is found in all MAC components except
for the smallest protein, C9. Outwith the modular core that is shared by all members of
the MAC protein family, human C6 and C7 additionally have a pair of complement
control protein modules (CCPs) following EGF and TSPC that precede a pair of factor-I
11
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like modules (FIMs) - these four modules thus form the C terminus of both C6 and C7.
An interaction between C6/C7-FIMs-and the C-terminal domain of C5, C345C, is
considered to be of particular relevance to the early stages of MAC formation.
cs (tspM~sp> ldl|- macpf Ieg^tspaccW:cc"p-; hm*t fim
c7*jsp> LDl|- macpf egi-itsp-cccb ccpa fim / fim
c8al't!
c8p't5
c9'tsp ' ldl|-| macpf P
Fig. 3 Domain organization of the MAC protein family: Abbreviations: Thrombospondin type 1 (TSP),
low-density lipoprotein receptor class A (LA), MAC/perforin (MACPF), epidermal growth factor-like
(EGF), complement-control protein (CCP) and factor I module (FIM).
1.2.3.2 MAC pre-initiation complexes
The three paralogous proteins, C3, C4 and C5 share a similar C-terminal domain called
the C345C domain. The C345C domain of C5 appears to function as a binding site for
both, the C5 convertase39 and the pair of C-terminal Factor I-like modules (FIMs) of C6
and C7.40 In addition to the irreversible binding of C6 to C5b, and then C7 to C5b-6, in
MAC formation, it is important to note that solution-phase reversible binding occurs
between C6 or C7 and the uncleaved C5. This interaction site was also mapped, using
tryptic fragments, to the CCP and FIM module pairs of C6 or C7 and the C345C domain
of C5.41,42In blood plasma, such reversible, pre-activation interactions could clearly
increase local concentrations of C6 and C7 in the immediate vicinity of the newly
activated C5b* molecules (that remain capable of interacting with C6 for only a short
period of lime), thereby facilitating MAC formation. Although the physiological
significance of these reversible binding reactions has not been firmly established, it can
be reasoned that they reflect the arrangement of individual components within the stable,
fully formed MAC.43






1.2.3.3 Lytic MAC formation
Binding studies of truncated C6 proteins showed that the C6-FIMs are an aid to, but not
essential for, lytic activity, and (as mentioned above) are involved in binding to C5.42
Similarly the observations that (i) a C6 variant, devoid of FIMs, is responsible for
subtotal C6 deficiency but retains bactericidal activity44 and (ii) a common form of
mouse C6 lacks the FIMs, but is still active,45 also indicate that the C5-C345C:C6-FIMs
interaction is not essential to the stability of the fully assembled MAC. The role of C6-
CCPs has not been explored, although binding of truncated C6, devoid of FIMs, to C5 is
not fully eradicated unless the CCPs are also absent.41
On the other hand, both C5-C345C and C7-FIMs (as recombinantly produced fragments)
have been shown to inhibit MAC formation in vitro in surface plasmon resonance (SPR)
experiments and in vivo by inhibition of MAC-mediated hemolysis.46,47 Thus the
interaction between C7 FIMs and C5-C345C is pivotal for the formation of the MAC. As
C7-FIMs and C7 were found to bind C5 and C5-C345C with nearly identical affinities
(Table 1)(REF> it was suggested that the FIM-pair are primarily responsible for the
reversible binding of C7 to C5, with minor or negligible contributions from the C7-
CCPs.
Immobilised protein Protein in solution Kd (nM)
C5 C7 0.1
C7 C5 30
C5 C7 FIMs 70
C7 FIMs C5 40
C5-C345C C7 3
C7 C5-C345C 30
C5-C345C C7 FIMs 50
Table 1. List of molecular affinities for C6 and C7 interactions with C5 as derived by SPR.46,47
Interestingly, of 14 gene defects so far described as causing complete C7 deficiency (see
section 1.2.2), four are found in exons coding for the C7-CCPs and four in regions
coding for C7-FIMs. On the other hand, defects causing C6 deficiency are more evenly
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distributed across the C6 gene.32 This could reflect the biological significance of C7-
CCPs and C7-FIMs, and indicates that structural conservation in these modules is
necessary for authentic protein-function.27 Whilst the C7-FIMs appear to have a role in
directly binding C5-C345C before and during MAC assembly, the C7-CCPs are likely to
have an architectural or mechanical role in the putative domain rearrangements that
accompanyMAC formation: they could form part of a swinging molecular arm that
relocates the C7-FIMs to the C5-C345C during complex formation; subsequently they
might participate in secondary interactions with C5b that help to stabilize the self-
assembling complex as it accretes additional subunits.
A current model of initial steps in MAC formation40 (Fig. 4) suggests that the primary
C6-binding site is formed by conformational changes elicited by C5 activation exposing
a hydrophobic metastable binding region (in C5b*) that must react within minutes with
C6. The identification of these sites of interaction, however, is yet to be directly
explored. The C5b-6 interaction may be further facilitated by an interaction between C5-
C345C and C6-FIMs provided by a putative molecular arm. But if this exists at all, it
provides a relatively small amount of the overall binding energy and does not greatly
increase the stability of C5b-6; other C5/C5b-binding sites exist within C6. Subsequent
binding of C7 to C5b-6 results in replacement of any C6-FIMs:C5-C345C interaction by
the higher affinity C7-FIMs:C5-C345C interaction. The displaced C6-FIMs may then re-
associate with C6, associate itself with another region of C5, interact with C7, or remain
unattached. According to this model, the incorporation of C7 into the complex elicits a
conformational change that exposes a membrane-binding site, predominantly formed by
but not restricted to C7. This converts the soluble C5b6 complex into a membrane-
associating C5b-C7 complex. However, very little is known about the mechanism of
these steps or of further steps in the sequential assembly of the MAC on a membrane,
despite several decades of effort. It is a spontaneous process that must be directed by
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energetically favorable inter-protein domain-domain rearrangements and interactions
yielding nascent binding sites, and conformational rearrangements.
Fig. 4 Schematic of C5b-7 MAC model:25 First stage: C6 (pink) binds to a metastable binding site on C5b*
(cyan), with a possible stabilizing (non-essential) role played by the C6-FIMs:C5-C345C interaction. Second
stage: Upon C7 (red) binding any C6-FIMs bound to the C345C domain are displaced by the C7 FIMs due to
their higher affinity for C5-C345C. This release of the C-terminal molecular arm is coupled to major
conformational rearrangements of C7 that mirror those seen in MACPF-containing relatives such as perforin
and cholesterol-dependent cytolysins. This involves conversion of helical clusters into membrane-
penetrating beta-hairpins thus allowing C5b6 to target to cell surfaces.
1.3 MAC structure-function relationships
Structural studies on MAC protein modules, module-module interactions , full-length
MAC proteins and protein complexes are pivotal to elucidating the mechanisms involved
in the formation of the MAC. Probably because MAC proteins have a modular structure,
likely exhibiting flexibility at intermodular junctions, they have generally proved
refractory to X-ray crystallography analysis when studied as whole molecules.48
Pioneering negative-stain transmission electron microscopy studies revealed low-
resolution structural information on both individual MAC proteins and higher-order
MAC complexes (see section 1.3.6), these experiments afford valuable insights of how
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this technique is notoriously vulnerable to artifacts arising from sample preparation.
They should probably be repeated on the most up-to-date instruments and the data
coupled to recently obtained atomic-resolution structures of component domains.
In a very important recent development, two crystal structures of the C8a MACPF
domain - one alone,49 the other with the y-subunit50 attached - revealed a fold
reminiscent of the bacterial, pore-forming, cholesterol-dependent cytolysins. This
immediately suggests models of the later stages of MAC pore-formation (see section
1.3.2). First insights into the C5 structure were provided by NMR, which was used to
determine the structure of the C5-C345C domain. Subsequently, the atomic-resolution
structure of full-length C551 alone, and in a complex with a C5 convertase inhibtor
SSL752 have also been determined. While this is not a component of the MAC, C5 will
likely have many similarities with its activated counterpart C5b (see section 1.3.3), and
the C5 to C5b transition might emulate the major conformational changes observed in
the case of C3 conversion to C3b. NMR was also employed to provide the first high-
resolution structural information on C7, revealing the FIMs53 structure and highlighting
putative regions for interacting with C5-C345C54 (see section 1.3.4).
Thus, despite much efforts, there are currently no atomic-resolution structures of any
full-length MAC proteins, and there is no atomic-level structural information regarding
any of the protein-protein interactions and conformational changes involved. A
combination of atomic-resolution X-ray/NMR-derived structures and lower-resolution
approaches such as electron microscopy, small-angle X-ray scattering and chemical
cross-linking (see section 1.4) integrated with functional data, will be necessary for the





C5 X-ray Crystallography Nat. Immunol. (2008) 9:753-60
C8a-MACPF X-ray Crystallography Science (2007) 317:1552-4
C8a-MACPF-y X-ray Crystallography J.Mol.Biol (2008) 379:331-42
C7-FIMS NMR J.Biol.Chem (2009) 284:19637-49
C5-C345C NMR J. Biol. Chem. (2005) 280:10636 45
Table 2: Journal Articles of particular relevance to MAC proteins structure.
1.3.1 C8:a, p, y
Following the attachment of the C5b-7 complex to the target cell membrane, the
incorporation of C8 and perturbation of the membrane initiates C9 circular
polymerization. With respect to bacterial killing it has been useful conceptually
to consider the C5b-8 complex as a receptor to which C9 binds with a conformational
change allowing C9 to cross the outer membrane to reach the periplasm.55,56 C8 consists
of a disulfide-linked C8a,y heterodimer that is non-covalently associated with C8p. C8a
and C8(3 are paralogous with C6, C7 and C9 (see Fig. 3). C8a has sites for the
simultaneous binding of C8p, C8y and C9.57 C8p, on the other hand, reciprocally
contains a binding site for C8a and an additional site for C5b-7.58 Binding studies
indicate that C8a-MACPF provides the primary binding site for C8P, C8y and C9 and
while the small N- and C-terminal modules stabilize these interactions, they do not
confer specificity, i.e. interactions involving the small modules are an aid to but not
essential for protein-protein interactions.59"61 In the case of C8p, the TSPN module and
the MACPF cooperatively bind C8a-y62,63 and the LDLRA and the MACPF are essential
for specificity in binding C5b-7, whilst the C-terminal modules do not confer specificity
but stabilize the complex presumably through secondary interactions.62
Inclusion of C8y in the fully formed MAC enhances MAC mediated hemolysis. It is not
essential however, and does not result in deeper membrane penetration by C8, but
likely maintains C8 in a favourable conformation.66 It is unrelated to any complement
proteins and is a member of the lipocalin protein family. These share a core structure
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consisting of an eight-stranded anti-parallel (3-barrel that resembles a calyx or cup-like
structure. The cup contains a binding pocket used by lipocalin family members to bind
small hydrophobic ligands although, to date, the natural ligand/s for C8y have remained
elusive (Fig. 5). The experimentally-derived structures, solved with the C8a indel (C8y
binding sequence of C80O,64 in the C8a-MACPF-C8y co-crystal,65 represent the indel in
the upper portion of the ligand-binding pocket of C8y. This has led to two hypotheses
regarding the nature of the C8y binding pocket. One hypothesis is that the sole role of
the binding pocket is to initiate contact between C8a and C8y, prior to formation of the
disulfide link between them. The other possibility is that binding of the putative natural
ligand of C8y is regulated by binding to C8a. According to this model, C8 incorporation
into the MAC causes a conformational change that disrupts the C8oc indel:C8y
interaction, promoting either the binding or the release of a ligand.
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Fig. 5: C8y and C8a-indel binding. Superposition of the C8yindel structure (green) on C8y (white). The
indel is shown in blue. PDB ID: 1IW2 Adapted from paper.54
The global architecture of C8 has been probed in a pre-publication release of three-
dimensional negative-stain electron microscopy studies.68 Refinement of the C8
structure, determined by fitting the C8a-MACPF and C8y structures and a homology
model for C8(1-MACPF into the density map, converged on a reconstruction whose
resolution was 24 A. According to this low-resolution model (Fig. 6), the C8 quaternary
structure consists of a core domain where the two L-shaped MACPF domains (from C8a
and C8p) are sandwiched together and a globular protrusion contains the C8y subunit.
Because of the resolution of the reconstruction there were two possible placements of
C8(3, both plausible given the filling of density space with the modules and their
availability for known MAC interactions.57"63 The orientation in which the MACPFs have
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the same orientation in a cis configuration was favoured, as the trans configuration was
in disagreement with the solvent-accessibility of a predicted glycosylation site. This
orientation, would result in a closer proximity of the regions of C8a and C8p-
MACPF ,thought to be responsible for membrane binding (see next section). Clearly,
more detailed structural data are essential for a full molecular understanding of these
proteins.
Fig. 6: EM mesh showing relative locations of protein modules in C8 as determined by electron
microscopy:The crystal structure (PDB: 2RD7) of C8a-MACPF (blue ribbons) and C8y (yellow ribbons)
were unambiguously fit into the reconstruction (grey mesh). Two possible placements of C8(3-MACPF,
related by a 180° rotation, interchanging the arms of the "L," were scored. The one shown here corresponds
to the lower refinement residual and is rendered as an isosurface filtered to 25 A (green). The N and C
termini of C8a-MACPF are cyan spheres; the N and C termini of C8P-MACPF are brown spheres.
Quaternary structure schematics are shown for each view. Adapted from paper.66
1.3.2 MACPF and pore formation
Crystal structures of the C8 a-MACPF49 65 domain (Fig. 7) revealed a thin L-shaped
molecule with a fold similar to that of the bacterial cholesterol-dependent cytolysins
(CDCs) with a central kinked four-stranded p-sheet surrounded by a-helices formed by
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two structural segments, domains dl and d3. Absent from MAC proteins, but present in
CDCs, the d2 region forms a linker between dl and d3 and the d4 region responsible for
membrane association. Despite an undetectable relationship by sequence analysis, the
structural similarity of C8a-MACPF to the CDCs indicates that they share a common
mechanism of membrane insertion and pore formation. Insertions between pi-p2 and
P3-04 of the central (3-sheet of CDCs form two clusters of a-helices that correspond
with two clusters of a-helices (HC1 and HC2) that refold to form transmembrane P-
hairpins (TMH1 and TMH2), forming a P-barrel pore , upon membrane insertion.69
TMH1 is loosely sandwiched between the central P-sheet and the stalk-like p-sheet of
d2, while TMH2 is more solvent exposed. The CDC molecules oligomerise, forming a
pre-pore on the membrane surface, whereupon transition to the pore state involves a
series of conformational changes.70 Mutational and photo-labeling studies suggest that
edge-to-edge stacking of the P-sheet core68 and movements in d4 upon interaction with
the membrane69 lead to deformation of d2 and the loss of contacts with d3,72
accompanied by straightening of the bent P-sheet, freeing the helical bundles, allowing
d3 to move down on to the membrane surface, and the helical clusters to extend into
amphipathic P-hairpins for membrane insertion and subsequent formation of the p-barrel
pore.73 It has been proposed that a similar mechanism exists for pore formation in the
MAC whereby the sequential addition of MAC proteins is akin to CDC oligomerization.
74 In this model binding of C8 to C5b-7 arises from C8P-C6/C7 interactions. These
potentially include edge-to-edge stacking of MACPF p-sheet cores. These interactions
induce unfolding of the putative HC1 and HC2 in C8p, and subsequently those in C8a,
to form an extended series of aligned P-hairpins that penetrate the lipid bilayer. These







Fig. 7: Structure of C8a-MACPF-Y Vs CDCs. (A) Ribbon representation of aMACPF-y (PDB ID: 2RD7).
C8y is green, the core p-sheet is blue, the TMH segments are red and, the C8a-indel is purple and the other
structural regions are in gold. Regions corresponding to dl and d3 are labelled accordingly. (B) Top view of
C8a-MACPF-y. (C) Ribbon representation of intermedilysin (ILY) as a representative bacterial CDC (PDB
ID: 1S3R). Colours and labels are as in C8a-MACPF-y. In addition, domain 4 is in pale purple. Adapted
from paper.50
Electron micrographs of the MAC reveal a torus-like pore with ~100 A inner-diameter,
~160 A height, and ~200 A outer-diameter. Photo-labelling studies indicates that the
TSP and LDLRA modules are fully exposed on the exoplasmic side of the polymer, and
the EGF is partially embedded in the cylindrical wall of poly(C9) and a small rim at the
cytoplasmic base of the pore.7'An in silico representation of the pore, was built, based
on the C8a-MACPF structures but using more extended TMH sequences as are found in
C9-MACPF. These sequences were modelled as extended beta-hairpins (as in CDCs)
and eighteen copies of the molecule were placed in rings, with the [31 to [34 strands of d3
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placed on the inside (Fig. 8). The modelled pore structure is consistent with the EM
studies.49
Fig. 8: C9 pore model. Shown is a hypothetical model of the C9 pore derived from a ring of 18 monomers
of C8a-MACPF. (Left) Cross section of the pore, with MACPF domain forming the torus. (Right) Two
orientations of the torus in surface representation, with two individual monomers highlighted (in blue) for
convienience. Adapted from paper.49
While sequence homology (47%) indicates that the C9-MACPF domain is similarly
folded to that of C8a; and a hypothetical model of the C9 pore based upon the C8a-
MACPF structure is consistent with pore dimensions derived from electron microscopy
(see Fig. 8), it does not necessary follow that C9 uses the same structural elements to
enter a membrane as similarly folded CDC proteins. Disruption of TMH1 in C9 by
cleavage75 and by glycosylation,77 in conjunction with photo-labelling studies,78 indicate
that the transmembrane region proposed from the release of the C8a-MACPF structure
may be more important for formation of circular poly(C9) as opposed to forming the
membrane pore itself. A recent study that probes C9 topology by glycosylation mapping,
anti-peptide antibody binding, and disulfide modification suggests that there are two
modes of membrane interaction in C9. C5b-9 complexes containing less than four C9
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molecules are anchored to the membrane in a monotopic fashion utilizing the conserved
helices, while in fully formed poly(C9) other structural elements may refold and
becomes staves of a transmembrane barrel.75 This would reflect the ability of C9 to bind
lipids without MAC incorporation.78
The recent solving of the X-ray crystal structure of the murine perforin monomer, in
combination with a cryoEM reconstruction of the entire perforin pore, indicates that
there is remarkable flexibility in the mechanism of action of the conserved
MACPF/CDC fold. It also provides new insights into how related immune defence
molecules, such as complement proteins, assemble into pores.79 Perforin, like the MAC
proteins, contain a MACPF domain followed by an EGF-like domain. The EGF-like
domain is a short (~30 aa) disulfide-rich, flexible domain that, in the perforin protomer
structure,79 is in close association with the HC1 region and the C-terminal end of the
MACPF. The EGF-like domain and the C-terminus of the MACPF domain together
form a shelf upon which the bulk of the MACPF domain "sits". The HC1 region of the
MACPF domain is loosely held between this shelf and the central beta sheet core.
Earlier studies of C9 had indicated that its EGF-like domain similarly folds up against
the equivalent putative p-hairpin-forming region.81
Unexpectedly, the cryoEM evidence suggests that the perforin MACPF domain within
the pore-form is in the opposite orientation to the MACPF domains within pores formed
by the CDCs. It appears that the perforin molecule does not undergo a major collapse in
the pore-form as has been observed in, for example, pneumolysin pores.73 Instead it is
postulated that perforin, and by extension MAC proteins C8 and C9, achieve membrane
insertion without a major buckling of the molecule but via extended CHI and CH2
sequences. When these regions unfurl to form loops, they are therefore long enough to
permit passage over the shelf and to thereby reach and insert into the membrane, without
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buckling the molecule. B-factor analysis, in agreement with EM-based evidence,
indicates that the shelf region in perforin is flexible and is less ordered79 in comparison
to the domain 2 region of CDCs which similarly associates with the TMHs. An attractive
idea is that MACPF:EGF shelf interactions are lost upon inclusion of monomers into the
MAC promoting extension of TMHs, mirroring the deformation of d2 and subsequent
extension of TMHs implicated in CDC pore formation.
Comparison of the putative MACPF TMH regions in C8 and C9 with C6 and C7 (Fig. 9)
one can see that the CHI segment is shorter and largely hydrophilic suggesting that
membrane penetration as a P-hairpin structure would be limited. The disulphide loop
region in CH2 is shorter in C6 and C7, however, C7's sequence is still relatively
hydrophobic in nature, while the sequence in C6 has many charged residues. This is
consistent with C7 providing the principal membrane binding site, although
contributions from C5b and C6 have not been ruled out. The much shorter TMH regions
proposed for C7 could be possible membrane binding regions as deep penetration of the
membrane is not required, however other regions of the protein and the C5b-7 complex
may also be associated with the membrane. It is clear that any structural information
regarding the domain arrangements and re-arrangements necessary for the sequential
binding of MAC proteins will be the key to elucidating the underlying mechanisms of
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Fig. 9: Comparison of TMH sequences in MAC proteins. Secondary structure is shown as a cartoon
above the sequnces. PFO refers to perforin and ILY to the CDC intermedylsin. Sequences are aligned with
positively charged residues in red, negatively charged residues in green and neutral/hydrophobic residues in
yellow. Figure from paper.50
1.3.3 C5b
Full-length C5 is the 188-kDa precursor of the proteolytically activated 185-kDa C5b
molecule. Therefore, (in the absence of a C5b structure) insights into structure-function
relationships in C5b can be gained from the X-ray crystallography structure of its
inactive counterpart.51,52 Members of the a2M superfamily, such as C5, have been
suggested to share a common architecture prior to cleavage of the bait/anaphylotoxin
regions, with the development of features unique to each protein.82 As with all a2M
family members C5 has a stable core of eight macroglobulin domains (MG), MG 1-5
and part of MG 6 are formed by the (3 chain, followed by a linker (LNK) domain (Fig.
10A). The a-chain begins with the cleavable anaphylatoxin domain (ANA), followed by
the second portion of MG 6 and MG 7. A second insert incorporates the CUB domain
and the thioester-containing domain (TED), or the structurally equivalent C5d domain in
C5 (that does not contain an internal Cys-Gln thioester bond as in C3), with the C-
terminus ending in the final MG domain, MG8. C3, C4 and C5 additionally contain an
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anchor connecting MG8 to the C345C domain. Together these domains form two
superdomains: the MG core or superhelix formed by the a and P-chains, and the CUB-
TED/C5d-MG8 superdomain anchored to the MG core via MG8. While the MG core is
structurally stable in a right-handed superhelical formation, the CUB-TED/C5d-MG8













Fig. 10: C5 structure. (A) Ribbon representation. (B) C5 crystal structure (PDB ID:2A73) colour coded as
in A. (B) Potential binding sites of C5 for C3bBbC3b and C4bC2C3b: the convertase cleavage site Arg751-
Leu752 (red, spheres) sandwiched between the MG3 and MG8 domains; residues 1628-1633 of the flexibly
attached C345C domain (blue, spheres); the C5d domain (green, ribbon); A region at the bottom of the
molecule formed by MG1 (pink, ribbon) and MG5 (brown, ribbon) and residues of the linker (cyan,
spheres). Potential binding sites for C6 and C7: the C345C, C5d and MG1 and MG6 are marked with arrows
(C) A close up of the cavity on the opposite face of the convertase cleavage site created by MG2, MG6,









The structure of C551 and C5 complexed with a convertase inhibitor protein, SSL7 from
Staphylococcus aureus,52 in combination with binding studies85 and observations from
conservation analysis,51 have suggested up to five regions of C5 that might be involved
in binding to the C5 convertase enzymes, covering extensive regions of the molecule
(See Fig. 10B, C). Following enzymatic cleavage on a complement-activating cell
surface the C5b* molecule remains attached to the convertase enzyme, awaiting C6
binding. It has been proposed that the C5b* conformation will be akin to that of an
intermediate form of C3b (C3b*) where the CUB and TED domains are completely
detached from the (3-chain, prior to attachment to the target cell-surface.83 Recent
structural studies on C3u (also called C3(H20)), the spontaneously activated form of C3
from the alternative pathway, structurally and functionally akin to C3b, suggest that the
TED domain is significantly extended away from the MG1-MG8 domains in solution.85
An attractive option is that the conformational change induced by C5 activation propels
the C5d domain towards the C345C domain and away from the MG core for binding C6.
This is in agreement with proteolytic stripping86 and photolabelling87'89 experiments that
have indicated that the a-chain of C5b is proximal to the membrane facing the MAC
pore, while the (3-chain is further from the membrane, peripherally positioned within the
MAC. Binding regions within C5b for C6/C7, other than the C345C domain (see next
section), have not been identified. Other regions of C5 must be involved in the
interaction, however, as the flexibly attached C345C domain would not be sufficient to
discriminate against MAC formation with native C5.51
The extensive convertase binding sites on C5b and the sites for C6/C7 binding likely
share close proximity or some overlap. This would account for early MAC complex
release from the convertase upon binding of C6, and in particular of C7, to C5b. The
proposal that C5d51 is a putative C6 binding partner therefore seems highly plausible and
would parallel the importance of the C3b equivalent, i.e. the TED domain, in covalent
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attachment to target-cell membranes. Moreover, it has also been proposed that the
transient nature of C5b* is conferred by a further movement of the C5 CUB-C5d-MG8
superdomain to adopt a more C3b-like conformation (see section 1.4.2).51 This would
result in the C5d domain being closely associated with the MG core and therefore
shielded from interaction with C6. Similarly, occupation of the convertase binding site
by SSL7 is likely to reflect the binding of this bacterial protein to activated C5b, an
interaction that results in the inhibition of hemolysis and soluble MAC formation.84 Thus
according to this binding model, occupation of the SSL7-binding region within C5/C5b
(primarily provided by MG1 and MG5 with minor contributions from MG2 and MG6)
competes with functionally critical interactions between C5/C5b and C6/C7, by directly
or indirectly masking C6/C7-binding sites.
1.3.4 C7-FIMs:C5-C345C
Even the best characterized of the early MAC assembly interactions - that between C5-
C345C and the C7-FIMs - where three-dimensional structures are available for both
domains, is poorly understood. The structure of C5-C345C consists of an
oligosaccharide/oligonucleotide-binding fold that is similar to the fold of the netrin-like
module family. In this structure, two helices (a-subdomain) pack against a five-stranded
P-barrel (P-subdomain, strands A-E, Fig. 11). While mutagenesis studies87 indicate the
DE loop of the C5-C345C domain in convertase binding, no mutations have been
discovered that affect its interaction with FIMs. Unpublished (Dr Ron Ogata, Torrey
Pines Institute, Florida) mutagenesis studies have excluded AB, BC, and CD loops, and
the Cys-Ser-Ser-Cys bulge in the loop connecting the sub-domains, leaving the
unexplored a-subdomain to be provisionally identified as a likely candidate.53
Comparisons made with C3 and C4, i.e. structural homologues with no affinity for C6 or
C7-FIMs, highlighted characteristics of the a-subdomain that are unique to C5; this
further implicates this subdomain in C6/C7-FIMs binding. The highlighted residues
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consist of a pair of exposed hydrophobic sidechains, Phe1654 and Leu1655, within a-
helix-2, adjacent to a strikingly electronegative patch that extends over both helices. C7-
FIM1 and C6-FIM2 were implicated as the domains that dominate FIMs binding to C5b
in the context of a C5bC6C7 complex. This is due to the high pis of C7-FIM1 (9.5) and
C6-FIM2 (9.2) indicating a compatibility with the electronegative patch of C5-C345Cs
a-subdomain.90 Moreover, an absence of detectible binding of lone C7-FIM2 with C5-
C345C53may reflect the importance of C7-FIM1 in the interaction, but does not exclude










Fig. 11: C5-C345C structure. (A) Two orthogonal views of the structure of C5-C345C in a ribbon
representation. Strands and loops of the P-subdomain and helices of the a-subdomain are annotated. Color
scheme progresses sequentially from blue (N-terminus) to red (C-terminus). (B) Electrostatic surface




The NMR solution structure of C7-FIMs53 reveals two type-1 follistatin domains (FD)
that have an intimate interface in a homodimer-like, pseudosymmetrical arrangement
(Fig. 12). Each FIM is further subdivided into two subdomains. An N-terminal FOLN
subdomain, which is a disulphide bonded section that includes a P-hairpin, connected
via a 3io helix to a C-terminal KAZAL domain, which consists of an a-helix packed
against a triple stranded antiparallel P-sheet. The N-terminal domains constitute the
'body' of the homodimer with a 60° angle between the 'wings' formed by the KAZAL
domains. While the linker region Ala767-Ala772 between the domains appears to be
flexible, the two domains are immobile with respect to one another on an NMR time-
scale (ps-ns and ms timescales). The intimate interface between the modules is supported
by both electrostatic and hydrophobic interactions (Fig. 12), including module-bridging
hydrogen bonds and three salt bridges (Arg704-Glu800, Lys716-Glu800, and Asp726-Arg824),
as well as aromatic-to-cysteine and aromatic-to-aromatic interactions. The C7-FIMs
structure highlights a region in FIM1, worthy of mutagenesis studies; on the FIM1 face,
opposite to that of the interface with FIM2, an electropositive patch is interrupted by
hydrophobic residues and could provide a complementary binding surface for the
previously mentioned electronegative and hydrophobic patches on C5-C345C (Fig. 12).
The FIMs lie at the C terminus of C7, which is consistent with them having at least one
solvent-exposed face. Due to the length of the linker between the preceding CCP domain
of C7 and FIMs, it is neither possible to predict which face of the FIMs this is likely to















Fig. 12: C7-FIMs structure. (A) Ribbon representation of C7-FIMs NMR structure on the left (PDB ID:
2WCY) with putative with FIM1 and FIM2 overlayed on the right. (B) Surface electrostatic representations.
(C) Cartoon showing the secondary structure and sequence of C7FIM1 and C7FIM2. Adapted from paper.53
A second binding mode is postulated based on comparison of C7-FIMS with other
proteins that contain multiple FDs. The close association of the two C7-FIM modules is
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in marked contrast with the structures of other FD-containing structures all of which
have been solved in complex with their respective ligands.91'92 These adopt an open,
elongated arrangement, displaying large tilt angles between FDs and a lack of symmetry.
It has been proposed that FD pairs undergo a closed to-open transition upon ligand
binding. Hence, by extension, it is conceivable that the C7-FIMs (and C6-FIMs) open up
during MAC self-assembly, with the enthalpic cost of disruption of the intermodular
interface compensated for by other protein-protein interactions within the complex.53
Although it is currently postulated that C7/C6-FIMs are in the closed conformation in
protein monomers, it is also possible that FIMs-MACPF/module interactions within the
protein itself maintain the FIM pair in an open configuration.
1.3.5 CCPs
CCP modules are found extensively throughout the proteins of the complement system,
and particularly within the RCA family. The common splice variants of the RCA family
each contain between 4 and 30 tandemly arranged CCP modules. CCP modules are
approximately 60 amino acid residues in length and are characterised by a consensus
sequence that includes four invariant cysteines (disulfide linked Cys-I-Cys-III and Cys-
II-Cys-IV), an almost invariant tryptophan and highly conserved prolines, glycines and
hydrophobic residues.94 While there are no experimentally derived structures for the two
CCP modules of C6 or of C7, there are now over 40 structures of CCP modules, derived
by NMR or X-ray crystallography, within the Protein DataBase (PDB).93 These
structures revealed a characteristic fold; a compact hydrophobic core wrapped in a p-
sheet framework of up to eight P-strands, held together by the two strictly conserved
disulphide bridges; there is generally a so-called "hypervariable loop" between strands
B and C that is a region of poor sequence conservation and varied length, and often a P-
bulge (again of variable composition) between strands E and F.91 Despite sharing a
broadly similar structure, CCP modules within complement proteins are functionally
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non-equivalent, and indeed carry out a wide range of different functions. These include
protein-protein recognition, protein-carbohydrate recognition, and spacing or positioning
roles. This presumably reflects the versatility of a structural scaffold that has been
adapted by evolution to suit a variety of purposes. The abundance of CCP structures has
prompted homology-based, large-scale modeling of the CCP module family,94 an
exercise that highlighted the importance of the very diverse surface electrostatic surface
properties displayed by even closely related CCP modules in their various functions.
The sequences of the C7-CCPs and C6-CCPs are fairly typical of CCP modules
permitting the production of homology-based models that have been deposited in the
CCP module database94 (Fig. 13, models available for C7-CCP1, C7-CCP2 and C6-
CCP1). While the modeled modules display the characteristic CCP module structure,
analysis of surface electrostatics indicates that the surface of C7-CCP1 is highly
electronegative. On the other hand, the C7-CCP2 model has an extensive electropositive
surface patch that dominates one face together with its N-terminal end; its C-terminal
end features an electronegative surface region. C6-CCP1 on the other hand is largely
neutral but has a prevalence of positive charge and negative charge at its N and C-
terminus respectively. The differences between the C7-CCP modules are reflected in
their respective pi's of 4.8 and 7.9.53A similar difference is observed for C6-CCPs with
respective pi's of 4.4 and 7.6.
In light of the model structures for both C7-CCP modules, an electrostatically favourable
close association between these CCP modules is concievable, however, with a four-
residue long linker between the modules bending will be resisted (see below) and any
such association is likely to be sterically restricted. Moreover, the negative patch at the
C-terminal end of C7-CCP2 could form an electrostatic interaction with the positive
patch on FIM1.53 The potential for extensive interactions between the CCPs within C7
and the FIMs raises the possibility that the C7 FIMs (and indeed the C7-CCPs) could in
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fact adopt a different - presumably more open - orientation (with respect to one another)
when they are in the context of the longer protein. These putative surface charges could
also play a direct role in intra/inter-protein interactions. Or they may have indirect but
vital architectural roles in putative module rearrangements that accompany formation of
the preactivation complex(es) of C5 with C6 and/or C7, or in formation of the successive
post-activation complexes.
A
Fig. 13: CCP model structures of the MAC. (A) Model structure of C7-CCP1 showing secondary structure
in standard view (left) and surface electrostatic properties displayed in standard view (middle) and with 180°
view of the "back" of the module. (B) The same views as in A but for C7-CCP2. (C) The same views as in A




The relatively short linking sequence of four residues (Q627KIA630) between CCP1 and
CCP2 suggests a degree of intermodular rigidity on the grounds that the hydrophobic
portion of the linker will likely be buried; this would reduce the length of the potentially
flexible part of the linker. Similarly, surface-exposed hydrophobic residues at the C-
terminal end of CCP1 and the N-terminal end of CCP2 suggest that the two domains
could be intimately associated with a fixed intermodular angle. On the other hand, values
of intermodular tilt and twist between CCPs appear to vary in a way that can not easily
be predicted from the sequence or even from knowledge of the structures of the
contributing modules.93
Further downstream, there is 13-aa linking sequence between the final cysteine residue
of CCP2 and first cysteine of FIM1, i.e. V689QKENPLTQAVPK701; the length and
predominantly polar nature of these residues hints at a high degree of solvent
accessibility and flexibility. However, these residues could also be sandwiched between
CCP2 and FIM1, possibly shielding surface-exposed hydrophobic residues of FIMs and
thereby contributing to a more opened up conformation of the two C-terminal FIMs (see
previous section).
Thus an experimentally derived three-dimensional structure of the C-terminus of C7,
consisting of both CCPs and FIMs, is needed to understand how these modules fit and
work together. Structural insights may shed light on the putative swinging arms of C6
and C7 and their potential role as safety catches on their MACPF domains, ensuring they
do not become activated inappropriately. The current work thus set out to test various
predictions of this hypothesis.
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1.3.6 C6, C7 and early MAC formation
Although the structure of the C7-FIM pair has been solved, little is known so far
regarding the overall architecture of the protein monomers and even less is understood
about the C5b-6 and C5b-7 complexes, with most knowledge arising from early
electron-micrograph studies.95'96 For both C6 and C7 molecules, two structural regions
were identified: a larger globular domain and smaller filamentous appendage (Fig. 14).
Taking molecular dimensions of C8a-MACPF into account (each lobe is 60-70A long)
the globular regions are likely dominated by the MACPF (Fig. 14), with the appendage
accredited to a molecular arm containing the C-terminal modules. In the EM images, the
molecular arm of C6 folds back on itself, making contact with the globular region.
Whilst for C7 the molecular arm was fully extended, away from the globular region.
Although these conformations may hold true for the molecules in a physiological setting,
the negative staining methods used dehydrate the molecule and can result in exposure of
hydrophobic regions and molecular distortions. The extremity of the extension of C7's
molecular arm may be a bi-product of the staining method used. However, the C7 EM
images show a highly pliant structure and it was suggested that its molecular arm unfurls
in binding C5b-6; with the EM images representative of the arm-open conformation.
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Fig. 14: EM Images. (A) Representative image of C6 (B) Representative EM image of C7. Adapted from
paper.96
While the perforin structure has implicated a close association between the EGF and the
helical clusters within the MACPF,77 the relative location and flexibility of the other
modules with respect to the MACPF domain (and one another) requires further
investigation. Whether these modules harbour binding sites that confer specificity for
other MAC proteins (as in C8(3), or if they only stabilise the primary MACPF
interactions, is yet to be fully explored. A potential role for C6-TSPC in binding C5 has
been suggested.97 Moreover, the mechanisms by which MAC proteins reveal or
cooperatively create their protein binding sites are currently unknown. The predominant
theory is the'modular fusion hypothesis.96 The hypothesis is that the modules of each
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subunit bind to corresponding modules of the other MAC subunits sequentially,
exhibiting cooperativity. As a result, the inter-subunit interactions cause the proteins to
unfold, exposing binding sites for protein adjuncts and/or hydrophobic sidechains for
membrane attachment. The observation that MAC complexes aggregate in the absence
of membranes - and in the case of C5b-7, form rosettes - supports the exposure of
hydrophobic side-chains.95 However, no studies have provided evidence as to the
mechanism by which these side-chains are exposed.
The CDC/Perforin mechanisms of oligomerisation and pore formation used to illustrate
the later stages of MAC formation, in combination with the molecular fusion hypothesis,
can be further extrapolated to the formation of the early MAC (Fig. 15). Following
activation of C5 and movement of the alpha-chain exposing a metastable binding site for
C6, C6 binds facilitated by the C5-C345C domain were possibly provided by a
molecular arm. The C7-FIMs displaces the C6-FIMs:C5-C345C interaction resulting in a
fixed positioning of the C7 molecular arm, which may be accompanied by edge to edge
stacking between C6 and C7 MACPF domains as in CDCs/Perforin, possibly in addition
to modular interactions. Nevertheless, formation of the C5b-7 complex results in an




Fig. 15: MAC formation model: C5/C5b is shown in teal, C6 in magenta, C7 in red, C8a-y in pruple, C8(3
in blue and C9 in grey. Domains of C5 (structure known) are labelled as previously described. Briefly, the
image shows the activation of C5 to the metastable C5b* and binds C6 including a C5-C345C:C6-FIMs
interaction. This is later displaced by C7-FIMs, by C7 incorporation into the complex and subsequent
membrane binding. This allows for the addition of C8 and multiple C9 molecules to form the MAC pore.
1.4. Chemical cross-linking
1.4.1 Analysis of 3D structures and protein-protein interactions
The use of chemical cross-linkers in combination with mass spectrometry (XLMS) to
infer structural information about protein conformations and protein-protein interactions
was introduced at the end of the 1990s.90"105 Cross-linking reagents can act as molecular
rulers for the estimation of spatial relationships in protein structure-function studies.
There are two principal applications of chemical cross-linking of proteins. It can be used
in 3D structural analysis to estimate the spatial relationships within a protein by
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evaluation of intra-molecular cross-links. This can give an indication of the proximity of
domains to one another, which can be applied to conformational changes. Alternatively,
it can be applied to protein-protein interaction analysis to estimate the spatial
relationship between two (or more) binding partners by evaluation of inter-molecular
cross-links.99,101,105 This can identify potential binding sites and highlight domains or
protein regions worthy of further analysis. Furthermore cross-linking can provide spatial
information on flexible regions of proteins or transient conformations, which are
commonly absent from X-ray crystallography structures, and allows structural analysis
of proteins in solution of higher-order multiple-protein complexes that are not amenable
to NMR studies.
A typical cross linking study is a multistep process: the cross linking reaction, the
optional purification of a single cross-linked species (monomer, dimer etc.), the cleavage
of the cross-linked proteins into peptides by enzymatic digestion, the optional separation
of the peptides, and the mass spectrometry based detection, analysis, and identification
of the cross-linked peptides. In recently developed innovative strategies, cross-linking
reactions are conducted in living cells by directly incorporating reactive groups into the
protein, using the cell's own biosynthetic machinery.100
Since proof of principle experiments conducted over a decade a go,98,99 the application
of XLMS has expanded through developments in methodology, instrumentation, and
bioinformatics.100"105 The Rappsilber group developed a method" that was used to
analyse by cross-linking the largest complex to date by extending the 13-subunit, 530-
kDa RNA polymerase II (Pol II) X-ray structure to a 15-subunit, 670-kDa complex of
Pol II with the initiation factor TFIIF.106 Following cross-linking, proteolysis, and LC-
MS/MS of the resultant peptides, an algorithm automatically finds and validates cross-
linked peptides using peptide MS/MS fragmentation spectra. The use of a 1:1 mixture of
stable isotope-labelled and non-labelled cross-linkers results in the appearance of
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doublets in the mass spectra of cross-linked peptides with 1:1 signal ratio, separated by a
mass corresponding to the difference between the heavy and light isomers. This reduces
the false positive rates of the process. A combination of a standard database search tool
(Mascot)107 and a purpose built cross-link database (XDB) containing all possible
combinations of cross-linked peptides is used to generate the list of cross-linked
peptides. Each cross-link identified is assigned a score. The confidence score is
calculated by database searches conducted under conditions that yield only false results
by searching an XBD with reversed sequences and searching the XBD using a false
mass for the cross-linker. The development of this methodology has expanded the
complexity of the protein complexes studied by cross-linking.
The Poll II complex X-ray structure and a model of its binding partner, the initiation
factor TFIIF, were validated by cross-linking and analysis of the Poll ITTFIIF complex
identified the sites of interaction between the proteins.106 Using the same technique to
understand the global fold of protein monomers in the absence of atomic resolution
structures of the full-length protein thus seems achievable, given the provision of
structures of its individual domains.108 109 Ultimately, for a single protein, distance
constraints derived from cross-linking sites could lead to structure elucidation. However,
with the sparsity of the identifiable cross-links produced for a single protein with current
approaches, and the lack of software programs that calculate structure models solely
from cross-linking restraints, this degree of structure elucidation is currently unattainable
103
Cross-linking, in conjunction with mass spectrometry is therefore a very promising tool
to yield structural information on proteins and protein complexes that are difficult to
address using standard structural methods. Given that MAC formation is driven by
conformational changes and domain-domain interactions and that protein complexity
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increases with the sequential addition of each monomer, the MAC would provide a good
model system for cross-linking/MS studies. Cross-linking could provide valuable
structural information regarding the MAC, as the large and predicted flexible nature of
the MAC proteins makes standard structural analysis by X-ray crystallography and NMR
highly challenging. However, the general application of cross-linking to produce a model
of a protein in the absence of atomic structures is yet to be achieved and strategies and
techniques are currently in development. Therefore atomic resolution structures are
required to develop and confirm reliable techniques and the resultant data.
1.4.2 C3/C3b
C3ref has the same domain arrangements as the C5 structure51'52 As with the transition of
C5 to C5b, conformational changes induced by proteolytic cleavage allow for binding to
new partners and additionally expose the reactive thioester in the TED domain for
binding to target surfaces. Crystal structures of both C3 and C3b are available,412"414
which makes the transition from C3 to C3b an ideal candidate to test using the
Rappsilber group's XLMS method. Moreover, there has been much controversy
regarding the C3b structure and the orientation of its domains (Fig. 15). Whilst there is a
general consensus that the MG core is a structurally stable platform, relativity unchanged
between C3 and C3b, the location of the TED and CUB domains has been the subject of
dispute. In C3 the TED domain is closely associated with the CUB and MG8, which
shields the thioester. In two C3b structures (Gros et al, PDB: 2I07;111Wiesmann et al,
PDB:2ICF)112 the activated thioester is fully exposed for covalent attachment to target
surfaces and is more than 85 A away from the buried site in native C3, with the TED
contacting MG1. This has come about through a reorientation of the CUB domain that
has retained all of its secondary structure. A third, nominally higher resolution, C3b
structure (Murthy et al, PDB:2HRO)113 reveals a marked loss of secondary structure in
the critical CUB domain and a different position and orientation of the TED . It
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subsequently emerged that closer scrutiny of the PDB entry for 2HR0 reveals physically
implausible features that are claimed to undermine the validity of the deviant C3b
mode.113 Only when the experimental diffraction images are made available can the
model be either verified or falsified.114 Nonethess, the arguments against 2HR0 and the
underlying diffraction data were rebutted,115 functional implications of the structure have
been supported and paper continues to receive citation. The controversy regarding the
structure of C3b and the orientation of its domains, could be resolved with the aid of
XLMS, as this would reveal the true location of the TED in solution and could also shed
light on the compactness of the CUB domain. Moreover, if the cross-linking technique
can be successfully applied to C3 and C3b, it implies that a similar approach will yield
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Fig. 16: C3 structure and structural transitions. (A) A schematic representation of C3 domains,
sequence and organization/8' (B) Cartoon representation of crystal structures of native C3 and the two
proposed structures for C3b. Diagrams were generated in Pymol.34 The thioester of the TED domain
is shown space-filled in red. Abbreviations and colour code: MG, macroglobulin domain (1-6 grey, 7
cyan, 8 yellow); LNK, linker domain (grey); ANA, anaphylatoxin domain (red); CUB domain (blue);
anchor (pale yellow); C345C domain (burnt red). Adapted from paper.110
1.4.4 C7 Architecture
The application of XLMS to an isolated MAC protein, for which the structures of
individual domains have been established, should help to establish the arrangement of
domains and thus reveal the architecture of the protein. In the case of the MAC we
envisage a mechanism driven by domain re-arrangements (as is the case in the C3 to C3
46
CHAPTER 1: INTRODUCTION
transition) and thus structural information at this level could be highly valuable. While
features of the domain arrangements in C5b (from the C5, C3 and C3b structures), in C8
(from the C8 EM reconstruction) and in C9 and poly-C9 (EM and photo-labelling) have
emerged, the domain arrangements within C6 and C7 remain unexplored.
In the specific case of C7, XLMS might give an indication as to the locations of the N-
terminal and C-terminal modules with respect to the central MACPF. In particular,
XLMS might shed light on how these presumably autoregulatory modules are organized
relative to the helical clusters (HCs) of the MACPF, which are hypothesized to undergo
conformational rearrangements forming transmembrane hairpins. If HC1 and HC2 are
predominantly accessible in C7 then the parallels with perforin and the CDCs are
obvious and extrapolations with regard to mechanisms of activation are valid. If on the
other hand the HCs of the MACPF are shielded by the other modules in C7, this would
support our "safety catch" hypothesis (in which the C-terminal modules maintain C7 in
an inactive form and they must be released in order for C7 to undergo its activating
conformational transition). Moreover, cross-linking studies could potentially reveal the
conformation of the FIMs - are they open or closed - in addition to their location in the
context of the whole molecule.
The XLMS technique may capture flexible molecule in a conformation or range of
conformations adopted within the time-scale of the cross-linking reactions. Therefore it
is valuable to combine these data with other data, such as NMR-based protein dynamics,
studies to build up an understanding of the flexibility between modules, and particularly
the nature of the C-terminal modules and their relation to the MACPF. Taken together
these findings may confirm or refute a CDC/Perforin membrane-binding mode and
current hypotheses regarding the swinging arm of C7. They should expand the structural
understanding of the mechanisms involved in MAC assembly. They would also represent
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an early example of the use of XLMS to define the tertiary structure of a protein for
which no high-resolution structure is available.
1.5 Project Aims
The aim of this PhD project is to employ various biophysical techniques including
NMR, and mass spectrometry in conjunction with cross-linking to study the structure
and function of the terminal components of the complement pathway. Applying this
highly structural approach to C7 of the MAC will provide a more detailed account of the
early steps in MAC assembly.
In order to study the domains within the C5b-7 proteins—particularly C5-C345C and the
CCPs and FIMs of C6 and C7, recombinant expression from a system capable of
yielding at least milligram amounts of highly purified, soluble, fully folded protein is
required for further characterization and binding studies. Protein fragment studied
include C6-CCPs, C7-CCPs, C7-CCP2-FIM1-FIM2 (CFF), C7-CCP1-CCP2-FIM1
(CFF), C7-CCP2-FIMS (CF), C7-FIMs, C5-C345C and C3-C345C.
With the completion of the C7-FIMs solution structure, a NMR derived structure of the
pair of CCP modules preceding the FIMs will add significantly to the limited
information on the MAC proteins. Moreover NMR studies of a CFF module triplet will
be used to link the structures of the FIMs and CCPs, giving a more complete picture of
the C7 C-terminal arm. Combining insights from NMR studies with intra-molecular
cross-linking data will provide information regarding the domain arrangements within




2.1 DNA manipulation, recloning and expression vectors
2.1.1 Estimation of DNA concentrations
A UV spectrometer (Eppendorf BioSpectrometer, Eppendorf, Hamburg, Germany) was
used to estimate DNA concentration as nucleic acids have an absorption maximum at
260 nm. The degree of sample purity was evaluated by calculating the A[26o]/A[280] ratio to
assess protein contamination and the A[260]/A[230] ratios to assess organic compounds.
Values of 1.8 for A(260]/A[280] and 2.0-2.2 A[26o]/A[230] signify pure DNA samples.
2.1.2 Agarose gel electrophoresis
l%w/v agarose gels were made by heating agarose in Tris-acetate-EDTA (TAE) until
dissolved, followed by addition of ethidium bromide (50 ng/ml). The solution was then
poured into molds to set. DNA samples were combined with 6x loading buffer
(bromophenol blue (0.25%w/v), xylene xyanol, sucrose (40%v/v)) and loaded onto the
gel. The gel was run at constant voltage (200 V) for approximately 30 minutes.
2.1.3 pET15b Escherichia coli expression vector
The pET15b vector (Invitrogen, for vector map see Appendix A), is a 5.7 kb bacterial
expression vector which possesses a 6xHis-tag at the N-terminus, a subsequent thrombin
cleavage site for removal of the tag and multiple cloning sites for target gene insertion.
Ampicillin resistance is conferred via expression of the gene from the TEM 1 promoter,
while the strong bacteriophage T7 promoter is used for high-level expression of the gene
of interest via T7 polymerase provided by the host cell. 5' of the promoter is a lac
operator for selective expression in the presence of IPTG to prevent repression by the
lac repressor encoded by the lacl gene.
2.1.4 Transformation of E.coli
2.1.4.1 Preparation of electrocompetent E.coli
A vial ofOrigami™ B(DE3)pLysS Competent Cells (expression strain, Invitrogen) or
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One Shot®TOP 10 cells (storage, Invitrogen) were thawed on ice for inoculation of a 5
ml yeast-tryptone (YT, Appendix B) starter culture (overnight/37°C/200 rpm). This was
used to inoculate a larger 500 ml YT culture (-2 hours/ 37°C/200 rpm) until an OD6oo
value of 0.3-0.4 was reached. All subsequent steps were performed on ice and using ice-
cold media that was either autoclaved or sterile filtered (0.2 pm MWCO) to maintain
cell health and prevent contamination. The cells were washed with 500 ml ice-cold
autoclaved FLO and twice with 50 ml 10%v/v glycerol by resuspension following
centrifugation (10 min/1000 xg/4°C). Lastly, the cells were resuspended in 1 ml ofGYT
medium (Appendix B) and diluted if necessary to achieve the desired concentration of
2.5 x 10" cells/ml (lOOx dilution OD6oo= -3.75). 40 pi aliquots (~lxl010 cells) were flash
frozen and stored at -80°C.
2.1.4.2 Plasmid DNA extraction
E.coli colonies containing the pET15b constructs were grown in 5-10 ml ofYT
(overnight/3 7°C/200 rpm) containing carbenicillin (50 pg/ml) for selection of the vector.
Carbenicillin was substituted for ampicillin due to its longer half-life. The plasmid DNA
was extracted using a QIAGEN® PlasmidMini Prep kit as specified by the manufacturer,
yielding 2-10 pg of DNA per construct.
2.1.4.3 E.coli transormation bv electroporation
10-50 ng of purified pETl 5b construct DNA was combined with 40 pi of freshly thawed
electrocompetent E.coli cells for transformation by electroporation. The mixture was
transferred to an electroporation cuvette and incubated on ice for 5 minutes. The cells
were then pulsed with a charging voltage of 2500 V, capacitance 25 pF and resistance
200 mO, 1 ml of room temperature Super Optimal Broth (SOB) with subsidiary glucose
(SOC) was added immediately and then transferred to a 15 ml FalconIM tube for shaking
incubation (lhr/37°C/200 rpm) to allow expression of the antibiotic resistance gene. 10-
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250 pi aliquots were spread on YT agar plates with the carbenicillin (50 pg/ml) for
vector selection and incubated at 37°C overnight. For Origami™ B cells kanamycin( 15
pg/ml), tetracycline (12.5 pg/ml) and chloramphenicol (34 pg/ml) were additionaly
included for selection of the gor mutation trxB mutation and pLysS plasmid respectively
(See 2.2.5.1 Overview ofOrigami™ B pLysS host strain)
2.1.5 Redone into eukaryotic expression vectors
2.1.5.1 pGAPZaB and pPICZaB Pichia pastoris expression vectors
pGAPZaB and pPICZaB vectors (Invitrogen, see Appendix A) are 2.9 kb and 3.6 kb
respectively and are used for recombinant protein expression by P.pastoris. These
vectors are used if the protein is normally secreted, glycosylated or directed to
intracellular organelles. This is ideal for all target proteins due to the presence of
disulphide bonds which result in the packaging of protein into insoluble inclusion bodies
when expressed in E.coli. While pGAPZaB is designed for high-level, constitutive
expression via the glyceraldehyde-3-phosphate dehydrogenase (GAP) promoter, the
pPICZaB vector is designed for tightly regulated, methanol-inducible expression for the
gene of interest via the AOX I promoter. While higher yields are expected for expression
from pGAPZaB, the inducible expression provided by pPICZaB is ideal for NMR
labelling strategies. Both vectors also contain the native S.cerevisiae a-factor secretion
signal that constitutes efficient secretion ofmost proteins by P.pastoris.116 The vectors
also contain a TEF I and EM7 promoters to drive expression of the Sh ble gene in
P.pastoris and E.coli respectively. Furthermore the vectors contain a pUC origin which
permits replication and maintenance of the plasmid in E.coli. Lastly, they contain SacI,
Pmel and BstXI restriction sites for vector linearization for efficient integration into the
P. pastoris genome.
2.1.5.2 Cloning strategy
To reclone the C6 CCP, C7 CCP, C7 FlMs, C7 FIM(l), C7 FIM(2), C7 CFF, C7 CCF, C7
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CF, C5 C345C and C3 C345C target genes from the pET15b vector, a standard strategy
was employed (Fig. 17) whereby the PCR amplified target gene is sub-cloned into the
high copy TOPO vector to obtain high yields of the target gene for insertion into
pGAPZaB. A shorter cloning strategy was attempted for recloning into pPlCZaB, for
direct ligation of the target-gene PCR products without TOPO subcloning (Fig. 17).
pET vector/cDNA
Recombinant protein
Fig. 17: Cloning Strategy Flowchart. The recloning stategy for pGAPzaB clones is depicted. Technical
steps are shown in yellow and progress landmarks shown in hlue. The red arrow highlights the steps
omitted in the pPICzotB cloning strategy.
2.1.5.3 Amplification of target genes
The polymerase chain reaction (PCR) was used to amplify the C6-CCP, C7-CCP, C7-
FIMs, C7-F1M( 1), C7-FIM(2), C7-CFF, C7-CCF, C7-CF, C5-C345C and C3-C345C
coding sequences from the pET15b vector using complementary primers (Table. 3). 1 pi
of forward and reverse primers (10 pM) were mixed with 200-250 ng of template DNA,
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1 ul triphosphates (dNTPS, 2.5 mM, Invitrogen) and 0.75 pi ofDMSO was used to
prevent primer dimerisation. 1 U of Pfu polymerase (Fermentas®) was used for
amplification for insertion into pGAP to produce blunt-end PCR products for TOPO®-
subcloning; while 1U of Taq polymerase (Invitrogen) was used for amplification for
insertion into pPICZaB as Taq has independent terminal transferase activity which
results in the addition of 1> adenosine nucleotides at the 3' end of the extension product.
This extends the short 3-4 nucleotide overhang from the 3' restriction enzyme site
ensuring successful digestion for direct insertion into pPIC vector. The final reaction
volume was made up to 20 pi with ddFFO prior to PCR using the program in Table. 4.
Oligo. Name DNA Sequence Restriction site
F C3-C345C GTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCTGAGGAGAATTGC Xhol
RC3-C345C CTAG TCTAGACTATCAGTTGGGGCACCCAAACACAACAT Xbal
F C5-C345C GTATCTCTCGAGAAAAGAGAGGCTGAAGCTGCTGATTGTGGG CA Xhol
R C5-C345C CTAG TCTAGACTATTAGCATCCATTTAAAAAGATATCTTC Xbal
F C6-CCP GAAGC TGCAGCTTCCGGGTGTCCTCAG Pstl
RC6-CCP CI AG1C1AGAC1A11II1CACAGG1GAGAGAGIIIG Xbal
F C7-CCP GAAGCTGCAGAATTCTGTCCATCACCTCCT Pstl
RC7-CCP CTAGTCTAGACTATTGTACACAGCGGGCATTCT Xbal
F C7-CCP1 CTAGTCTAGACTATTTGAGACTCCACCCAGTTTG Xhol
RC7-CCP1 CTAGTCTAGACTATAGCTCACACACGTTTTG Pstl
F C7-FIM1 GTATCTCTCGAGAAAAGAGAGGCTGAAGCTAAAGAAAATCCGT Xhol
RC7-FIM1 CTAGTCTAGACTATGAGGCAGGCAGAGTACAGC Xbal
F C7-FIM2 CTATCTCTCGAGAAAAGAGAGGCTGAAGCT GCTGAGAAAGCTTG Xhol
Table. 3: Primer oligonucleotides. The oligonucleotide naming system indicate whether the primer is for
forward (F) or reverse (R) priming directions. Restriction enzyme sites are shown in bold.
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Step Temperature (°C) Time (min) Repetitions
Initialisation 95 1 1
Denaturation 95 0.5
Touch-down annealing steps Tm 0.5
Elongation 72 1.0/kb DNA 14
Denaturation 95 0.5
Annealing T -7m 0.5
Elongation 72 1.0/kb DNA 19 to 24x
Final Elongation 72 5 /
Table. 4: PCR cycling program. Annealing temperatures were determined using the melting temperatures
of the primers as indicated by manufacturers. In cases where the forward and reverse primers melting
temperatures did not match, the lower melting temperature was used.
2.1.5.4 TOPO cloning reaction
For cloning into pGAP the blunt-end PCR products were sub-cloned into the plasmid
vector, pCR®4Blunt-TOPO® using the Zero Blunt®TOPO® cloning kit (Invitrogen).
Following protocol 2 pi of PCR product, 1 pi of salt solution and 1 pi of pCR®4Blunt-
TOPO® were mixed and incubated at room temperature for 10 mins. The reaction was
then placed on ice and subsequently used for transformation into One Shot®ToplO
chemically competent cells.
2.1.5.5 Transformation of plasmids into E.coli chemically competent cells
Approximately 5 ng of the ligation mixture was incubated with 50 pi of One Shot®
TOP 10 Competent Cells for 30 mins on ice, heat shocked for 30sec in a pre-warmed
42°C water bath followed by the immediate addition of 250 pi of room temperature SOC
and incubation on ice for 5 mins. The cell culture was incubated for 1 hour at 37°C, 200
rpm, and 50 pi of cells were plated on low salt LB agar plates containing zeocin™ (100
pg/ml) and grown overnight at 37°C.
2.1.5.6 Plasmid DNA extraction
TOP 10 colonies containing the TOPO vectors with inserts and the pPIC and pGAP
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vectors were grown overnight at 30°C in 250 ml of low salt Lysogeny Broth (LB)47
containing kanamycin (TOPO, 50 pg/ml) and ZeocinIM (pPIC/pGAP, 100 pg/ml) for
selection. The plasmid DNA was extracted using a QIAGENPlasmidMaxi Prep kit as
specified by the manufacturer, yielding 100-500 pg of DNA per construct.
2.1.5.7 Restriction enzyme digestion
Double digestion of the TOPO® constructs (pGAP) and taq-PCR products (pPIC) and
the corresponding digestion of the empty pPIC/pGAP vectors was performed overnight
at 37°C and the enzymes inactivated by incubation at 62°C. The restriction enzymes
used for each construct are shown in Table. 3. DNA gel electrophoresis was employed to
ensure successful digestion and to separate the digested fragments. The insert and vector
bands were excised accordingly for solubilization and DNA extraction using the
QIAquick® Gel Extraction kit (QIAGEN).
2.1.5.8 Ligation reactions
A 3-fold molar excess of insert was used to ligate into 50 ng of the pPIC/pGAP vector.
The T4 Ligase Quick Ligation Kit (New England Biolabs) was used whereby insert and
vector are mixed with 1 pi of lOx Quick Ligation Buffer (NEB) and 1 pi of T4 DNA
ligase (400 U/pl, NEB) to a final volume of 20 pi. The reaction mixture was mixed
thoroughly and then incubated at room temperature for 5 mins, followed by
transformation into TOP10 chemically competent E.coli (see 2.1.4.3 E.coli
transformation by electroporation).
2.1.5.9 Screening of E.coli colonies
TOP 10 colonies potentially containing pPIC/pGAP and insert were screened via PCR.
Small samples of colony cells were dissolved in 20 pi of ddLLO and heated at 95°C for 3
mins to lyse the bacterial cells and solubilise the vector DNA. 2 pi of this was mixed
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with 1.5 ul each of 10 pM forward and reverse primers (Table. 3) and 5 pi of PCR
Master Mix® (Promega), which contains Taq DNA polymerase (50 U/ml), dNTPs (400
pM each) and MgCl2 (3 mM). The PCR was then carried out using the program outlined
in Table. 5 and the presence of the insert established by visualisation of the correct sized
band following agarose gel electrophoresis.
Step Temperature (°C) Time (min) Repetitions
Initialisation 95 1 1
Denaturation 95 0.5
Annealing 50 0.5
Elongation 60 1.0/kb DNA 30
Hold 4 hold /
Table. 5: Mastermix screening PCR program
2.1.5.10 Sequencing of plasmid DNA
To confirm correct insertion of the genes of interest into the P. pastoris expression
vectors, the DNA was sequenced using the chain termination method, a-factor primers
(Addgene) directed against the a-factor signal sequence adjacent to the inserts were
added to 200-300 ng of plasmid DNA along with 4 pi ofABI prism BigDye® terminator
mix (Applied Biosystems, Foster City, CA). The BigDye® contains a mixture of all four
standard deoxynucleotides (dATP, dGTP, dCTP and dTTP), all four fluorescently
labelled dideoxynucleotides (ddATP, ddGTP, ddCTP and ccTTP) and AmpliTaq DNA
Polymerase. Amplification of the target sequence using BigDye® and the PCR program
outlined in Table. 6 results in a mixture of fragment lengths due to random incorporation
of dideoxynucleotides which terminates chain elongation due to the absense of a 3'-
hydroxyl group. The mixture was then separated by polyacrylamide gel electrophoresis,
where a pattern of fluorescent bands corresponding to the terminating ddNTPs for each
fragment can be read off using the ABI 3730 instrument carried out by the School of
Biological Sciences Sequencing Service (SBSSS), Edinburgh.
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Step Temperature (°C) Time (min) Repetitions




Elongation 60 1.0/kb DNA
Hold 4 hold /
Table. 6: PCR program for DNA sequencing
2.1.6 Transformation of P.pastoris
2.1.6.1 Preparation of DNA
As above the TOP 10™ colonies containing the pPIC/pGAP constructs were grown in
low salt LB and had DNA extracted using a Q1AGEN Plasmid Maxi Prep kit. The
purified DNA was linearized using the restriction enzyme SacI for incorporation into P.
pastoris. Complete linearization was assessed by agarose gel electrophoresis (see 3.5.1)
and when complete,the enzyme was inactivated by incubating at 62°C for 20 mins. To
purify DNA from the DNA-enzyme mixture, samples were subject to phenol-chloroform
extraction; whereby an equal volume of phenol: chloroform: isoamyl alcohol (25:24:1,
saturated with 10 mM Tris, pH 8.0, 1 mM EDTA) was added to the DNA sample
followed by vortexing and centrifugation (1 min/10,000 rpm, 4°C). The resultant bi-
phasic mixture contains the DNA in the aqueous phase, which was removed and the
above steps repeated until no protein was visible in the organic phase. Finally an equal
volume of chloroform was added to the DNA sample and the centrifugation steps
repeated to remove any residual phenol from the sample.
Ethanol precipitation was then used to concentrate the DNA. Firstly the salt
concentration was adjusted to 0.3 M, using 3 M sodium acetate, pH 5.2, providing Na+
ions. The solution is mixed with 2.5 volumes of ice-cold ethanol (100%), vortexed and
placed on ice for 1 hour. Adding ethanol to the solution disrupts screening of charges by
water and the Na+ ions and the DNA's phosphate backbone form stable ionic bonds,
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precipitating the DNA out of solution. The precipitate is then collected by centrifugation
for 30 mins/13,000 rpm/4°C and removal of the supernatant. To remove residual salts
from the DNA 750 pi of 70%v/v ethanol was added and then centrifuged for 5
mins/13,000 rpm/4°C. The resultant DNA pellet was air-dried and resuspended in the
desired volume of ddH20.
2.1.6.2 Preparation electrocompetent P. pastoris
A 5 ml Yeast Peptone Dextrose (YPD, Appendix B) overnight culture of P. pastoris
(KM71H strain) was used to inoculate 500 ml ofYPD medium and grown at 30°C until
an OD6ooof 1.3-1.5 was achieved. The cells were centrifuged (5 mins/1500 xg/4°C) and
resuspended in 500 ml of ice-cold ddfTO. Centrifugation was repeated and the cells
resuspended in 250 ml of ice-cold ddTHO. After another round of centrifugation the cells
were resuspended in 20 ml of ice-cold 1 M sorbitol, which was reduced to 1 ml
following a final round of centrifugation.
2.1.6.3 P. pastoris transformation bv electroporation
5-10 pg of purified and linearized plasmid DNA was combined with 80 pi of freshly
prepared electrocompetent cells for transformation by electroporation. This was
transferred to an electroporation cuvette and incubated on ice for 5 mins. The cells were
then pulsed for 5 seconds with a charging voltage of 1500 V, capacitance 25 pF and
resistance 200 mft. 1 ml of ice-cold 1 M sorbitol was added immediately and then
transferred to a 15 ml Falcon™ tube for incubation without shaking for 3 hours at 30°C.
150 pi and 300 pi aliquots were spread on 100 pg/ml and 300 pg/ml YPDS, Zeocin™
plates and incubated at 30°C for 3 days.
2.2 Protein production, manipulation and purification
2.2.1 Estimation of protein concentrations
A UV spectrometer (EppendorfBioSpectrometer, Eppendorf, Hamburg, Germany) was
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used to estimate protein concentrations. UV absorbance was detected at 280 nm due to
the primary absorbance by tryptophan, tyrosine and cysteine with their molar absorption
coefficients decreasing in that order. The ratios A[280]/A[260], and A[280]/A[320] were used to
assess the purity of the sample. The protein concentrations were calculated according to
the Beer-Lambert law equation: A=slc, where absorbance, A; is equal to the product of
the extinction coefficient, e (calculated by ExPASy, ProtPram tool); the path-length of
light, 1; and the concentration, c.
2.2.2 Concentration of protein samples
Buffer-exchange for NMR samples, and all the concentration steps for the variously
labelled protein samples were performed in 0.5 ml, 6.0 ml or 20 ml Vivaspin™
concentrators (Sartorius Mechatronics UK Ltd, Epsom,United Kingdom), with an
appropriate molecular weight cut-off membrane (3000 - 10000 Da).
2.2.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis
SDS-PAGE analysis was employed to detect the presence of recombinant proteins and
protein contaminants. Samples were mixed with reducing and non-reducing Laemmli
loading buffer (Invitrogen, 4x concentrated) then boiled, followed by centrifugation if
necessary, and run on aNuPAGE 4-12% Bis(2-hydroxyethyl)-imino-]
tris(hydroxymethyl)-methane (bis-tris) gel at a constant voltage (200 V) for
approximately 30 minutes in the NuPAGE gel system (Invitrogen). Gels were then
washed in water, stained for protein using Coomassie Brilliant Blue R-250 Staining
Solution (BioRad) and destained in water. For cross-linking gels a specialized gradient
gel, NuPAGE 3-8% tris-acetate gel, was used for separation of high molecular weight
protein bands.
2.2.4 Chromatography sytems
All chromtography steps were implemented using the AKTA-design1M FPLC system
60
CHAPTER 2: METHODS
(pump P-920, UV detector unit UPC-900) bar reverse-phase HPLC which was
performed on an AKTAexplorer™ or manual sample application and elution where
stated.
2.2.5 Mass Spectrometry
Spectra were collected on an Applied Biosystems DE-STR MALD1-TOF (Matrix
Assisted Laser Desorption lonisation - Time of Flight) with a nitrogen laser. Sinapinic
acid was used as matrix and prepared by sonicating and vortexing 10 mg sinapinic acid
in 50%v/v MeOH/FFO mixture with 0.03%v/v trifluoroacetic acid (TFA). 0.5 pi protein
sample was mixed with 0.5 pi matrix directly on the target plate. The lowest laser
intensity that gave a suitable peak was used to minimize protein fragmentation. The
instrument was calibrated with the external standards Cytochrome C and Florse
Myoglobin (HHM). Liquid Chromatography (LC)-MS was submitted for analysis to the
Scottish Instrumentation and Resource Centre for Advance Mass Spectrometry
(SIRCAMS).
2.2.6 E.coli protein expression
2.2.6.1 Overview of Origami™ BpLvsS host strain
Complement proteins and their associated domains characteristically contain multiple
disulphide bonds. The natural reducing environment of E.coli cytoplasm however, does
not support disulphide bonding and can result in protein misfolding and the formation of
inactive aggregates known as inclusion bodies. Thus expression in a system that supports
formation of disulphide bonds is essential. The Origami B strain of E.coli was utilized to
obtain folded domains in the soluble phase. Origami strains benefit from mutations in
both the thioredoxin reductase (trxB) and glutathione reductase (gor) genes, the
combination ofwhich greatly enhances disulphide bond formation in the cytoplasm."7
Thioredoxin reductases are the only known enzymes to reduce thioredoxin, which in its
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active thiol form reduces other proteins by cysteine thiol-disulfide exchange.
Meanwhile, glutathione reductase reduces glutathione disulfide to the sulfyhdryl form,
which serving as an electron donor result in reduction of disulphide bonds . Thus
mutations in both the trxB and gor genes prevent recombinant protein reduction via the
interuption of the thiorodoxin and glutaredoxin systems. The B form of the Origami
strain are derived from a lacZY mutant of the conventional E.coli expression strain
BL21(DE3) and similarly expresses T7 RNA polymerase upon 1PTG induction for
expression of the recombinant protein via the strong bacteriophage T7 promoter of the
pET vector. Moreover, combining the Origami B strain with the low-level expression
plasmid pLysS allows for precise control of expression levels. Whilst the Origami B
strain has an additional lac permease (lacY) mutation allowing for uniform entry of 1PTG
into all cells in the population, producing a concentration-dependent, homogeneous level
of induction. The pLysS plasmid expresses T7 lysozyme, which inhibits T7 RNA
polymerase at the pET vectors lac promoter, until expression is induced with IPTG,
when the polymerase is over-expressed.
2.2.6.2 C7-CCPs expression
C7-CCPs pET-15b vector DNA was transformed into pLysS/OrigamiB competent cells
by electroporation and cells were spread on yeast tryptone (YT, Appendix B) agar plates
containing ampicillin (75 pg/ml), kanamycin (15 pg/ml), tetracycline (15 pg/ml) and
chloroamphenicol (15 pg/ml) for selection of the bla, trxB and gor mutations and the
pLYS plasmid mutations respectively. Plates were incubated at 37°C overnight.
Transformed cells were grown at 30°C in YT medium (natural C12 and N14 abundance)
and M9 salts medium (Appendix B) supplemented with either l5N ammonium sulphate
and l5N Isogro ( 15N single labeling) or 15N Ammonium sulphate, 13C Glucose and 15N,
13C Isogro (l3C, 15N double labeling). Expression was induced with 1 mM isopropyl (3-D-
1-thiogalactoside (IPTG) at an Optical Density (O.D •6oo) of 0.6 for overnight expression
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at room temperature. The cells were harvested by centrifugation (15 min/6000 rpm/4°C),
frozen, thawed and then lysed with BugBusterIM reagent supplemented with Benzonase
Nuclease and a protease inhibitor cocktail as recommended by the supplier. The cell
lysate was cleared by centrifugation (2 hrs/11000 rpm/4°C) and filtered using a 0.45 pm
molecular weight cut-off (MWCO) Mini-start filter (Sartorius).
2.2.7 C7 CCPs purification
Lysate was applied to a 1 ml HiTrap chelating column (GE Healthcare) loaded with
Co2+/Ni2+for coupling with the His-tag using phosphate wash buffer (20 mM KP04, 0.5
M NaCl, 10 mM imidazole) and elution buffer (20 mM KP04, 0.5 M NaCl, 500 mM
Imidazole). Various pHs of buffer were tested to obtain the highest yield with fewer
impurities. Eluted fractions were assessed by SDS-PAGE for the presence ofC7-FIMs
and pooled. C7-CCPs were thrombin cleaved to remove the His-tag using biotinylated
thrombin (1 pl/mg protein) and 10X cleavage buffer (200 mM Tris-HCl pH 8.4, 1.5 M
NaCl, 25 mM CaCL). Streptavadin-agarose was used, as recommended, to remove
thrombin. To remove His-tag from solution and further purify samples, they were
reapplied to the HiTrap column followed by application to either a HPLC column
(Discovery® BIO Wide Pore C8-5 pm, 25 cm x 4.5 mm, Supelco) or gel filtration
column (HiLoad™ 16/60 Superdex™75 prep grade, GE Healthcare).
2.2.8 P. pastoris protein expression
2.2.8.1 Overview of KM71H P. pastoris host strain**
P. pastoris is a eukaryotic yeast expression system and therefore has advantages of
higher eukaryotic expression systems such as protein processing, protein folding, and
post-translational modification."8 They are easy to manipulate, have a relatively rapid
growth rate and can be grown to higher cell densities than bacteria. It shares many of
Saccharomyces cerevisiae's molecular and genetic manipulations, whilst has the added
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advantage of 10-100-fold higher heterologous protein expression levels.
As with S.cerevisiae, P.pastoris is a methylotrophic yeast, and is able to use methanol as
a carbon source in the absence of glucose. In the peroxisome organelle, methanol is
oxidized to formaldehyde and the harmful biproduct hydrogen peroxide using molecular
oxygen and alcohol oxidase (AOX). The formaldehyde, partly leaves the peroxisome
and is further oxidised to form carbon dioxide by cytoplasmic dehydrogenases,
providing the organism with energy. The formaldehyde remaining within the peroxisome
is used to produce cellular constituents. Whilst the hydrogen peroxide is rapidly
consumed via the action of a catalase, producing water and the less reactive gaseous
oxygen. Alcohol oxidase has a poor affinity for 02, and the cells compensate by
generating large amounts of the enzyme. Consequently the AOX promoters concerned
are exceptionally strong and are exploited to obtain high, inducible yields of
recombinant protein.
The genome of P. pastoris encodes for two alcohol oxidases, A0X1 and A0X2. The two
enzymes are 97% identical to each other and share approximately the same specificity.119
However, methanol metabolism is mainly carried out through the catalytic action of the
A0X1 gene product, which promotes a more rapid catabolism ofmethanol relative to
A0X2. P. pastoris growing on methanol as a carbon source expresses A0X1 levels of
more than 30% of total soluble protein. Regulation of the AOX1 gene involves two
mechanisms. First, there is a repression/derepression mechanism, whereby in the
presence of glucose the AOX1 gene is repressed. Absence of glucose on its own is not
sufficient to stimulate the AOX 1 expression as, secondly, the presence ofmethanol is
required as an induction signal prior to AOX1 gene transcription."9 There are two
different methanol-metabolising P.pastoris phenotypes: MUTsand MUTT The loss of its
main methanol catabolic enzyme AOX 1 results in P. pastoris MUTS strains (methanol
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utilization slow) that have to rely on their facility to catabolise methanol through the
more slowly metabolising AOX2. Whilst MUT+refers to the wild-type phenotype of
growth on methanol as a sole carbon source. The P. pastoris strain used throughout this
study was KM71H (Invitrogen) of the MUTS phenotype. Once the heterologous protein
sequence has been transformed into the expression cassette and subsequently integrated
in the genome, it is under the control of the strong and highly-inducible AOX1-promotor.
Therefore recombinant protein expression can be regulated through the feeding of
methanol to cell cultures.
Recombinant protein expressed in P.pastoris can be intracellular or secreted.
Secretion requires a signal sequence that is provided by the pPICZaB vector in order to
direct the protein to the secretion pathway. As P. pastoris only secretes very low levels
of native protein into the medium, and is able to grow in minimal medium, secretion can
be an important first step in purification of the heterologous protein.119
Regarding post-translational modifications benefits the P. pastoris-based expression
system does not cause hyperglycosylation as with S.cereviciae. However O- and N-
linked glycosylation does occur at the same sites as the native protein. Another asset of
relevance to complement proteins is that native disulfide bonds patterns are generally
formed in the secreted product. Usually this system expresses foreign proteins in high
yields, although yields are generally not as high as for alcohol oxidase itself.119 In
conclusion the P. pastoris expression system is appropriate for generation of micro- to
milligram quantities of pure recombinant protein with native disulfides and the option of
isotopic enrichment for NMR studies.
2.2.8.2 Identification of expressing clones
5-10 colonies were tested for expression of each construct. pGAP expression trials were
carried out in 50 ml sterile Falcons™, with single colonies used to inoculated 10 ml of
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YT media, grown for two days and then protein expression induced with 0.5%v/v
methanol for two days. Similarly for pPIC constructs, single colonies were used to
inoculate 10 ml of buffered minimal glycerol (BMG, Appendix B) in a 50 ml sterile
FalconIM conical tube and incubated for two days in a shaking incubator at 30°C.
However, this culture was then used to inoculate 90ml ofBMG in a 250 ml baffled glass
flask and again incubated for 2 days at 30°C. Protein expression was induced at the
lower temperature of 15°C with the addition of 0.5%v/v methanol for two consecutive
days. The flask cultures were then harvested (10 min/3000 rpm/SH-300 rotor/4°C) and
resuspended in 25 ml of buffered minimal methanol (BMM, Appendix B) to induce
protein expression. The cultures were incubated for a further 2 days with 0.5%v/v
methanol added each day. Following expression the cells were then harvested by
centrifugation (10 min/3000 rpm/SH-300 rotor/4°C) and the supernatant containing the
secreted protein was filtered (Millipore, Millex sterile syringe filters, PVDF 0.22 pm,
Millipore, Watford, UK). 500 pi of filtered supernatant was concentrated to 50 pi to be
analysed for protein expression by SDS-PAGE (see section 2.2.3). For pGAP expressed
protein, the supernatant samples were also buffer exchanged via the concentrator to
remove the majority of the peptides present in the YT expression media.
2.2.8.3 CFF fermentor expression
The use of fermentors in recombinant protein production, allows for control and logging
of pH, agitation, air and oxygen supply, thus maintaining cell constitution and generating
higher protein yields than a shaker flask. In addition pronounced protein expression
levels from the AOXI promoter can be achieved at growth-limiting rates acquired via
fermentor expression, as opposed to excessive feeding in shakers.
Unlabelled CFF expression and l5N labeled or l5N and l3C labeled expression for NMR
structural studies was performed in 5 L and 2 L BioFlow 3000 vessels using 600 ml and
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300 ml BMG shaker flask starter cultures (2days/30°C) respectively. The contents of the
initial basal salts media (Appendix B), and the details of the feeding schedule, depend
upon whether the protein product was to be unlabelled, 15N-labeled, or 15N, 13C-labeled;
however, for CFF double labeling conditions were used during the single labeled run in
order to gauge double labeled expression levels.
To attain sterile growth conditions the fermentor vessel containing the media and all the
probes were fully assembled prior to autoclaving the fermentor unit. The dissolved 02-
probe was charged over night, with air bubbled continuously into the vessel through a
sterile filter and agitation was set to 200 rpm in order to saturate the medium with
oxygen. Prior to inoculation a relative oxygen level of 40 was maintained by varying the
agitation rate (e.g. during yeast metabolism the aeration is held at a constant level but the
agitation rate is increased to counteract oxygen level dropping below 40). pH and
temperature probes, as well as a feeding line for a 2 M KOH solution (base feed) were
also attached. The temperature and pH were set for maintenance to 30 °C and 5.0
respectively. 0.5 ml Antifoam 206 (Sigma-Aldrich) and 2.5 ml of high-purity grade
fermentation trace mineral salts (PTM1 salt, Amresco®) were also added to the media
(per 700 ml).
For natural abundance expression ammonium sulfate (7 g) and D-glucose (15 g) were
added to the media before inoculation. This was substituted by ammonium-15N-sulfate
(Isotec™) for single labeling, together with D-Glucose-l3C (Isotec™) for double
labeling. Cells were then pelleted (10 min/1500 xg/4°C) and resolubilised (20 ml 100
mM potassium phosphate, pH 6.0) for inoculation of the fermentor media. Cells were
grown until nutrients were metabolised and agitation levels returned to baseline.
Similarly an additional glucose (10 g) was added and metabolised, followed by a final
feed of glycerol (1 g) and ammonium sulfate (1 g): all of which were isotopically
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labelled for I5N, l3C protein expression. After ~1 day of growth the temperature was
reduced to 15°C for initial induction with 0.5% (v/v of total culture volume) methanol
(or Methanol-13C for double-labeling). Further feeds of 0.75% to 1.5% methanol were
provided over a course of 3-4days. The frequency of methanol feeds was determined on
the basis of carefully monitoring the agitation-rate and dissolved oxygen curves so as to
avoid overfeeding or poisoning. Every glycerol and methanol feed was accompanied by
a 0.1 ml addition of PTM1-salts and all labels were added in saturated sterile filtered (0.2
pm MWCO) ddH20 solutions.
In all cases, the supernatant was harvested by an initial centrifugation step (10min/5000
xg/4°C), followed by a more powerful spin (30min/10000 xg/4°C), before sterile
filtration (0.2 pm). And, ahead of protein purification, PMSF and EDTA were added to
inhibit protein degradation (final concentrations of 0.5 mM and 5 mM, respectively).
2.2.9 CFF Purification
For the initial purification step cation-exchange chromatography was employed. The pi
of 6.4 calculated by ExPASY's ProtParam tool dictated that cation-exchange
chromatography would be the initial purification step. Theoretical pH titration curves
were calculated by the program Sedenterp, indicating that a pH of 4-5 would insure the
protein is positively charged. An XK 26 column (Pharmacia, Biotech) manually packed
with SP Sepharose™ (GE Healthcare) was used. The column was pre-equilibrated with
20 mM sodium acetate buffer (pH 4.0) and cell supernatant (pH 4.0, diluted 1:6 with
water) was passed over the column using a peristaltic pump. Elution of the protein was
then achieved by applying a 0-100% linear salt gradient using elution buffer (20 mM
sodium acetate, 1 M NaCl, pH 4.0).
The N-linked glycosylation site within FIM 1 (Asn754) was removed using the Endo Hf
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enzyme (a recombinant fusion of endoglycosidase H and maltose binding protein, New
England BioLabs ). Endo H, cleaves within the chitobiose core (two N-
acetylgulcosamine residues, Glc-NAc) of the N-linked oligosacharide chain, leaving the
Endo Hf treated protein with one Glc-NAc from the core. 400-800 units of Endo Hf (106
U/ml) were used to deglycosylate 1 ug of protein (5 hours, 37°C) at the optimal pH for
deglycosylation, 5.6.
Size exclusion chromatography was employed as the final purification step. A HiLoadIM
16/60 Superdex™ 75 prep grade column (GE Healthcare) pre-equilibrated with running
buffer (20 mM sodium acetate, 100 mM NaCl, pH 4.0) was used. Following SDS-PAGE
analysis selected fractions containing highly pure protein were pooled for further
analysis.
2.2.10 CFF Dynamic Light Scattering
2.2.10.1 Introduction
Dynamic light scattering (DLS) is a spectroscopic technique that measures the scattering
ofmonochramatic coherent laser light (typically 633 nm) from a molecule in solution.
The light is scattered by the molecules at all angles due to Brownian motion. However, a
DLS instrument only detects the scattered light at one angle (typically 90°) and therefore
the intensity of the scattered light fluctuates with brownian motion and is measured as a
function of time and described by an autocorrelation function. Autocorrelation is the
cross-correlation of a signal with itself. Thus, it is the similarity in intensity of light
scattered from the molecule as a function of the time separation between them. So for
short differences in time there is a relatively high degree of correlation as the particle has
not moved extensively, whilst for long differences in time there are greater changes to
the molecules position and therefore a smaller correlation. In the simplest case this
function is an exponential decay, and is a function of the diffusion coefficient of the
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molecule in question. The diffusion coefficient is a factor of proportionality representing
the amount of substance diffusing across a unit area through a unit concentration
gradient in unit time and can be transformed to molecular size through the Stokes-
Einstein equation (equation 1).
6jiijR
Equation 1: Stokes-Einstein equation. The diffusion coefficient, D, for a particle in a free
volume depends on the Boltzmann constant (k), the absolute temperature (T), the viscosity of the
solution (r|), and the hydrodynamic radius (R) of the particle.
The size calculated is the hydrodynamic radius or Stokes radius. Specifically it is the
radius of a hard sphere that diffuses at the same rate as the molecule. This radius depends
not only on the size of the molecular "core", but also on surface structure i.e. the
hydration shell of a protein and shape effects. Moreover scattering intensity is
proportional to the square of molecular weight and therefore even small amounts of
protein aggregates can be detected in the sample.
2.2.10.2 Instrumentation
To estimate the hydrodynamic size of the protein and to assess protein
mono/polydispersity under various storage conditions (4°C, freeze-drying and -80°C)
and various buffer conditions (20 mM sodium acetate, 0/100 mM NaCl, pH 4.0 and 20
mM potassium phosphate, 0/100 mM NaCl, pH 5.0) the Zetasizer Auto Plate Sampler
Dynamic Light Scattering system (Malvern Instruments Ltd, England) was used at the
Biophysical Characterisation facility at the Centre for Translational and Chemical
Biology, Edinburgh. -50 ul of sample was loaded into each well in a standard 384 well
plate and samples returned to the well following averaged analysis. All samples were
analysed at 25°C using a standard He-Ne laser (3 mW, 633 nm) and the scattered light
detected at 90° to the incident light. All standard operating procedures and data
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processing were implemented using Zetasizer APS software.
2.3 NMR Structural Studies
In this study no development ofNMR method was developed. Henceforth an extensive
overview ofNMR theory is unnecessary,120 however the basic principles of protein NMR
are outlined in section 2.3.1. This is notwithstanding a list of the NMR experiments
collected for structure determination (see section 2.3.3, Table.7) and key concepts
relating to the nature of the experimental data. A guide to instrumental setup and
experimental details of the suite ofNMR experiments used can be found at the
experimental pulse sequence repository and supporting webpage (http://nmr-
linux.chem.ed.ac.uk/highfield/highfield.htmn maintained by Dr Dusan Uhrfn.
2.3.1 Introduction
When placed in a magnetic field, NMR active nuclei (e.g. 'H, l5N, l3C) absorb energy at a
resonant radio-frequency characteristic of the isotope, known as the excitation frequency.
In a magnetic field, NMR active nuclei have a nuclear spin, 1=1/2, which has an
associated magnetic moment in a magnetic field, B0, which generates two energy states
separated by an amount of energy, AE, which is field dependent (Fig.l 8).






Fig. 18: Energy levels for a nucleus with spin quantum number Vi.
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The sum of the magnetization of the individual spins or bulk magnetization, M, will be
spin aligned with B0 (z-axis in the vector diagram Fig. 19).
Bf
1M
Fig. 19 Vector energy diagram. The bulk magnetization is shown spin-aligned with the external magnetic
field B0.
The force generated by B0 on M is a torque which causes M to process about B0, known
as Larmour precession. Applying a magnetic radio-frequency pulse perpendicular to B0
at the Larmour frequency tips M into precessing around the xy plane, which generates a
measurable oscillating current in a receiver coil. When the excitation pulse is turned off,
there are influences that cause the magnetization to decay and M returns to precession
around the z-axis. The diminishing signal acquired by the receiver coil in the xy plane is
called free-induction decay (FID). The FID which is collected and analyzed is the
difference between this NMR signal or resonant frequency and the excitation frequency,
or Larmour frequency as an expression of time. This complex time-domain signal, the
FID, is related to the illustrative frequency domain spectrum by a mathematical process
called Fourier transformation.
As the resonant frequency is influenced by the surrounding chemical environment,
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chemically nonequivalent nuclei do not experience the same magnetic field due to
magnetic shielding by electrons, and every NMR active nuclei in the sample will have its
own characteristic resonant frequency. This frequency is proportional to the
gyromagnetic ratio, y, for a particular nucleus and the strength of the applied magnetic
field and therefore in an NMR spectrum the frequency is expressed as a standardized
value known as the chemical shift.
For the majority of proteins and protein domains, the vast number of protons creates a
complex, overlapped ID 'H-spectrum. Therefore multidimensional NMR experiments
are recorded using RF pulse sequences that exploit dipole-dipole coupling (J-coupling,
Fig. 20) between covalently linked nuclei to employ multiple magnetization transfer
steps which correlate the frequencies of distinct nuclei ('H, 15N, 13C).121 This resolves
overlap by deconvolution in additional dimensions and thus increases the amount of
accessible information. The size ofC7-CCPs (14 kDa) is more than accessible for
structure determination using a suite of standard heteronuclear NMR experiments
facilitated by a l5N, 13C labelled recombinant protein sample. Whilst C7-CFF's size (24
kDa) inherently generates more complex spectra. Thus use of high strength magnets (see
section 2.3.2) and careful processing of the FID (see section 2.3.4) are required to
determine its atomic structure using the standard suite of experiments. The standard set
of heteronuclear experiments for proteins of this size provide all the necessary
information for assignment of the protein backbone and side-chains atoms to their





















Fig.20: Through bond J-coupling constants. J-couplings (Hz) are shown between two sequential spin-
systems denoted i and /-I. Adapted from paper.121
2.3.2 Spectrometers
A Bruker AVANCE™ 18.77 Tesla (nominal 800MHz 'H frequency) spectrometer and a
Bruker AVANCE™ 14.1 Tesla (nominal 600MHz 'H frequency) spectrometer. Both
spectrometers were fitted with a 5-mm triple-resonance cryoprobe to increase the
signal/noise ratio andz-axis pulse field gradient coils. Topspin1M software (Bruker
Bopspin 2005) was used for data acquisition and primary processing and analyses of
NMR data.
2.3.3 Sample preparation, optimisation and data collection
Purified natural abundance recombinant protein samples were concentrated in spin
concentrators and buffer-exchanged (20 mM potassium phosphate, 100 mM NaCl, pH
6.5) and the presence of tertiary structure identified using 'H ID NMR experiments.
Concentrations for 1-D experiments ranged from 100 to 300 pM. Following this l5N
labelled sample conditions were tested to determine the best conditions for 3D NMR
experiments by comparison of l5N-HSQCs. Salt concentration (0, 50 and 100 mM), pH
(4.0, 4.5, 5, 5.5, 6.5 and 7.0) and temperature (15, 20, 25, 30, 35 °C) were tested. All
subsequent spectra for structure determination (Table. 7) were recorded in the optimal
buffer with azide and ethylenediaminetetraacetic acid (EDTA) to maintain the sample
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(20 mM potassium phosphate. 5 pM EDTA, 0.02%w/v NaN3, pH 5.0).
Experiment Ref No Experiment Type Labelling Dim 1 Dim2 Dim3
15N-HSQC Through-bond 15N 1H 15N n/a
13C-HSQC Through-bond 13C 1H 13C n/a
CBCA(CO)NH Through-bond 15N, 13C 1H 13Ca/p 15N
CBCANH Through-bond 15N, 13C 1H 13Ca/p 15N
HBHA(CO)NH Through-bond 1SN, 13C 1H 1Ha/(B 15N
HBHANH Through-bond 15N, 13C 1H 1Ha/(B 15N
HNCO Through-bond 15N, 13C 1H 13CO 15N
HN(CA)CO Through-bond 15N, 13C 1H 13CO 15n
15N-TOCSY Through-bond 15N, 13c 1H 1H 15N
HCCH-TOCSY Through-bond 15N, 13c 1H 1H 13C
(HB)CB(CGCD)HD Through-bond 15N, 13C 1H 13carom n/a
(HB)CB(CGCDCE)HE Through-bond 15M, 13C 1H 13carom n/a
Aromatic 13C-HSQC Through-bond 15n, 13c 1H 13carom n/a
15N-HSQC-NOESY Through-space 15N 1H 1H 15N
13C-HSQC-NOESY Through-space 15N, 13C 1H 1H 13C
13C-Methyl-HSQC-NOESY Through-space 15N, 13C 1H 1H 13C
Table. 7 NMR Experiments for structure determination used in this study.
2.3.4 NMR data processing
The process program from the AZARA suite of programs (Department of Biochemistry,
University of Cambridge, UK) were used to process the raw free-induction decay (FID)
data by Fourier transformation and by maximum entropy processing. The application of
a variety ofwindow functions to maximise resolution of the resulting frequency
spectrum was included. Spectral processing with the process command requires a
parameter file (ser.ref) and a script input file (scr) from the Bruker aquired data. An
example of these files can be found in appendix C. Maximum entropy processing was





CcpNmr Analysis (collaborative computational project for the NMR community, CCPN)
is a graphical NMR spectra analysis and assignment program. The alpha release was
used for the CCPs assignment and the beta-release was used for the CFF assignment.
This software was written as an extension of the CCPN data model* which represents all
of the information used in NMR analysis and how they relate to one another (Fig. 21).
The Resonance object in the CcpNmr Analysis data model is fundamental to the
assignment process, linking all NMR information, including cross-peaks, chemical shifts
and atomic assignments. It does not represent an atom or associated value, but
represents the connection between an atom and the NMR parameters it gives rise to. This
means that one Resonance can be connected to many chemical shift values associated
with different experiments as for pH and temperature titrations. Also interrelated cross-
peaks can be linked to a Resonance without knowing which atom or group of atoms it
relates to as is done during the sequential backbone assignment, aliphatic and aromatic
resonance assignment and NOE cross-peak assignment processes (see sections 2.3.5.3,
2.3.5.4, 2.3.5.5 and 2.3.5.2 respectively). The assignment ofNMR data to a Resonance
and the assignment of this Resonance to a particular atom are thus separate processes,
which do not have to be performed simultaneously.
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Fig. 21: Main concepts of the Data Model NMR package, and their relationships. Resonance is found
in darker grey in the centre of the diagram, wher almost all relationships use the Resonance as an
intermediary. Diagram from paper.135
2.3.5.2 General resonance assignment strategy
Assigning chemical shifts associated with cross-peaks to specific atoms in a protein
generally requires a suite of three- dimensional (3D) experiments recorded on I3C,15N-
labelled sample. The central reference spectrum for most 3D experiments is the 2D l5N-
HSQC, in which every cross-peak corresponds to an amide (i.e. (CO)-NH-) and thereby
correlates an amide nitrogen frequency with its attached proton frequency, except proline
which is devoid of an amide hydrogen. The various 3D experiments allow these
correlations to be extended through-bonds to include other atoms. In this way, nuclei, as
identified by their chemical shifts, may be assigned to clusters corresponding to
covalently linked groups of atoms. For sequential backbone assignment three pairs of 3D
experiments were used: CBCANH/CBCA(CO)NH, HBHANH/HBHA(CO)NH and
HNCO/HN(CA)CO. The redundancy of information between experiment pairs allows
atoms to be placed in sequential order and then matched to specific stretches of amino
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acid residues within the polypeptide sequence due to the characteristic chemical shifts of
some atoms.
Together with the HCCH-TOCSY experiment (see section 2.3.5.4), which yields cross-
peaks for every aliphatic (attached to 13C) side-chain 'H, these experiments should in
theory enable the assignment of all of the non-aromatic side-chain atoms. Aromatic
atoms were identified by a set of 2D experiments that correlate aromatic H5 and He
shifts with C(3 shifts of the same side-chain (see section 2.3.5.5). All assignments are
subsequently transferred to the l3C- and l5N-edited NOESY spectra to facilitate
assignment ofNOESY cross-peaks that arise from NOE transfers between non-
covalently linked protons which are close in space (see section 2.3.6.1).
2.3.5.3 Sequential assignment of the backbone resonances
For the backbone experiments the first two dimensions are the amide proton (HN) and
amide nitrogen (NH) frequencies and therefore the plane established by these two axes
represents the 15N-HSQC spectrum and act as a general point of reference in the
identification of spin-systems. Whilst an extension into the 3rd dimension (H/C) results in
strips of cross-peaks associated with that spin-system. For any given spin-system (one
amide peak), one experiment in the pair has cross-peaks for that residue (/) and its
previous (z'-l) residue, while the other experiment has z'-l peaks only. Therefore
overlaying the experiments with one another allows for the distinction between i and z'-l
resonances. The z'-l shifts are then used to search for spin-systems with z peaks of the
same frequency, namely the /-I residue. Thus a series of connected strips, each
corresponding to a unique amide cross-peak are established.
The 3-D CBCANH experiment connects the Ca and C(3 shifts of residues z and z'-l with
the amide cross-peak of residue z. Whilst its partner, the CBCA(CO)NH experiment
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connects the Ca and C(3 shifts of the i-1 residue with the amide cross-peak of residue i.
Therefore spin-systems can be linked sequentially via their Ca and C(3 resonances. The
CBCANH/CBCA(CO)NH pair is of particular significance as serine, threonine, glycine
and alanine have characteristic Ca and CP chemical shift patterns. This serves as a basis
for matching sequential spin systems with corresponding segments of the primary amino
acid sequence. Serine and threonine Ca and C|3 shifts typically have their Ca chemical
shifts up-field of their respective C(3 shifts unlike all other residues. Moreover the shifts
for the Ca (53-63 ppm for serine and 56-68 ppm for threonine) and C(3 (60-68 ppm for
serine and 66-74 ppm for threonine) are both relatively high making them easily
distinguishable from other residues. Alanine residues C(3 shift is distincly down-field
from the chemical shifts of other residues. Glycine residues on the other hand were
identified from the lone Ca and its markedly high shift (42-48 ppm) in comparison to
other residues' Ca shifts.
The 3D HBHANH/HBHA(CO)NH can be seen as an extension of the
CBCANH/CBCA(CO)NH pair as they correlate the Ha and HP shifts instead of the C
and CP shifts to the amide of residue i. Whilst the 3D HN(CA)CO/HNCO pair (/-1// and
/-1 experiments) are used to obtain the backbone carbonyl shift completing the
backbone assignment. The higher sensitivity and less crowded spectra associated with
the HN (CA)CO/HNCO experiments allowed for the resolution of any ambiguities from
the sequential assignment with the other two experiment pairs. The magnetization






















Fig. 22: Backbone assignment. (A) depicts the [1H, 15NJ-HSQC, (B) the CBCA(CO)NH and (C) the
CBCANH experiments. The top of each panel shows colours those atoms that are labelled during the
evolution of the pulse programs and whose dimensions are detected in the spectra below. Arrows indicate
the magnetisation transfer steps of the experiment. Single spectral strips are shown for (B) and (C) from
the corresponding amide cross-peak.
2.3.5.4 Aliphatic side-chain assignment
Total Correlation Spectroscopy (TOCSY) experiments were employed for the
assignment of the remaining 'H and l3C side-chain resonances. These experiments make
use of the TOCSY through-bond coherence transfer to all coupled spins in a scalar-
coupled network (e.g. all l3C atoms in an amino acid sidechain), using isotropic mixing
pulse.'30 The l5N-TOCSY-HSQC correlates aliphatic side-chain proton shifts from the (i)
residue with root resonances (HN and NH shifts) of the same residue (Fig. 23). This is
useful for confirming and supplementing main TOCSY experiment's (l3C-HCCH-
TOCSY) assignments and assigning side-chain NFF groups. Side-chain assignments
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were transferred to the l3C-HSQC spectrum which then served as a reference point for
the assignment of the I3C-HCCH-TOCSY spectrum. As the l3C-HCCH-TOCSY
experiment correlates each aliphatic proton of a spin-system (including prolines) to all
other aliphatic protons from the same spin-system, this provides an extra level of











































Fig. 23: Aliphatic proton assignment. (A) shows ['H, lyN]-HSQC, (B) the l5N-TOCSY-HSQC, (C) the
['H, l3C]-HSQC and (D) the HCCH-TOCSY. The top of each panel shows colours those atoms that are
labelled during the evolution of the pulse programs and whose dimensions are detected in the spectra
below. Arrows indicate the magnetisation transfer steps of the experiment. Single spectral strips are shown
for (B) and (D) from the corresponding HSQC cross-peak.
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2.3.5.5 Aromatic side-chain assignment
Due to the hydrophobic nature of aromatic rings, aromatic side-chains (histidine,
phenylalanine, tyrosine and tryptophan) are usually buried in the core of soluble
proteins, yielding important NOE restraints that help fold the protein in the structure
calculation. Relative to aliphatic protons, aromatic protons tend to be deshielded from
magnetization due to aromatic ring current effects, giving them a distinguishably higher
shift of 6-8 ppm. Consequently, two 2-D experiments specialised for detecting aromatic
proton shift, (HB)CB(CGCD)HD and (HB)CB(CGCDCE)HE, were employed for shift
assignment. These experiments correlate C(3 shifts of aromatic amino acids with Eld
((HB)CB(CGCD)HD ) and He ((HB)CB(CGCDCE)HE) ring protons (Fig. 24). In case
of assigned C(3 shifts not significantly overlapped in the 2-D aromatic spectra, the H5 or
He ring protons could be correlated to the C5/£ shift in the 13C-HSQC spectrum. Shifts
that remained elusive were identified via the l3C-NOESY-HSQC. This was largely based
on the assumption that the most intense cross-peaks arise from intra-residue NOEs
between protons within the aromatic ring.
A B




2.3.5.6 Cis-trans- Proline assignment
The partially double amide bond renders the amide group planar, occurring in either cis
or trans isomers (Fig. 25). The trans form is overwhelmingly preferred in most peptide
bonds (1000:1, trans-.cis), however, X-Pro peptide bonds have an appreciable number in
the cis conformation (3:1, trans:cis) ; presumably because the symmetry between Ca and
C6 atoms of proline make the isomers nearly equal in energy. There are 10 proline
residues in C7 CCPs and 13 proline residues in C7 CFF. Trans- or cw-configuration of
the proline peptide bonds was determined by calculating the difference between the C(3
and Cy shifts of each proline residue. A statistical analyses of C chemical shifts from
high resolution NMR structures136 revealed C(3-Cy in trans prolines to be 4.51 ±1.17
ppm and in cis prolines to be 9.64 ± 1.27 ppm. This was confirmed by visual inspection
of the l3C-NOESY-HSQC as in cis isomers the Ha of the proline has a strong crosspeak
with the Ha of the preceeding residue. While in trans conformation the HS of the proline
has a strong crosspeak with the Ha of the preceeding residue.
Fig. 25: Proline cis and trans isomers. Each isoform has a characteristic NOE pattern whereby a strong
Ha-HaNOE crosspeak (Xaa-Pro) is indicative of a cis isoform and a strong Ha-H8 NOE crosspeak is
indicative of a trans isoform.
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2.3.6 Distance restraints for structure calculations
2.3.6.1 Distance restraints derived from the Nuclear Overhauser effect
Following resonance assignment, structure determination by NMR spectroscopy relies
on the generation of distance restraints within the molecular system studied. The most
commonly used distance restraints are derived from the nuclear Overhauser effect
(NOE), which occurs between spins that have an appreciable magnetic dipole-dipole
interaction (dipolar coupling) due to close proximity in space (< ~5 A for 1 H-l H
NOE). Crosspeaks in NOE-spectroscopy experiments or NOESY experiments signify
spatial proximity between the two nuclei in question and the distance between the two is
proportional to the intensity of the peak.
Two NOESY experiments were used for both the CCPs' and CFF's structure calculations
the I5N-N0ESY-F1SQC and the 13CH-NOESY-HSQC where magnetization is exchanged
between the N/C nuclei associated with each FISQC cross-peak and all hydrogens within
NOE range. Additionally, for OFF, a l3CH3-NOESY-HSQC was recorded, producing a
spectra relating only to l3CFE carbons, allowing deconvolution of this crowded region.
In order to calculate the correct tertiary structure, it is essential that the NOESY peaks
are assigned correctly so that the distances extracted co-ordinate the correct nuclei. Thus
assignments from the 15N-HSQC and l3C-HSQC were transferred to NOESY strips for
every assigned N and C nucleus in the molecule. By overlaying the N and C-strips with
the l5N-HSQC TOCSY and 13C-HCCH-TOCSY respectively, cross-peaks corresponding
to intra-residue NOEs were completely assigned. In the case of C7 CCPs the clarity of
spectra and the relatively low overlap of resonances allowed for the remaining inter-
residue cross-peaks to be ambiguously assigned on the basis of chemical shifts using the
structure calculation software CYANA. CFF's NOESY strips inter-residue assignment
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was not wholly unambiguously assigned. A single distance restraint between a pair of
protons normally results in symmetry related NOE cross-peaks, originating from each
corresponding NOESY strip (Fig. 26). Using the chemical shift list information obtained
from sections 2.3.5, the final dimension of an NOE cross-peak was unambiguously
assigned to a lone matching Resonance candidate if there was an equivalent symmetry
related cross-peak in the NOE strip from the candidate. Unambiguous assignment of
proton shifts in the F2 dimension was mainly focused on amide-to-amide, amide-to-side-


























Fig. 26: NOE-cross-peak assignment. (A) shows ['H, l5N]-HSQC, (B) the l5N-NOESY-HSQC, (C) the
['H, 13C]-HSQC and (D) the l3C-NOESY-HSQC. The top of each panel shows colours those atoms that are
labelled during the evolution of the pulse programs and whose dimensions are detected in the spectra
below. Arrows indicate the magnetisation transfer steps of the experiment. Single spectral strips are shown
for (B) and (D) from the corresponding HSQC cross-peak.
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The amide-to-amide cross-peaks reveal characteristic secondary structural patterns,
which are critical in defining structural elements in the early stages of the simulated
molecular dynamics calculation. Additionally, the side-chain to amide NOE cross-peaks,
in particular, from the Ha NOE strips, are readily identifiable in the l3CH- NOESY-
HSQC and can also serve as a guide to the secondary structure formation. However,
those protons that happen to share similar chemical shifts gave rise to ambiguous
distance restraints and were left unassigned (in the free 'H dimension) and were treated
as ambiguous by CYANA. Peak lists for distance restraints, chemical shift tables for all
atoms in the molecule and the amino acid sequence were exported in XEasy format,
using the FormatConverter ofCcpNmr Analysis were used as input for structure
calculation with CYANA.
2.3.6.2 Distance restraints derived from H-bonds
For CFF additional distance restraints inferred from intra-molecular hydrogen bonds
were used for structure calculations. A modified HNCO experiment, FINCOhbond, was
used to exploit the small coupling constant associated with the slight covalent character
of carbonyl-amide hydrogen bonds. Resultant cross-peaks correlate the carbonyl carbon
with the amide nitrogen of hydrogen bonded pairs, with peak intensity being
proportional to bond-length, with observable peaks having a proton to carbonyl oxygen
distance smaller than 2.2 A.** As with the NOESY restraint, hydrogen bonding restraints
were exported using the FormatConverter ofCcpNmr Analysis were used as input for
structure calculation with CYANA.
2.3.7 Relaxation
2.3.7.1 Introduction
The absorption of electromagnetic radiation leaves a population of spins in the excited
state; that is the distribution of spins is perturbed from the equilibrium (Boltzman) state.
Following an NMR excitation pulse, it is the relaxation rate of the bulk magnetization to
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thermal equilibrium that determines the lifetime of the FID and consequently dictates the
line-breadth of the data; with fast relaxation rates and short relaxation times causing
severe line broadening, translating into poor spectral resolution and low-signal to noise
ratios. Moreover, in protein NMR, relaxation data are converted into parameters - spin-
spin (R2) and spin-lattice (Ri) relaxation rates and heteronuclear NOEs - that describe
both the overall tumbling, the relative motion of domains and the extent and rate of
internal motions of a macro-molecule.
Nuclear spin magnetic relaxation is a direct consequence of the magnetic coupling and
the associated energy exchange of the spin system (protein) to its surrounding
environment, termed the lattice i.e. the buffer solution. As the lattice modifies the local
magnetic fields associated with the protein's nuclear spins, the lattice and the spin system
are magnetically coupled (weakly). And due to stochastic Brownian motions of
molecules in liquid solutions, this renders the local magnetic fields time-dependant. This
magnetization can be resolved into two components: a nonadiabatic component
perpendicular to the magnetic field (transverse) and an adiabatic component parallel to
the magnetic field (longitudinal). The longitudinal component is associated with one of
the two main relaxation process', namely, spin-spin (or longitudinal) relaxation. While
the transverse component contributes to both of the two main relaxation processes: spin-
lattice (or transverse) and spin-spin relaxation. Routinely in protein NMR the
relationship between relaxation and molecular motion is exploited to study the backbone
dynamics of a protein via the spin-lattice and spin-spin relaxation times (section 2.3.7.2
and 2.3.7.3 for 7) and 77 respectively) and also steady-state heteronuclear NOEs (see
section 2.3.7.4) of backbone amide bonds.137
2.3.7.2 15N spin-lattice (Ti) relaxation
T\ relaxation is the process by which the lattice acts as a thermal reservoir, accepting
energy from the excited spins as they return to thermal equilibrium. There are three
87
CHAPTER 2: METHODS
principle types ofmagnetic interaction which contribute to spin-lattice relaxation of spin
Vi nuclei. The first, dipole-dipole interactions is where the nucleus experiences a
fluctuating field due to the motion of neighboring spins. The second, chemical shift
anisotropy, where different orientations of the molecule exposes the spins to differing
field strength as the magnetic shielding from the surrounding electron density fluctuates
with rotational motion of the molecule. The third, spin-rotation interaction, results from
the generation of a small electric current from molecular tumbling in turn inducing a
small fluctuating magnetic field at the nucleus*. The spin-lattice relaxation time, T,, is a
time constant that characterizes the rate at which the longitudinal Mz component of the
bulk magnetization (M(t)) recovers to equilibrium (M(0)) along the z-axis, following being
flipped into the transverse Mxy plane, and is the time taken to recover approximately
63% of its initial value.120
In the recording of 7j data the transverse components ofmagnetization are eliminated to
prevent contributions from Ti relaxation. The 7j time constant is measurable by various
types of experiments, however, in this project 7j was measured using multiple inversion
recovery experiments. This involves applying a series of pulse sequences of the type
180°-t-90°, where x is a small time which is varied from one experiment to the next. The
first 180° pulse inverts Mz, which decays exponentially for time x until application of a
standard 90° pulse tips the bulk magnetization into the xy plane for detection. The T,
value is then extrapolated from the resultant series of partially relaxed spectra as peak
size is a function of T|.
To obtain T, values for backbone amide nitrogens a series of interleaved ['HI5N]-HSQC
experiments, one for each different x value were collected. Following identical
processing in AZARA the individual amide cross-peaks in each spectra were picked in
Analysis, excluding very weak peaks and peaks in overcrowded regions where
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calculation of T, will be associated with a large error. Within CcpNMR, the Rates
Analysis function was used to determine each amides T\ value from an exponential fit of
the intensity of the crosspeak as a function of relaxation delay times. Furthermore the
Rates Analysis function was used to calculate time constant errors from the fitting error
from multiple fitting routines.
2.3.7.3 15N spin-spin (T?) relaxation
Following a radio-frequency excitation pulse, excited spins relaxing to the ground-state
lose their coherent (in-phase) magnetization. This occurs not only from the conversion of
transverse magnetization to longitudinal magnetization through the relaxation mechan¬
isms described above, but also by loss of phase coherence (de-phasing) of the initially
synchronous population of oscilating spins. However, the associated rate of decay of the
x and y components of transverse magnetisation is characterised by the time constant
T2*. This value distinguishes it from the true transverse relaxation time, T2, as T2* (T2* <
T2) also accounts for static inhomogeneities in the Mz direction of the external magnetic
field that also contributing to dephasing.
To extract the T2 value caused by spin-spin relaxation alone (i.e. independent of field in-
homogeneity) from the T2* a series of spin-echo experiments are performed. This in¬
volves applying a series of pulse sequences of the type 90°-x-l 80°-x. Where a 90' pulse
flips the spins into Mxy, allowed to dephase for time x, followed by a 180° pulse, and al¬
lowed to refocus for a period of time x. This reverses the order of the spins with the
slower ones now ahead (and falling back) and the faster ones behind (and catching up),
allowing spins which were dephasing due to field inhomogeneneity to regain their phase
coherence and thus eliminating their contribution to T2. The effective rephrasing of spins
results in a reappearance of the FID (spin-echo), which is smaller than the original signal




The pulse sequence used in the current study included Carr-Purcell-Meiboom-Gill
(CPMG) pulse segments to reduce contributions from field inhomogeneitymolecular dif¬
fusion and chemical exchange, including conformational changes. And as with the ob¬
taining Ti values for backbone amide nitrogens, T2 values were obtained from a series of
interleaved ['H,15N]-HSQC experiments, one for each different t value where t < T2.
Again the spectra were processed identically in AZARA and amide cross-peaks were
picked in Analysis, excluding very weak peaks and overlapping peaks. Within CcpNMR,
the Rates Analysis function was used to determine each amides T2 value from an expo¬
nential fit of peak intensity as a function of relaxation delay times as well as their associ¬
ated time constant errors.
2.3.7.4 Hetero-nuclear steady state [1H15N] NOE
The ['H,I5N] heteronuclear NOE cross-relaxation rates are more sensitive to internal
dynamics than the Ti and T2 relaxation rate measurements and therefore provides
information regarding the motion of individual amide bond vectors in the shorter ns
timescale.'" NOE cross-relaxation occurs via dipole coupling of an excited spin with
spins close in space. Those spins that undergo motion faster than the overall tumbling of
the molecule will show a decreased NOE intensity relative to a reference spectrum. Thus
the more mobile the amide bond (on a ns timescale), the lower the amide cross-peak
intensity. The ['H,15N] heteronuclear NOE was expressed in terms of the ratio of the
intensity under saturating conditions over the intensity under non-saturating conditions
to reflect the impact of the negative NOE enhancement on intensity.
2.3.8 Structure calculation and refinement
2.3.8.1 Introduction
Two of the several reliable methods for obtaining 3-D protein structures from NMR data
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were employed in the structure determination ofC7 CCPs and CFF. The first method
employed using CYANA138 version 2.1, is the conjugate gradient minimisation of a
variable target function using torsion angle dynamics. The second method employed
using the structure calculation software Crystallography and NMR systems (CNS),139 is
the minimisation of a hybrid energy target function using restrained molecular dynamics
in Cartesian space. CYANA was used to semi-automate the NOE assignment procedure
and generate the initial non-refined structures. Following this, CNS was used to refine
the structures in water solvent. Both methods involve multiple parallel searches of
conformational space in order to minimise a potential energy target function as well as
satisfying the experimental data set. CYANA uses torsion angle dynamics in which the
empirical restraints (i.e. bond lengths, bond angles, prochiralities) are kept fixed at their
optimal value to minimise a variable potential energy target function in torsion angle
space subject to the experimental distance restraints. Conversely, CNS achieves this in
Cartesian space by solving Newton's equations ofmotion for all atoms using a hybrid
energy target function of empirical and the experimental restraints. In both methods, the
energy minimization function reduces the target function while implementing simulated
annealing. In simulated annealing, the application of repeated in silico heating steps
followed by slow, progressing cooling steps enables adequate sampling of
conformational space and the avoidance of local energy minima to reach a global energy
minimum.
2.3.8.2 CYANA
The CYANA program for NMR structure calculation is based on its predecessor
DYANA (DYnamics Algorithm for Nmr Application).140 Unlike DYANA, CYANA 2.1
includes the Combined automated NOE assignment and structure determination
(CANDID) software module.141 This enables NMR structure determination of proteins
by automated assignment of the NOESY spectra. The routine used for CYANA structure
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calculation (Fig. 27) is an iterative approach that runs through seven cycles ofNOE
cross-peak assignment (by the CANDID module) followed by DYANA-driven structure
calculation (torsion angle dynamics).
Amino acid sequence
Chemical shift assignment list









Fig. 27: General scheme for the annotated NOE assignment and structure calculation in CYANA
2.1. Figure adapted from paper.138
The inaugural cycle incorporates the input fdes into the calculation: peak lists for
distance restraints, chemical shift tables for all atoms in the molecule and the amino acid
sequence in XEasy format. CANDID generates a primary assignment list of one or more
assignment contributions for each NOESY cross-peak (chemical shift tolerances set to
0.03, 0.04 and 0.45 ppm for the direct 'H, indirect 'H and l5N/'3C dimensions
respectively). Subsequently this list is filtered by applying a normalized score to each
assignment and retaining those that are high ranking. An approach called network-
anchoring is then used to remove possible noise peaks with low generalized contribution
score values and to reduce ambiguity within each peak by eliminating peak contributions
with low scores. The score is formulated to rate the initial, chemical shift-based
assignment on the basis of how well the assigned NOE-connection is embedded in a
(consistent) set of neighbouring NOE cross-peak assignments that support it. Therefore
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the lowest scores are applied to single isolated constraints not mutually supported by
other constraints and favours NOE cross peaks embedded in a redundant network of
NOE connectivities. In the first two cycles only the Constraint Combination function of
CANDID is also applied to combine long-range distance constraints, thereby reducing
the influence of single incorrect distance restraints originating from NOE artefacts.
Lastly the cycle is complete by a structure calculation step using the DYANA torsion
angle dynamics (TAD) algorithm defined by the CYANA target function138 with
simulated annealing. A conformation that satisfies the torsion angle restraints and
distance restraints in the absence of steric overlap will lead to a desirably lower target
function value. During the simulated annealing, a series of 10000 TAD steps minimize
the target function with the system is couples to a temperature bath and held at 9600K
for the first 2000 steps and then slowly cooled down over the following 8000 steps to
overcome energy barriers of local minima. All subsequent cycles incorporate the three-
dimensional protein structure from the previous cycles, in addition to the complete input
used for the first cycle.
As cross-peak evaluation is also driven by compatibility with the intermediate 3-D
structure in proceeding cycles, it is critical that the correct polypeptide fold is found
during the first cycle. This was confirmed with a backbone RMSD for each individual
CCP domain (of the structures generated in cycle 1) being equal to or lower than 3A".
Initially two sets of structure calculation were performed in parallel; one where the
conserved disulfide bonds in each module were not defined, and the second with the
disulfide bonds were defined. Consistency in the observed structures allowed
confirmation of the defined disulfide bonds. Compliance with the remaining specified
criteria138was essential prior to importing the NOE assignments from the final CYANA




CNS unlike CYANA allows for the refinement of protein structures in explicit solvent.
This has been shown to significantly improve structural quality criteria such as backbone
confirmation, the number of unsatisfied hydrogen bond donors/acceptors, packing
quality and Ramachandran-plot statistics.139 However CYANA has an explicit
automated-NOE crosspeak assignment function and is therefore used to produce
complete NOE assignments from the final CYANA structure. These were imported into
analysis via the FormatConverter and the NOE cross-peak relative intensities were
translated into distances in angstroms. Finally, using the FormatConverter, the distance
restraints were exported in CNS format.
CNS Version 1.2 employs restrained molecular dynamics based simulated annealing in
Cartesian Space to minimize a hybrid energy target function139 for the calculated
structures. The overall energy (EOVeraii) target function is composed of two energy terms.
The first energy term refers to the experimental restraints (Enoe) associated with the
NOE distance restraints, where a large NOE energy term dictates a large number ofNOE
violations. The second term pertains to empirical restraints (EFF) and is expressed as a
force field described by covalent terms maintaining idealized bond lengths (Ebond), bond
angles (Eangies), dihedral angles (Eimproper), chiralities (Eimproper) and a van der Waals
repulsive term (EVdw), that inhbits steric clashes between atoms based on their van der
Waals radii.
Each CNS structure calculation progresses through three stages: 'random', 'regularise'
and 'refine'. The first stage involves the generation of 100 reduced and non-bonded
random protein structures. The random structures are calculated via 50 steps of energy
minimization using the Powell minimization algorithm, with NOE restraints present and
empirical forces set to low values. Molecular dynamics simulations are then employed to
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calculate the time dependent behavior of the protein with respect to atomic motions
within the molecule. At 2000 K 300 steps of molecular dynamics are simulated,
followed by three time-step varying rounds of 500 molecular dynamics steps at a lower
temperature of 1500 K.
The 100 'random' structures form the starting point for the 'regularise' stage of the
structure calculation, whereby their local geometry are optimized. Specifically, the
idealized bond length, NOE and vdW terms were reduced by Powell minimization in
400 steps, followed by another 400 steps of Powell minimization of bond angles.
Chirality and planarity terms were then gradually introduced over four rounds of
molecular dynamics of 250 steps each, followed by a further two rounds ofmolecular
dynamics of 500 steps each. Next the correct handedness of the molecule was
established using chiral swapping whereby the chiral moieties within the protein
(methyl, methylene and side-chain amide protons) have their handedness swapped
randomly. This is performed during three rounds of simulated annealing, therefore
allowing the system to escape local energy minima traps by adopting higher energy
conformations. The weightings of the van der Waals and NOE terms were then increased
in the Powell minimization in conjunction with system cooling (2000 to 100K) over
2000 steps, prior to a final 400 minimization steps.
The random regularized simulated annealed structures obtained from the 'regularize'
stage of the calculation form the input for the final 'refine' stage. Firstly, molecular
dynamics simulations are preformed at high temperature (2000 K) over 10000 steps,
with the NOE and H-bond derived restraint terms weightings set much higher with
respect to covalent and non-bonded terms. The system was again cooled to 100 K over a
total of 10400 energy minimization steps, including prochiral swapping and whereby the
final 400 steps involve an increase in the weighting of the covalent and non-bonded
95
CHAPTER 2: METHODS
terms to be equivalent to the experimental terms weighting.
The 100 refined structures are then ranked and plotted in terms ofNOE energy and
overall energy. Those structures converging with the lowest energies (ideally >20%)
were probed for violated NOE distance restraints. Violated restraints cross-peaks were
then investigated and the upper distance value adjusted upon identification of peak
artifacts (i.e. peak overlap and noise signal or diagonal interference) and the CNS
calculation was repeated.
Following meeting the specified criteria the ensemble of structures is subjected to a final
CNS refinement step in water solvent. This was achieved by mimicking the
physiological environment of a protein in solution using the Lennard-Jones non-bonded
potential and electrostatic force field in the RECOORD protocols
(http://www.ebi.ac.uk/msd/recordf. Four simulated annealing and molecular dynamics
rounds are used in the explicit water refinement, whilst the protein is immersed in a 7 A
shell ofwater molecules. The first three molecular dynamics rounds involve system
heating from 100 K to 500 K over 200 steps, then 500 K maintenance over 2000 steps
and cooling to 25 K over 200 steps. With the protocol concluded with a final energy
minimisation over 200 steps.
2.3.8.4 Molecule visualisation programs
Individual structures and protein ensembles were viewed in the molecular visualisation
programs MOLMOL'42 2k.2 and PyMol.143 MOLMOL was also used for the calculation
of backbone root mean square deviation (RMSD) values.
2.3.8.5 Structural analysis programs
The quality of the calculated structures was assessed using Procheck144 (Ramachandran
plot statistics) and the course quality packing control module from WHATIF.145 Surface
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electrostatics were determined using the Adaptive Poisson-Boltzmann Solver (APBS)146
within PyMOL (DeLano Scientific, San Carlos, CA) using PARSE forcefield generated
PQR files calculated using the PDB2PQR server ('http://krvptonite.nbcr.net/pdh2pqr/).
Surface lipophilicity was determined using the MOLCAD module147 of SYBYL v6.9
(Tripos Associates, St. Louis, MO). The buried surface area at the intermodular junctions
was calculated using GETAREA 1,0,148 being computed as: (SA Modulei + SA Modulej)
- SA Bimoduleij. Intermodular angles were determined using the same protocol as previ¬
ously described using the program XYZ. Protein interaction sites were identified using
the online STP server (httpf/opus.bch.ed.ac.uk/stp/T Combinatorial extension149 was em¬
ployed to compare each experimentally determined CCP structure within the comple¬
ment system against the closest-to -mean individual structures of CCP1 and CCP2.
2.4 Low Resolution Structural Studies
2.4.2 Small Angle X-ray Scattering
SAXS data acquisition and model production for C7-CFF was performed by Dr.
Elizabeth Blackburn (Edinburgh University). Synchrotron radiation X-ray scattering data
were collected on the ID 14-3 BioSAXS beamline (ESRF, Grenolble) using a PILATUS
1M pixel array detector (Dectris, Switzerland) and four frames of 30 seconds exposure
time. Solutions ofC7-CFF (8 mg/ml) were measured at 10 °C in 20 mM sodium acetate
buffer, pH 4.0 (NMR buffer conditions), at protein concentrations of 4 and 8 mg/ml.
Radiation damage was observed as a significant increase in the intensities of low-angle
data after the second 30-s exposure. Thus, 5%v/v glycerol was added and the sample was
continually flowed through the 1.8 mm qaurtz capillary sample cell during data
acquisition. Data from the detector were normalized to the incident beam intensity,
averaged and the scattering of buffer solutions subtracted. The difference curves were
scaled for solute concentration. All data manipulations were performed using the




2.4.3.1 The cross-linking reaction
Chemical cross-linking coupled with MS was utilised to analyse the architecture of three
complement proteins: C3, C3b and C7. The chemical cross-linker BS2G-dO
(BisfSulfosuccinimidyl] glutarate), and its deuterated equivelant BS2G-d4 (Thermo Fischer
Scientific) where used dissolved in DMSO in equal quantities for the final cross-linking
reactions, to identify cross-linked peptides by their 4 Da mass difference. For trial cross-linking
reactions a series ofprotein:cross-linker ratios 1:100, 1:300, 1:1000 and 1:3000 were performed
on 100 pmol of either C3b or C7 in a final reaction volume of 1 OOpl. The proteins were cross-
linked in 10 mM HEPES pH 7.0, 200 mM potassium acetate for lhr at room temperature. The
reaction was stopped by adding 5 pi of 1M ammonium bicarbonate. The reaction mix was
seperated on a NuPAGE 4-12% Bis-Tris gel using MES running buffer and Coomassie blue
stain. The optimum cross-linker ratios were selected by SDS-PAGE analysis and additionally, as
required in the case of C7, by MS analysis. Upon selection of the optimum cross-linking ratio
final cross-linking reactions were carried out on 80 pg, 80 pg and 50 pg ofC3, C3b and C7
proteins respectively, using the same conditions described above.
2.4.3.2 Sample preparation. MS analysis and database searching
Following completion of the cross-linking reaction sample preparation, MS analysis and
database searching was performed by Zhuo Chen (Juri Rappsilber group, Edinburgh University).
Monomer bands in the SDS-PAGE gel were excised and the proteins reduced and digested using
standard trypsin digest protocols. Using the published protocol" cross-linked peptides were
fractionated using SCX-StageTips. The peptides were then fractionated using strong cation
exchange chromatography (200 X 2.1 mm Poly SULFOETHYLA column; Poly LC, Columbia,
MD, USA) and were eluted directly into an LTQ-Orbitrap classic mass spectrometer. Peptides
and their subsequent iontrap fragments were detected at high resolution in the Orbitrap. The raw
MS files were processed into peak lists using MaxQuant151 using default parameters. Searches
were conducted using a database containing the sequences of C3, C3b, or C7 using the in-house
software Xi. All identified peptides contained either a lysine residue or a protein N-terminus at
the most likely linkage position as determined by observed fragments. Cross-linking candidates
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were manually validated using the in-house Xaminatrix program and sorted into high and low
scoring using an in-house algorithm.152 Cross-linking reactions and analysis were repeated and
only those peptides that were reproducible, had mass-errors within 6 ppm of the predicted
peptide mass, had exceptional database search scores and had a well-explained spectrum with
fragment information for both peptides, were considered high confidence cross-links and used
for further analysis.
2.4.3.3 C7 Architecture
For the assessment of protein architecture using the high confidence cross-link list,
models were required for C7's protein modules. The MACPF was homology modelled in
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MODELLER153 on the X-ray structure ofC8a-MACPF and was provided by Dr
Dinesh Soares (Edinburgh University). All other C7 module's models were produced by
the online homolgy modelling server PHYRE. These protein models had reasonable
alignment scores, modelling scores and WHATIF145 coarse packing quality scores (Table.
8).
Target Template from % Identity E scores Whatif scores
TSPN Thrombospondin TSP1 33 1.30E-011 COCO1
LDLRA Rhinovirius 38.5 4.00E-006 -3.2
MACPF C8a-MACPF 30 n/a -2.6
EGF-like Factor VII 28 1.30E-011 -3.5
TSPC Properdin TSP2 35 3.00E-006 -2.5
Table. 8: Table of module homolgy model quality.
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3.1 Introduction and overview of constructs
The DNA encoding the C-terminal domains of C3 and C5, in addition to a series of
construct coding for C-terminal modules of C6 and C7, were originally cloned into
pET-15b vectors by members of Dr Ronald Ogata's laboratory. Despite expression in the
Origami B pLYSs (Novagen) bacterial strain, many of the constructs, and particularly
the larger ones, resulted in very low yields of soluble protein. In the current work, all
constructs were re-cloned for expression in P. pastoris. This organism was chosen
because, as a eukaryote, it promotes disulfide pattern formation in the endoplasmic
reticulum. Moreover it can secrete proteins into the medium thus easing purification, and
it can produce very large amounts of recombinant protein yet grow on miminal media
consistent with incorporation of isotopic labels (for NMR).154 Figure 28 illustrates the
constructs used for re-cloning. Table. 9 summarises the N- and C-terminal sequences of
the constructs.












Fig. 28: Summary of constructs re-cloned into P.pastoris expression vectors. A schematic representation
of a MAC protein is shown at the top for comparison. The modules draw below indicate the composition of
the various recombinant proteins that were subjected to investigation in the current study.
3.2 Re-clone into P. pastoris
3.2.1 DNA Manipulation
The inserts were doubly digested from TOPO vectors (in the case of pGAP cloning) or
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from PCR-amplified DNA inserts (in the case of pPIC cloning). The DNA inserts were
successfully ligated into compatibly digested pPIC/pGAP vectors. pPIC/pGAP vectors
were compatibly digested following amplification and extraction of the plasmid DNA
from TOPIO cells. Digestion mixtures were subjected to agarose gel electrophoresis, and
the appropriate plasmid or insert gel band was excised and gel extracted prior to the
ligation reaction. No figure is shown as visualization of the DNA bands by UV light can
damage the DNA, reducing the efficacy of the ligation process. Following ligation of the
inserts into pPIC/pGAP and transformation into TOPIO cells, the resultant colonies were
screened by PCR to ensure presence of an appropriately sized insert prior to
amplification and extraction of the construct DNA. Many TOPIO colonies did not
contain the insert, but instead contained empty vectors that allow them to grow on the
agar plates containing zeocin for selection. The problem of colonies growing with empty
vectors was subsequently resolved by using a higher ratio of insert to vector. Constructs
containing plasmids that had been positively identified by DNA sequencing were then
linearized for transformation into P. pastoris (strain KM71H). Transformation was

















C5C345C Xhol Ala^-Cyc1676 EAEA No Yes Yes, Asn1630 17193.6 / Yes
C3C345C Xhol Ala1514-Asn1663 EAEA No Yes Yes, Asn1617 17841.9 / Yes
CBCCPs Pstl Senys706 EAEAA Yes Yes No 14768 Yes Yes
C7 CCPs Pstl Glu^-GIn590 EAEAA Yes Yes No 13689.7 No Yes
CCF Xhol Glu^-Ser768 EAEA No Yes Yes, Asn754 22465.9 / Yes
CF Xhol lle629-Ser768 EAEA No Yes Yes, Asn754 15849.4 / Yes
CFF Xhol lle^-GIn843 EAEA No Yes Yes, Asn754 23784.3 / Yes
FIMs Xhol Lys^-GIn843 EAEA Yes Yes Yes, Asn754 17200.6 Yes Yes
Fiml Xhol Lys691-Ser768 EAEA Yes Yes Yes, Asn754 9265.7 Yes Yes
Fim2 Xhol GI^-GIn843 EAEA No Yes No 8282.2 / Yes
Table.9: Re-cloning summary. Summary of constructs and re-cloning success (from pET15b to
pGAPzaB/pPICzaB) for all available constructs.
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3.2.2 Screening for expressing clones
Successfully transformed P. pastoris clones were tested for protein production in "mini-
scale" (see section 2.2.8.2) trials. Protein production trials for pGAP-transformed clones,
in which 10 ml of YT media, were inoculated with a single colony and incubated in 50
ml Falcon tubes. As pGAP allows for constituent protein expression, which is costly for
isotopic labelling of recombinant proteins, rich media was used to maximise protein
production for non-NMR based applications. Subsequent analysis of the cell supernatant
yielded SDS-PAGE results that were difficult to interpret due to the presence of peptone
in the expression media and a consequent poor resolution of bands (Fig.29J).
Nonetheless, even from these poor-quality gels it was evident that clones transformed
with pGAP containing DNA encoding C7-FIM1, C7-CCPs (i.e. both CCP modules) and
C7-FIMs (i.e. both FIM modules) produced proteins of the expected size and therefore
glycerol stocks were stored for future analysis. In the case of pPIC-transformed clones,
50 ml of minimal growth media (BMG) in 150 ml baffled flasks were used in protein
production trials to maximise aeration of the cell cultures in the hope of increasing yields
of recombinant protein. After two days initial growth the cells were transferred to BMM
media containing methanol to induce expression. Because these cells were grown in
minimal media (to assess protein production under conditions for future isotopic
labelling) the SDS-PAGE performed on concentrated media yielded clearer results.
Each of the clones produced a recombinant protein of the expected size and in easily
detectable (Coomassie-blue staining) quantities (Fig 29).
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Fig.29: Mini-scale protein production trials of P. pastoris clones. Gels (A-I) represent the outcome of
protein production trials of pPIC clones and (J) for pGAP. Non-reducing (NR) conditions are to the left and
reducing (R) to the right. In Gel (I) all samples were run under reducing conditions. A: C5-C345C; B: C3-
C345C; C: C6CCPs; D: C7-CCPs, D*:C7-CCF; E: C7-CFF; F: C7-CF; G: C7-FIMs; H: C7-FIM1; I: C7-
FIM2; J: C6-CCPs, J*: C7-CCPs, J2": C7-FIMs. In all gels (C ) is the negative control and the numbers
correspond to the number of clones tested.
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3.3 C7 CCPs expression, purification and characterization
3.3.1 Expression
The C7-CCPs construct was originally produced in the Origami B strain of E. coli
freshly transformed with the suitably manipulated pET-15b vector, prior to re-cloning
into P.pastoris. As described previously (see section 2.2.6.1) the OrigamiB pLysS
expression system has been optimized for tightly regulated expression and production of
soluble disulfide-containing proteins. Using expression conditions as determined by
collaborators (Dr. Ron Ogata et at, Torrey Pines Institute, Florida), identical to those
used for production of C5-C345C and C7-FIMs,53,54 some C7-CCPs is observed in the
soluble fraction but the majority of recombinant material (judging by the intensity of
bands on SDS-PAGE) was found as an insoluble aggregate in inclusion bodies (Fig. 30).











Fig. 30: Reducing SDS-PAGE of C7-CCPs recombinantly produced in the OrigamiB strain of E. coli:
(1) media supernatant (2) cell lysate (3) cell pellet (produced by addition of 20pl of H20 added to cell-pellet
and heated at 100°. lOpl was loaded in each lane.
3.3.2 Protein purification
A protein purification procedure was optimized to obtain highly purified protein and to
minimize loss. In the first purification step, C7-CCPs was purified from the cell lysate
by binding via its N-terminal His6-tag to divalent metal ions immobilized on an
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Immobilised Metal Affinity Chromatography (IMAC) sepharose resin column (1 ml, GE
Healthcare). Depending on the metal ion used, varying degrees of E. coli protein
impurities will bind to an IMAC column. Moreover, changes in the pH of the buffer
alters the affinity of the contaminating proteins as well as the His6-tagged protein for the
metal ion. With higher metal ion binding affinities non-specifically bound proteins
compete with His6-tagged protein for binding metal ions. This can result in reduced
yields of recombinant protein and the resultant loss of protein in the flow-through.
Therefore binding of C7 CCPs and protein impurities and elution from the column using
an Imidazole gradient was assessed on both Ni2+and Co2+-loaded affinity resins, over a
range of pH values, with the goal of obtaining strong but selective binding of C7-CCPs
(Fig. 31). Non-specific binding was found to be greatly reduced (in comparison to the
use of Ni2+) when using Co2+ coupled to the resin, and a buffer pH of 6.5 provided
maximum resolution in the elution positions of C7-CCPs and the impurities. These
conditions were used in further purification attempts. Subsequently, 50 mM imidazole
was included in the wash buffer to wash out impurities that were non-specifically bound
to the column.
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Fig. 31: Optimization of metal-chelate affinity chromatography of C7-CCPs. The top panel shows the
chromatogram with UV traces of protein eluted from the Histrap column along an imidazole gradient (green-
solid). Nickel was used as the metal ion at buffer pH 6.5 (light-blue-dashed line, gel A) and pH 7.2 (dark-
blue line, gel B). Cobalt was used as the metal ion at buffer pH 6.5 (green-dashed line, gel C) and pH 7.2
(grey line, gel D). The bottom panel shows SDS-PAGE gels run on fractions representing the impurity peak
(fractions 7/8) and the numbered C7-CCPs-containing peak fractions.
The second stage of purification was the removal of the His-tag by thrombin cleavage at
the cleavage site that had been engineered in to the recombinant protein (see section
2.2.6.1). Following cleavage a second metal-chelate affinity chromatography step was
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performed. This removed the cleaved His-tag and impurities, while the His tag-free C7-
CCPs was recovered from the flow-through (Fig. 32). The sample still contained
impurities, however, (~10% as estimated from the gel) and requires a further 'polishing'
step. The efficacies of two potential polishing steps - reverse-phase HPLC and gel
filtration column - were compared (Fig.33) using SDS-PAGE run on the purified
fractions. Anion-exchange chromatography was also attempted, however no binding to
the column was observed (data not shown). According to this comparison, gel-filtration
proved more effective at removing impurities than reverse-phase chromatography as
may be judged from Figure 33.
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Fig. 32: Removal of the His6-tag. Lane (1) Before proteolysis; Lane (2) Flow-through fraction 1 (FT 1);
Lane (3) FT 2; Lane (4) FT 3; Lane (5) FT 4; Lane (6) FT 7; Lane (7) FT 8; Lane (8) FT 9; Lane (9) FT 10;
Lane (10) elution fraction 1 (ET 1); Lane (11) ET 2; Lane (12) ET 3; Lane (13) ET 4; Lane (14) ET 5. From
left to right, C7-CCPs before exposure to thrombin, C7-CCPs after cleavage, and finally the tiny N-terminal
HiSf, tag, are each depicted with arrows.
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Fig. 33: HPLC and gel filtration as a C7-CCPs purification polishing step. Chromatogram showing
elution of C7 CCPs samples from an HPLC column (Discovery® BIO Wide Pore C8-5 pm, 25 cm x 4.5
mm, Supelco) (A) or gel filtration column (HiLoadTM 16/60 SuperdexTM 75 prep grade, GE Healthcare)
(B). Impurities and C7 CCPs are marked with arrows.
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3.3.3 Characterization
Electrophoretic migration of C7-CCPs was retarded in the presence of the reducing
agent, mercaptoethanol (see Fig. 34B). This is consistent with loss of compact structure
by reduction of intra-molecular disulfide bonds. The folding of the recombinant protein
was further assessed by inspection of their 'H-NMR spectra (Fig. 34A). The spectra
contain peaks in the regions around 6 ppm and 9 ppm, indicative of tertiary structure.120
To confirm if full-length C7-CCPs had been successfully purified, samples were
analyzed by mass spectrometry (MS) (see Appendix D). The recombinant protein has a
predicted mass (including an N-terminal cloning artefact (GSHM)) of 13,985.1 Da (for
the oxidised protein, calculated in Protparam).33 MAFDI-TOF MS yielded a mass of 13,
984.8 Da +/- 1.2
Having established a working purification strategy for C7-CCPs produced by E. coli,
yielding ~1 mg per litre of expression media of pure, soluble, fully-folded protein, a 3F
batch of 15N-enriched C7-CCPs (500pg of purified protein/1 of expression media) was
similarly prepared for NMR optimisation. This was followed by production of a 7L
batch of 13C,15N- C7-CCPs (300 pg of purified protein /I of expression media) for the
purpose of assignment and NMR-derived structure determination.
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Fig. 34: C7-CCPs characterisation. (A) Shows a 'H-NMR spectrum with small-molecule impurities
marked with an arrow. (B) Shows the movement of protein on the gel under reducing (R) and non-reducing
(NR) conditions.
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3.3.4 Optimizing sample conditions for NMR
A 15N-labelled C7-CCPs sample was produced and purified (as described above) and
[1H,15N]-HSQC's were recorded (Fig. 35) for optimization of sample conditions for
NMR structural characterization. Firstly the issue of spectral folding was addressed.
Spectral folding is a phenomenon that occurs when the spectral width specified during
experimental set-up is insufficient to detect the full range of frequencies present. Under
these circumstances, NMR peaks occur in the spectra at frequencies different from their
real frequencies that are outside the chemical shift range of the spectral window. These
peaks may be inverted and occur within the spectra at the same distance inside the
spectrum boundary as they would have been beyond it had they not been folded. To
increase the digital resolution, reduce the recording time and/or enhance sensitivity of
multidimensional experiments, the spectral width of the 15N and or 13C dimension(s) was
set to a minimum whilst ensuring that folded peaks did not overlap with others, this was
achieved by recording HSQCs with different sweep widths, final sweep widths of 11
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Fig. 35: ['H,15N]-HSQC of C7-CCPs. Spectral folding in the 15N dimension was employed to increase the
resolution, with three folded peaks (negative) observed in cyan.
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The effects of varying salt concentration and pH of the standard potassium phosphate
buffer as well as the temperature of the sample were assessed by comparison of [1H,15N]~
HSQC spectra. A good quality [1H,15N]-HSQC spectrum proved to be a useful
experiment to assess the suitability of conditions for further NMR experiments aimed at
structure determination. At least one cross peak was expected for every residue in the
protein (except proline and the N-terminal amino acid residue) as each backbone amide
should give rise to a signal. In general, conditions were sought in which cross-peaks
were of uniform intensity since very strong or very weak peaks suggest regions in fast or
intermediate conformational exchange that are likely to pose problems later in the
assignment process. Tryptophan and other residues containing NH (or -NH3+) in their
side-chain give rise to additional peaks but these are less important, in general. The
ultimate aim of sample optimization was to resolve in so far as possible a detectable
peak for each backbone amide.
High salt concentrations can cause difficulty in tuning the NMR probe and will reduce
the sensitivity of both traditional and cryo-probes. Furthermore salt absorbs the radio-
frequency field applied to the sample during experimentation, which can lead to a
smaller bandwidth of excitation, reduce the homogeneity of the applied pulse and cause
temperature changes in the sample during the experiment.38 However, low salt
concentrations may have detrimental effects on the behaviour of the protein in solution,
such as precipitation or aggregation. For C7 CCPs there was a loss of sensitivity and
resultant intensity of peaks in the HSQC spectrum (Fig. 36) with an increase in salt
concentration. The highest quality HSQC spectrum was obtained with no salt in the
sample.
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Fig. 36: Comparison of C7-CCP's' ['H, 15N]-HSQC at different salt concentrations: 0 mM NaCl (blue),
50 mM NaCl (green), 100 mM NaCl (red).
The optimal pH of the solvent for any NMR sample is unlikely to exceed 7.0. This is
because the intrinsic exchange rate of a solvent-exposed backbone amide proton
increases as a function of pH,155 causing broadening of amide proton line-widths.
Therefore, although it is desirable to mimic physiological pH conditions, (about 7.2 in
blood plasma) it is often advantageous to maintain an acidic pH for NMR studies. Hence
it is important to ensure the protein conformation is not disturbed or even disrupted at
lower pH values. In the case of C7-CCPs, although some detectable peak movements
occurred, there were no drastic changes to the NMR "fingerprint" at lower pH values. It
was decided that pH 5.5 and 6.5 are too close to the theoretically calculated pi of 5.9 for
C7-CCPs and should not be used so as to avoid isoelectric precipitation effects. On
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balance, pH 5.0 was selected and, fortuitously, peaks were resolved at this pH that had
been overlapped at higher pHs.
ppm
Fig. 37 Comparison of C7 CCP's' ['H,' 'N]-HSQC spectra at various pHs: pH 5.0 (red), pH 5.5 (orange),
pH 6.5 (yellow), pH 7.0 (light blue), pH 7.2 (dark blue).
The temperature of the sample may also affect the strength of the NMR signal as well as
sample stability. A temperature titration (range: 15-30°C) revealed that temperature
changes had little effect on the C7-CCPs chemical shifts, although traceable movements
of some peaks were observed (Fig. 37). The peak intensity grew weaker with a decrease
in temperature, with signals at 15°C and 20°C being significantly weaker than other
temperatures. The choice of 25°C seemed a reasonable compromise between sample
stability, signal quality and physiological relevance. It is also consistent with the NMR
studies of the C7 FIMS, which could facilitate future investigations that aim to merge
CCPs and FIMs structures together.
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Thus the optimal conditions for C7-CCPs were 20 mM potassium phosphate buffer, no
salt, and pH 5 at 25°C. Under these optimised conditions, 3D spectra have been
obtained of a quality worthy of resonance assignment.
%
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Fig. 38: Comparison of ['H,I5N]-HSQC spectra of C7-CCPs collected over a range of temperatures.
Pale blue (15°C), blue (20°C), yellow (25°C), orange (28°C), red (30°C).
3.4 C7 CFF expression, purification and characterization
3.4.1 Expression
In "miniscale" protein-production trials, all five clones picked for CFF expression
produced a strong protein band (following SDS-PAGE with Coomassie blue staining) at
~30 , and a weaker band at ~24 kDa, with no evidence of protein degradation (Fig. 29).
It is reported that both P. pastoris and human cells add approximately 5 kDa of sugars
per N-linked glycosylation site and both express a mixture of glycosylated and non-
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glycosylated forms of a protein.118 Therefore the higher molecular weight band likely
corresponds to CFF that is N-glycosylated at Asn754 in FIM1, which is the single
consensus site (NXT, where X is any amino acid) in CFF. The lower band is thus likely
to correspond to non-glycosylated CFF. This was later confirmed, by deglycosylation
with the endoglycosidase enzyme EndoHf.
The strength of expression, the stability of the secreted protein to proteolysis and
evidence of a straightforward harvesting procedure in that the protein bound to loose SP
Sepharose™ beads (GE Healthcare) prompted progression to expression in a fermentor.
Yields of non-isoptopically enriched material were high at 15 mg/1 of cell culture. Using
a protocol for feeding P.pastor is that was well established within the laboratory (see
section 2.2.8.3) the overproduction of 15N-C7-CFF and 13C,15N-C7-CFF, both in double
labeling conditions, yielded 8 mg/1 and 10 mg/1 of cell culture respectively. The natural
abundance batch of C7-CFF provided samples for establishing a purification procedure
and for protein characterization. The 15N-C7-CFF sample was used for optimizing NMR
conditions and the subsequently produced double-labeled batch of
C7-CFF was sufficient for the task of assignment of nuclei and collection of NOESY
data.
3.4.2 Purification
Initial purification and harvesting from the supernatant was achieved via cation-
exchange chromatography wherein strong binding of the target protein to the resin was
observed, with CFF eluting from the column at 50-60% of the salt gradient (~500 mM
NaCl). As with the "miniscale" production trial, a mixture of both glycosylated and
unglycosylated recombinant protein was produced, resulting in the appearance of a
double band in SDS-PAGE analysis of the eluted fractions. Following treatment with
the endoglycosidase, EndoHf , the sample was reanalysed by SDS-PAGE to ensure
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completion of the deglycosylation reaction, which was judged by the absence of double
protein bands and the observation of a single band at ~24 kDa (Fig. 39). The presence of
substantial proteinaceous impurities (judging from the SDS-PAGE) at this stage dictated
the use of a size-exclusion based "polishing step". Indeed, gel filtration chromatography
resulted in removal of the majority of impurities, with several small peaks eluting prior
to the main C7-CFF peak. However, care was a taken in the selection of fractions for
further analysis as the first fractions eluted from the column produced smeary bands
upon SDS-PAGE. These were thought to be attributable to residual N-glycosylated C7-
CFF.
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Fig. 39: C7-CFF chromatographic purification. (A) Cation-exchange chromatography of C7-CFF using a
salt gradient (yellow line, 0-500 mM Nacl). SDS-PAGE analysis is shown with labels refering to elution
fractions. (B) Size-exclusion chromatography of C7-CFF, with SDS-PAGE gel depicting elution fractions.
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3.4.3 Characterization
Electrophoretic migration (Fig. 40B) of the C7-CFF was greater in non-reducing SDS-
PAGE samples compared to reduced samples, indicative of the expected compact
structure that is disrupted by reduction of the 11 intra-molecular disulphide bonds (two
in the CCPs component, four in FIM1 and five in FIM2). The folding of the recombinant
protein was further assessed by ID NMR spectroscopy (Fig. 40A). Peaks within such
spectra, in the regions around 6 ppm and 9 ppm, are indicative of tertiary structure.120To
confirm whether the full-length C7-CFF had been successfully purified, samples were
analyzed by mass spectrometry (see Appendix D). The recombinant protein has a
predicted mass, including an N-terminal cloning artefact (EAEA) and residual N-
Acetylglucosamine (220 Da, GlcNac from glycosylation), and with fully oxidized
cysteines, of 23,982.3 Da (calculated in Protoparam).33 LC-MS produced a mass of 23,
982.48 Da +/- 2.1, corresponding the fully oxidised mass.
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Fig. 40: C7-CFF characterisation. (A) Shows a 'H-NMR spectrum with small-molecule impurities marked
with an arrow. (B) Shows the movement of protein on the gel under reducing (R) and non-reducing (NR)
conditions.
Aggregation issues had been previously reported for C7-FIMs, produced in OrigamiB at
concentrations above 300 pM (personal communication). While the additional presence
of the CCP module and/or production in a eukaryotic system may overcome these
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aggregation issues, DLS was used to detect the presence of aggregates and also to
determine the best storage conditions for C7-CFF. Size distribution profiles indicate that
while a small amount of aggregate (or other large impurity) is present in relatively high
concentration samples (> 1 mM), the percentage of total high-molecular weight
"aggregate" is < 0.1%. Moreover, in further DLS experiments it was shown that the
absence of NaCl in the buffer, as opposed to 0.2 M salt used routinely in NMR
experiments, had no observable effect on the monodispersity of the protein, which is
ideal for NMR studies.
Regarding storage conditions, storage for a week at 4 °C, -20 °C and -80 °C visibly
altered the profile of the size-distribution graphs. For samples stored below 0 °C, the
aggregate peak increased in intensity and its uniformity was lost. Flowever the
percentage of aggregate still remained minimal at ~0.1%. The Stokes radius or
hydrodynamic radius RHwas calculated as 2.85 nm and the estimated molecular weight
of 39 kDa (calculated using an empirical mass vs. size calibration curve). The high
purity and monodispersity of the sample, along with the highly reproducible raw data
(see Fig. 41) gave a degree of confidence to these often disregarded values. Thus the
molecular weight overestimate is considered indicative of a non-globular, somewhat
extended molecule, with a representative hard sphere of radius 2.85 nm (Stokes radius)
diffusing at the same rate as the hydrated molecule, being much larger than the effective
space the molecule likely occupies itself.
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Size (d.nm) Size (d.nm)
Fig. 41: DLS analysis of CFF. (A) Shows correlation coefficient curve with time. In order of best fit:
300(jM and 1 mM samples (pink-solid and pink-dashed respectively), one month storage at 4jC (black),
freeze-dried (red), -20jC storage (blue), -80iC storage (green). (B) Shows the size distribution curve by
signal intensity and (C) by intensity for the 1 mM, samples with no salt.
3.4.4 NMR optimization
As with C7-CCPs a 15N-labelled C7-CFF sample was produced and purified for
optimization of salt concentration, pH and temperature for NMR structural
characterization. The larger size of the C7-CFF (24 kDa), and a possible extended
module conformation as indicated by DLS, adversely effects the signal-to-noise ratio
during NMR data acquisition, which could make full resonance assignment challenging
without deuterating (triple labelling) the sample.118 Thus optimising the NMR conditions
turned out to be essential for prevention of overlap of amide proton-nitrogen correlations
while maintaining the good signal-to-noise needed for successful resonance assignments.
Spectra] folding was employed. Unfortunately, the inherently crowded spectra did not
allow for as extensive a minimisation of the spectral width as was achieved for C7-CCPs
(Fig. 42). As indicated by DLS, the global fold of CFF was not affected by changes in
salt concentration, hence all buffer conditions during optimisation were devoid of salt to
prevent signal damping, enhancing the signal to noise ratio. Regarding the choice of
sample temperature (Fig. 43), peak intensity grew weaker with a decrease in
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temperature, but 25°C was selected to maintain consistency with C7-FIMs and C7-CCPs
NMR studies. A pH titration (Fig. 44) revealed that pH changes over the range tested did
not significantly alter the appearance of the HSQC spectrum, indicating the overall fold
of the protein backbone is unchanged. At pH 4.0 the best signal to noise was obtained
and consequently more peaks could be resolved and identified in the crowded central
portion of the HSQC. Moreover, at neutral pH values, initial signs of degradation were
observed in natural-abundance samples that had been stored at room temperature for a
month (data not shown). This phenomenon had been observed previously in the
laboratory (for expression of CCP modules in P. pastoris) when it was also found that
lowering the pH to 4.0 inhibited putative neutral P pastoris proteases. The stability of
the backbone, resolution and dispersion of peaks, and enhancement of protein stability,
as well as being far from the isoelectric point (6.4) indicated an optimum pH of 4.0.
Spectra at pH 7.0 and pH6.0 were not recorded due to the proximity to the pi. Therefore
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Fig. 42: pHj^NJ-HSQC of C7-CFF. Spectral folding in the 15N dimension was employed to increase the
resolution, with seven peaks (negative) observed in cyan.
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Fig. 43: Comparison of ['H,15N]-HSQC spectra of C7-CFF collected over a range of temperatures. Pale










Fig. 44: Comparison of C7 CCP's' ['H,15N]-HSQC spectra at various pHs: pH 5.5 (orange), pH 5.0
(blue), pH 4.5 (purple), pH 4.0 (red).
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CHAPTER 4: NMR STRUCTURAL STUDIES
4.1 Overview
The C-terminal modules of C6 and C7 have been hypothesised to act as swinging
molecular arms upon binding to C5b (or C5bC6). In order to investigate the structure
and flexibility of the putative molecular arm of C7 (consisting of the following sequence
of modules: EGF-TSPC-CCP1-CCP2-FIM1-FIM2) by NMR, a 'divide and conquer'
strategy was adopted.156,157 Having successfully optimised purification of C7-CCPs (i.e.
CCP1-CCP2) and C7-CFF (i.e. CCP2-FIM1-FIM2) produced in E. coli and P. pastoris,
respectively, both proteins were produced as [13C,15N], double-labelled samples for
characterization by NMR. The NMR assignment and the NMR-derived calculation of
their 3-D structures was achieved on the basis of data collected using a conventional set
of multidimensional double- and triple-resonance NMR experiments (see Methods
2.3.3). The larger size of C7-CFF (24 kDa), relative to C7-CCPs (14 kDa), and its extra
module, justified additional analysis of the bigger protein by SAXS. Based on structures
of C7-CCPs and C7-CFF, an initial model of C7-CCFF (i.e. CCP-CCP2-FIM1-FIM2)
was produced. The backbone dynamics of both C7-CCPs and C7-CFF were probed by
15N relaxation measurements. In addition, 2-D NMR was used to assess the overlapping
module pairs C7-ET (i.e. EGF-TSPC) and C7-TC (i.e. TSPC-CCP1) (gifts from Dr R
Ogata, Torrey Pines Medical Institute) to provide further valuable insights into the
"shoulder" region of the molecular arm. The function insights affored by these
structural studies are discussed in Chapter 6.
4.2 NMR-derived 3-D solution structure of C7-CCPs
4.2.1 NMR data
A standard suite of NMR experiments (outlined in section 2.3.3) was used for both
backbone and side-chain resonance assignments, and to provide the NOE-derived
distance restraints needed to calculate the 3-D solution structure of C7-CCPs. Excluding
the N-terminal cloning artefact, the good quality of spectral data for C7-CCPs allowed for
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completion of 95% of the backbone assignment and 95% of the side-chain assignment
(Table. 10). The amide of lie629 is the only residue missing from the assignment list. This
residue was expected (on the basis of a sequence alignment) to occupy the short linking
sequence between the two modules.
The extent of backbone amide assignment for C7-CCPs is illustrated in the pH^N]-
HSQC of Figure 45. This figure also shows the assignment of all Asn (four), Gin (four),
Trp (two) and Arg (three) side-chain resonances. The NMR data allowed for the
determination of a cis or trans conformation for each of the ten proline residues within
C7-CCPs. This was achieved by visual inspection of Xaa-Pro cross-peaks and also by
the difference between the C|3 and Cy shifts (outlined in section 2.3.5.6). Pro644 and Pro681
were identified as the cis isoform by both methods and were therefore treated as such in
structure calculations.
Category Available Assigned % Assigned
Element C 596 529 88.76
Element H 748 714 95.45
Element N 163 130 79.75
Amide 247 232 93.93
Backbone 505 484 95.84
Backbone non-H 387 368 95.09
Side Chain H 630 598 94.92
Side Chain non-H 372 291 78.23
Residue Ala 5 5 100
Residue Arg 3 3 100
Residue Asn 4 4 100
Residue Asp 4 4 100
Residue Cys 8 8 100
Residue Gin 5 5 100
Residue Glu 9 9 100
Residue Gly 14 13 92.86
Residue His 3 3 100
Residue lie 3 3 100
Residue Leu 9 9 100
Residue Lys 8 8 100
Residue Met 6 6 100
Residue Phe 5 5 100
Residue Pro 10 10 100
Residue Ser 11 11 100
Residue Thr 5 5 100
Residue Trp 2 2 100
Residue Tyr 3 3 100
Residue Val 12 12 100
All Residues 129 128 99.22
Table.10: Assignment report for C7-CCPs by CcpNmr Analysis. Table generated using the quality
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reports function, and it includes the N-terminal GSHM cloning artifact.
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Fig. 45: [!H15N]-HSQC of C7-CCPs. Recorded on an 800 MHz ('H frequency)) NMR spectrometer
equipped with a ctyoprobe. Backbone !H-15N correlations are labelled sequence-specifically. Cross peaks
connected by horizontal lines correspond to Gin and Asn side-chain amides, light grey cross peaks arise
from folded Arg side-chain resonances, and Trp side-chain resonances are marked with an asterix.
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4.2.2 Structure calculation
Table. 11 summarises the outcome of the automated assignment process via the
CANDID algorithm in CYANA, as described in section 2.3.8.2 of the Methods.
According to the published procedures138 there are five criteria for measuring the
reliability and success of a calculation performed in this way. All five of these were met
in the calculation of C7-CCPs structures.
First, more than 90% of the chemical shifts should be assigned. In the case of C7-
CCPs, this value was 95% (Table. 11) i.e. a total of 714 out of 748 atoms assigned in
all.
Second, the cross peak list should be a "faithful representation" of the NOESY spectra,
furnishing a large number of NOE cross peaks (4849 total and 3498 unique ones in the
present case) for calculations.
The third criterion states that the average DYANA target function (as explained in
section 2.3.8.2) should be <250 A2 in the first cycle and <10 A2 in the final of the seven
cycles, with >80% of all the originally picked NOESY peaks assigned and <20% of
initial long-range assignments being eliminated during the calculation. The target
function should approach zero as the available experimental and torsion angle restraints
become satisfied, with minimal steric overlap between non-bonded atom pairs.138 In the
case of calculation of the C7-CCPs structure, the target functions are well within limits,
with 87% of all NOESY peaks assigned and no long-range assignments eliminated over
the course of seven cycles.
The fourth criterion is that in the first cycle, the average backbone root mean square
deviation from the mean (RMSD) of the calculated ensemble of structures should be
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smaller than 3.0 A after the first cycle. For C7-CCPs structures of the first cycle, this
value was higher, at 5.0 A for both modules. But it was 1.6 A for each of the individual
modules (calculated in MOLMOL142). The large RMSD for the CCP-CCP pair in the
first round arose mainly from tilt variance between the two modules. Two bent
conformations predominated: a relatively 'open' conformation and a more 'closed'
conformation where the modules were brought into close proximity along the length of
their long axis. No NOEs, however, were found in support of the more closed
conformations, either by manual inspection of the NOESY spectra or by subsequent
rounds of CYANA calculations during which the closed conformation was eliminated.
As all other criteria fit, the backbone RMSDs of individual modules was less than <3 A,
and the overall backbone RMSD was progressively reduced in subsequent cycles, this
was not considered to detract from the validity of the final calculated structures.
Finally the RMSD "drift" between the first and last cycle indicates the extent to which
the first cycle captures the "true" polypeptide fold. This is encapsulated by the criterion
stating that the RMSD between the mean structures of the first and last cycle should be
below 3 A, and this was easily met with an RMSD of 1.3 A.
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Cycle 1 2 3 4 5 6 7 Final
Peaks:
selected 4849 4849 4849 4849 4849 4849 4849
assigned 4423 4450 4326 4335 4280 4224 4207
unassigned 426 399 523 514 569 625 642
with diagonal assignment 1 1 1 1 1 1 1
Cross peaks:
with off-diagonal assignment 4422 4449 4325 4334 4279 4223 4206
with unique assignment 1195 2702 3106 3162 3356 3491 3498
with short-range assignment |i-j|<=l 2874 2804 2718 2697 2656 2607 2608
with medium-range assignment l<|i-j|<5 560 486 424 436 419 414 414
with long-range assignment |i-j|>=5 988 1159 1183 1201 1204 1202 1184
Upper distance limits:
total 3262 3096 2894 2862 2768 2675 2756 2844
short-range, |i-j|<=l 1729 1570 1454 1395 1335 1275 1236 1280
medium-range, l<|i-j|<5 917 816 403 409 390 375 384 395
long-range, |i-j|>=5 616 710 1037 1058 1043 1025 1136 1169
Average assignments/constraint 5.59 2.35 1.38 1.37 1.29 1.22 1 1
Target Function
Average target function value 178.21 83.38 178.06 27.64 14.17 5.2 7.22 2.43
RMSD (residues 564..692):
Average backbone RMSD to mean 5.64 3.15 1.34 1.23 1.03 1.13 1.1 1.01
Average heavy atom RMSD to mean 6 3.4 1.53 1.47 1.28 1.34 1.3 1.21
Table. 11: Report on structure calculation of C7-CCPs by CYANA. Statistical tracking of cross peaks
picked, assignments to specific NOEs, distant-restraint deduction, target function values and RMSD values
are shown (over all CANDID cycles).
Following completion of all seven cycles, a total number of 3498 unique NOE-derived
restraints were generated. As shown in Table. 11, these constitute 2608, 414 and 1184
upper-distance bounds corresponding to intra-residue, medium-range (between residue i
and residues (i+1 to i+4)), and long-range (between residue i and residues i+( > 4))
restraints, respectively. The Format Converter of the CcpNmr software135 was then
utilised to convert the list of upper-distance restraints generated by CYANA into a
format compatible for subsequent CNS structure calculations. This was carried out
because CNS has been found (according to several members of the Barlow group,
personal communication) to provide superior water refinement in the final set of
calculations.
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The 100 structures thus re-calculated using scripts in CNS were ranked in order of NOE
energy and in order of total energy (Fig. 46). The 40 structures with lowest-NOE energy
and lowest overall energy converged well. However inflection points for structures 27
and 35 prompted a smaller selection, involving just the 20 lowest-energy structures for
refinement in water solvent. The final 20, water-refined, NMR structures overlay very
well, with low RMSD values for both the CCPs individually, and a respectable RMSD








structure ranked (according to NOE energy)
80 100
Fig. 46: Energy plot of the final, ranked 100 CNS-re-calculated C7-CCPs structures. The NOE energy
is shown in red triangles and the total energy is shown in blue squares.
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A B
Fig. 47: Backbone overlay of the ensemble of 20 water-refined C7-CCPs structures. (A) Backbone
overlay on CCP 1; (B) Backbone overlay on CCP 2; (C) Backbone overlay for both modules. MolMolref was
used for visualisation and calculation of the RMSDs. RMSD values are as indicated.
4.2.3 Structure description and quality analysis
Structure determination reveals that both CCP modules of C7-CCPs have archetypal
CCP-module characteristics, although CCP2 also displays some atypical features (Fig.
48). Combinatorial extension149 was employed (Dinesh Soares, University of Edinburgh)
to compare each experimentally determined C7-CCP structure within the current set of
48 atomic resolution CCPs structures within the complement system (see Appendix E).
Comparisons with the closest-to-mean individual structures of C7-CCP1 and C7-CCP2
are most similar to decay accelerating factor (DAF)-CCP1158(RMSD=1.6A) and the
recently solved mammalian control protein (MCP)-CCP3159(RMSD=2.2A) respectively
(Fig. 48). Out of all 48 known structures only 3 for CCP1 and 11 for CCP2 had
backbone RMSDs greater that 3.0A indicating that the structures are not deviant
modules.
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C7-CCP1 Vs. DAF-CCP1 C7-CCP2 Vs. MCP-CCP3
RMSD 1.62 A (60) RMSD 2.17 A (59)
Fig. 48: Comparisons of C7-CCP1 and 2 with the most similar atomic structures in complement.
Cartoon respresentations (MOLMOL142) showing a backbone overlay of C7-CCP1 and 2 (blue) and DAF-
CCP1 and MCP-CCP3. RSMDs of the overlay are shown as well as the number of residues used in the
comparison in brackets.
Overall CCP2 appears more spherical (and less ovoid) than CCP1 and is ~5 A shorter
(30 A versus 35 A). Both are stabilised by a cross-brace of Cys(I)-Cys(III) and Cys(II)-
Cys(IV) disulfide linkages that occur close to either end of each module. Each module
features five elongated stretches of amino acid residues; these pass back and forth in
approximate alignment with the long axis of the prolate module and are linked together
by turns and loop that occupy the poles of the module. Segments of the five extended
stretches from P-strands for parts of their lengths. These P-strands in turn form small
anti-parallel p-sheets in a sandwhich-like arrangement (Fig. 49A, B). The p-strand
network (as defined by the criteria for secondary structure embedded within the program
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MOLMOL142) appears more extensive in CCP1, which exhibits six (B, D, E, F, G and H)
of the maximum (across the CCP module family) eight strands (A-H),94 while CCP2 has
only three regions that are classified as (3-strands (B, D and F). CCP2 additionally
contains a canonical three-residue Bjo-helix1*within the C-terminal of its five extended
stretches of residues (occupying a region that lies between cannonical strands G and H
and often forms a bulge in other CCP modules).94 This feature was presentwithin all 20
members of the final ensemble of calculated C7-CCPs structures.
Like most CCP modules, both modules in C7-CCPs have hypervariable loops that occur
immediately after strands B (in CCP1: Q583DEGPM588 and in CCP2: H^PQKPF648). The
hypervariable loop of CCP2 converges better across the ensemble of 20 lowest-energy
structures than that of CCP1; this is also reflected in the approximation of motion in this
region (see section 4.2.4) derived from 15N relaxation measurements. To obtain a
summary of the angles of orientation of CCP1 with respect to CCP2, average values of
tilt, twist and skew (defined as in Fig. 49C) were calculated for the final ensemble of 20
structures"^ (Fig. 49C). The C7-CCPs have a 84° tilt between the modules, are twisted by
20° with respect to one another, and display only a small mutual skew angle.
Tin 3io helices the carbonyl group in residue i and the nitrogen of the amide group in residue i+3 are hydro¬
gen bonded. Canonical 3io helices have three residues per turn, with an angle of 120° between consecutive
residues, a helical rise per residue of 1.93-2.0 A, and a helical pitch of 5.8-6 A. In very simple terms, a 3i0
helix is more tightly wound, longer, and thinner than an a helix with the same number of residues.
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A B C
Fig. 49: Cartoon representation C7-CCPs' 3-D structure . (A) CCP1. (B) CCP2. (3-strands are labelled
and cysteine side chains atoms are shown as spheres. CCP dimensions are shown; average values for pitch
(P), number of turns (n) and radius (r, A) of the 310 helix are also shown. (C) Average values of intermodular
twist, tilt and skew calculated using XYZ as shown previously.160
The WHATIF "course packing quality score" was used to analyse the C7-CCPs
ensemble.145 The score gives an assessment of the normality of the local environment of
atoms surrounding the individual amino acids. A WHATIF score lower than -5.0 is
indicative of improper packing. The average score of the ensemble was well above this
value both before (-2.2) and after (-1.5) water refinement by CNS. Subsequently, the
program PROCHECK144 was used to evaluate the ensemble. PROCHECK evaluates the
stereochemical quality of protein as indicated by the extent of occupation by (J) and V)/
angles of energetically favoured regions of a Ramachandran plot (Fig. 50). 97.5% occur
in the most favoured and additionally allowed regions of the Ramachandran plot, a
finding which suggests reasonable stereochemical quality suggestive of reasonable
stereochemical quality.
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Phi (degrees)
Plot statistics
Residues in most favoured regions |A.B.L| 1526 73.4%
Residues in additional allowed regions |a.h.l.p| 501 24.1%
Residues in generously allowed regions |~u.-b.~l.~p| 38 1.8%
Residues in disallowed regions 15 0.7%
Number ot non-giycine and non-proline residues 2080 100.0%
Number of end-residues texcl. Cily and Fro) 20
Number of glycine residues i shown as triangles) 280
Number of proline residues 200
Total number ot residues 2580
Fig. 50: Ramachandran statistics (from PROCHECK) for water-refined ensemble of the 20 lowest
energy structures of C7-CCPs. Each small box represents a residue and the model number, save for
glycines and prolines which are shown as triangles. Outliers are named and shown in red.
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4.2.4 Relaxation Analysis
Ti and T2 relaxation time constants were collected for the [13C,15N]-C7-CCPs sample.
Incremental relaxation delays used for h measurements were 51.2, 301.2, 501.2, 701.2,
901.2, 1001.2, 1101.2 and 51.2. While for T2 they were 16.96, 33.92, 67.84, 84.8,
101.76, 118.72,135.68 and 16.96. Although extensive relaxation analysis of the protein
was beyond the scope of this project, the values of Tj and T2, the derived ratios Ti/r2,
and the [XH-15N] heteronuclear NOE measurements together provide useful insights into
C7-CCPs backbone dynamics (Fig. 51). Weak peaks or those in overcrowded regions
were excluded from analysis, due to their associated large error values. The highly
flexible cloning artifact was excluded from analysis, and the first two and last two
residues were not considered in the calculation of averages.
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616 628 640
Residue Number
Fig. 51: Backbone amide r'N relaxation measurements for C7-CCPs.From top to bottom: (A) T values
and associated errors at 14.1 Tesla. (B) T2 values and associated errors at 14.1 Tesla. (C) Ti/T2ratios and
associated errors. (D) ['H-15N]-heteronuclear NOE values and associated errors at 14.1 Tesla. Lines for the
average and +/- one standard deviation are shown for (A), (B) and (C), the 0.6 ns NOE cut off is shown in
(D). Schematic shows secondary structure with red slashes defining module boundaries.
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Low Ti/T2 values indicate backbone flexibility on the second-millisecond timescale and
therefore represent relatively large and relatively slow conformational changes.
Heteronuclear NOE values <0.6 indicate flexibility on the picosecond-nanosecond
timescale, representing backbone librations and side-chain motions. Residues displaying
flexibility on either of these timescales were mapped onto the lowest-energy C7-CCPs
structure to better visualise their spatial location and distribution (Fig. 52).
As expected from the number of distance restraints between the intermodular linker
residues and the modules themselves, the relaxation data show that linker residues have
average backbone mobility for this molecule, i.e. flexibility on the time scales discussed
above that is equivalent to residues located, for example, in p-sheets. The most flexible
region in C7-CCPs is the hypervariable loop of CCP1, between p-strands B and D
(Q583DEGTMF589). In this loop there is backbone mobility on both the ms and ps-ns
timescales, with only one residue, Thr587, having average mobility. In contrast, the
hypervariable loop of CCP2 appears to lack flexibility. The last of the five stretches of
residues within CCP1 also shows greater than average flexibility.
Many residues in CCP2 may be considered inflexible (on the slow timescale) on the
basis of their high TJT2 ratios. Half of these residues were found in regions of secondary
structure (P-strands B and D and the 3i0 helix. Some of these residues collected at the N-
terminal end of the module, with side-chains engaged in hydrophobic interactions with
one another (Lys654, Val655, Phe671, Trp684). Other residues that appear to be stable on the
millisecond-second timescale are found in S-turns and y-turns2*. CCP2 possesses a few
regions that are more flexible than average, in the first stretch of residues and in loop
segments between strand D and F. Interestingly, flexibility on the nanosecond-
2* A turn in a loop segment is a structural motif in which two residues, separated by one to five residues,
have their Cot atoms brought into close approach (<8A). Hydrogen bonds are not necessary, but one or two
may be present. Separation of two end residues by one, two, three, four and five residues denote a a, (3, y, 6
and it-turn respectively.
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picosecond timescale is observed in the lysine residue of the M^KN685 3io helix within
CCP2, despite rigidity on the slower timescale and these residues forming H-bonded
secondary structure.
In conclusion, although the modules have localised regions of flexibility in loops and
hypervariable regions, the majority of residues, including those in the linker, are rigid on
the timescales investigated.
Fig. 52: A summary of backbone dynamics in C7-CCPs. Residues falling within average values for Ti/T2
and ['H-15N] heteronuclear NOEs are shown in green. Residues deemed flexible on the ns-ps timescale, from
their heteronuclear NOE values, are shown as yellow spheres. Residues deemed flexible, or stable, on the
ms-s timescale from their Ti/T2 ratio are shown in orange and blue respectively. Residues exhibiting
flexibility on both timescales are shown in red.
4.2.5 Analysis of the intermodular interface
A degree of intermodular rigidity between CCP1 and CCP2 is reflected in the relatively
low RMSD of the superposition performed over both modules of the pair (= 0.8 A),
which in turn is a reflection of the relatively high number of NOEs assigned between
different modules (Table. 12) and also of NOEs between the body of each module and
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the linker (84 and 21 for CCP1 and CCP2, respectively). Intermodular rigidity is also
consistent with the relatively short intermodular linker (four residues between the last
cysteine of one module and the first of the next) and its partly hydrophobic nature with
three large side chains (Q627KIA630). A relatively rigid linker is also consistent with the
lack of any unusual features of the relaxation data for this region (see section 4.2.4).
Indeed a rigid bend is consistent with the intimate associations between amino acid
residues within the intermodular junction formed by the C-terminal end of CCP1, the
linker residues and the N-terminal loops and turns of CCP2. The side-chain of Gin627
within the linker is solvent-exposed and is essentially the final residue of CCP1 as it is
part of the last (3-strand, H, that is held in antiparallel P-sheet arrangement with E of the
previous strand. Indeed the linker, a patch of residues within CCP1 (E601GYS604) and two
patches of residues in CCP2 (Cys631,Val632 and f^YT650) participate in an extensive Id-
bonded network, comprising two H-bonds between the modules, six linker-CCPl Id-
bonds and two linker-CCP2 H-bonds. This intimate H-bonded network helps to ensure a
buried surface of 440 A between the modules (calculated using GETAREA,148 Fig. 53).
The end result is that Gin627, Lys628and lie629 (see Fig. 53B) are closely associated with
CCP1, while lie629 and A630, are closely associated with CCP2.
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CCP1 CCP2
Residue No Residue type Atom type Residue No Residue type Atom type Distance (A)
600 ASN HB3 632 VAL QQG 4.78
600 ASN HB2 632 VAL QQG 4.96
600 ASN HB3 632 VAL QQG 4.78
600 ASN HB2 632 VAL QQG 4.96
601 GLU QB 632 VAL QQG 3.53
601 GLU QB 648 PHE QD 4.83
601 GLU QB 632 VAL QQG 3.53
601 GLU QB 648 PHE QD 4.83
602 GLY HA3 632 VAL QG1 4.52
602 GLY H 648 PHE QD 5.43
602 GLY HA3 632 VAL QG2 4.52
602 GLY HA2 632 VAL QQG 4.18
602 GLY HA3 632 VAL QQG 3.78
602 GLY HA3 648 PHE HB3 5.15
602 GLY HA3 648 PHE HA 5.5
602 GLY HA3 632 VAL QG1 4.52
602 GLY HA3 648 PHE HA 5.5
602 GLY HA3 632 VAL QG2 4.52
602 GLY HA2 632 VAL QQG 4.18
602 GLY HA3 648 PHE HB3 5.15
602 GLY HA3 632 VAL QQG 3.78
602 GLY H 648 PHE QD 5.43
603 TYR QD 632 VAL QQG 4.52
603 TYR QE 632 VAL QGl 5.13
603 TYR QE 632 VAL QQG 4.15
603 TYR QD 632 VAL QG2 5.5
603 TYR QD 632 VAL QGl 5.5
603 TYR H 632 VAL QQG 5.33
603 TYR QD 632 VAL QG2 5.5
603 TYR QE 632 VAL QQG 4.15
603 TYR QD 632 VAL QQG 4.52
603 TYR H 632 VAL QQG 5.33
603 TYR QE 632 VAL QG2 5.13
603 TYR QE 632 VAL QG2 5.13
603 TYR QD 632 VAL QGl 5.5
603 TYR QE 632 VAL QGl 5.13
628 LYS HB3 632 VAL QQG 5.44
Table. 12: Intermodular CCP1-CCP2 NOEs. Linker residues Q627KIA630were excluded from analysis.
The distance between two atoms was determined within CYANA.
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Fig. 53: C7-CCPs intermodular interface. (A) Interface shown as spheres from two views rotated by 180 °
about the y-axis. (B) A close-up of the interface residues shown as lines, CCP1 residues are in cyan, linker
residues are in red and CCP2 residues are in blue.
4.2.6 Analysis of surface properties
A surface-electrostatic analysis (Fig. 54) of C7-CCPs reveals a strikingly negative
concave face of the 84°-bend. In contrast the convex face presents a mix of positive,
negative and neutral patches. Analysis of the lipophilicity (Fig. 55) of the surface reveals
a pronounced hydrophobic patch near the N-terminal end of CCP1 (Pro591, Phe590, Phe581,
Met589) Using the program STP this patch and two others (one on CCP1 and another on
CCP2, Fig. 56) were identified as potential hotspots for protein-protein interaction.
Interestingly, these hotspots accumulate on one face of the molecule that is between the
convex and concave surfaces (i.e. on the "side" of the molecule). Thus, while the
convex and concave faces of C7-CCPs could remain solvent exposed due to their
charged and hydrophilic surface the side of the molecule carrying the three protein-
protein interaction hotspots might be buried. It is unknown, however, whether these
143
CHAPTER 4: NMR STRUCTURAL STUDIES
hotspots are involved in interactions within C7 or with other proteins of the MAC
complex.
Fig. 54: Analysis of C7-CCPs surface electrostatics. Diagrams on the left are cartoon representations of
CCP1 (dark-green) and CCP2 (light-green) with secondary structure as determined by Pymol.143 Surface-
electrostatics are shown with a red (negative charge), white (neutral) and blue (positive charge) colour scale,
ranging from -5.0 to +5.0 k/T. The top view shows the concave face of the module pair and the bottom view
shows a 180° rotation of the convex face. Glu623 is boxed in both views.
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Fig. 55: Analysis of C7-CCPs surface lipophilicity. Diagrams on the left are cartoon representations of
CCP1 (dark-green) and CCP2 (light-green) with secondary structure as determined by Pymol.rPl Lipophilicity
is show on a scale from tan (hydrophobic) to green (neutral) to blue (lipophobic).
F570 M588
Fig. 56: Identification of ligand-binding sites using "surface triplet propensities". A surface
representation of C7-CCPs with a scale going from least favourable (blue), to neutral (green), to most
favourable (red) interaction site scores.
4.3 NMR structure of C7-CFF
4.3.1 Data
The same standard suite of NMR experiments used for C7-CCPs (outlined in section
2.3.3) were also used for both backbone and side-chain resonance assignments, and in
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order to compile the list of NOE-derived distance restraints used as a basis for
calculating the 3-D solution structure of C7-CFF. However, the larger size of C7-CFF
(219 residues as opposed to 129 residues in C7-CCPs ) resulted in inherently worse
quality spectra than were obtained for C7-CCPs. The hydrodynamic radius (see section
2.2.10, DLS) of C7-CFF equates to a ~40-kDa protein, and when this value is compared
to the MS-calculated Mwt of ~24 kDa, a somewhat extended molecule is indicated. That
C7-CFF has a slower tumbling rate than C7-CCPs is borne out by its shorter average T2
relaxation times. In fact these are not consistent across the modules of C7-CFF since
they are significantly shorter in the FIMs portion than in the CCP2 portion - see section
4.3.4 for a further analysis of relaxation. The shorter relaxation times reduce the
sensitivity of those pulse sequences that require long delays for coherence transfer steps.
118 This, coupled with the increased number of amino acid residues in CFF, gives rise to
more complex, crowded and noisy spectra. Maximum-entropy processing was therefore
employed to enhance the resolution of the spectra where necessary (see section 2.3.4).
The 13C-HSQC-NOESY spectra133were particularly overcrowded and noisy in some
regions and therefore picking of NOESY peaks was shared between four spectra: a 13C-
HSQC-NOESY (in D20), the same 13C-HSQC-NOESY but maximum-entropy
processed, a 13C-HSQC-NOESY (in H20), and a 13C-methyl-NOESY-spectra134 that
shows strips for methyls only.
Despite the overall inferior quality of the spectral data, 86% of the triple resonance
backbone and side chain assignment was completed (shown in Table 12), including 90%
of the backbone. Save for two side-chain carbon resonances (Asp638 Cy and Trp679 C') the
assignment of CCP2 was substantially complete. As with the previously reported NMR
assignment of C7-FIMs53 however, three stretches of residues within FIM2 featured few
or no observable resonances (Cys773-Gly774, P777-W779, and more extensively D783-K788).
Additionally, another couple of residues, Leu725-Asp276 had similarly exiguous
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assignments. On the other hand, the assignment of Gin693 within the linker between
CCP2 and FIMs was absent from the C7-FIMs assignment, yet was complete in C7-CFF.
The extent of backbone amide assignment for C7-CFF is illustrated in the []H15N]-HSQC
of Fig. 57. This figure also shows the assignment of Asn (four of five), Gin (8 of 11),
Trp (all three) and Arg (5 of 11) side-chain resonances. The NMR data allowed for the
determination of a cis or trans conformation for each of ten of the 13 proline residues
within C7-CFF. This was achieved by visual inspection of Xaa-Pro cross-peaks and also
by the difference between the CP and Cy shifts (outlined in section 2.3.5.6). Pro644, Pro681
(CCP2) and Pro694(CCP2-FIMs linker) were identified as the cis isoform by both
methods and was therefore treated as such in structure calculations.
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Category Available Assigned % Assigned
Element C 989 823 83.22
Element H 1274 1070 83.99
Element N 291 189 64.95
Amide 424 378 89.15
Backbone 862 782 90.72
Backbone non-H 657 593 90.26
Side Chain H 1069 884 82.69
Side Chain non-H 623 419 67.26
Residue Ala 17 15 88.24
Residue Arg 11 11 100
Residue Asn 5 5 100
Residue Asp 5 4 80
Residue Cys 22 22 100
Residue Gin 11 11 100
Residue Glu 21 19 90.48
Residue Gly 15 15 100
Residue His 3 3 100
Residue lie 6 6 100
Residue Leu 15 14 93.33
Residue Lys 14 14 100
Residue Met 6 6 100
Residue Phe 3 3 100
Residue Pro 13 12 92.31
Residue Ser 21 19 90.48
Residue Thr 10 10 100
Residue Trp 3 3 100
Residue Tyr 3 3 100
Residue Val 15 15 100
All Residues 219 210 95.89
Table. 13: Assignment report for C7-CFF by CcpNmr Analysis. Table generated using the quality
reports function, includes GSHM cloning artifact.
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Fig. 57: FH15N]-HSQC of C7-CFF. Recorded on an 800 MHz (1H) spectrometer equipped with a
cryoprobe. Backbone 'H-15N correlations are labelled sequence-specifically. Correlations connected by
horizontal lines correspond to Gin and Asn side-chain amides, light grey correlations arise from folded Arg
side-chain resonances, and Trp side-chain resonances are marked with an asterix.
4.3.2 Structure calculation
Table. 14 summarises the results of the automated assignment process utilised in the
current work that employed the CANDID algorithm in CYANA. As with the FIMs
calculation the disulphide bonding pattern of four cysteines within the FOLN domain of
FIM2 (Cys773, Cys776, Cys782, and Cys789) were the only disulphide bonds that were not
clearly inferable from the NOESY data. CYANA calculations, without these four
cysteines explicitly incorporated as disulphide bridges nonetheless resulted in all 20
structures adopting the Cys773-Cys782 and Cys776-Cys789 disulfide-bonding pattern. Thus,
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these linkages were used as constraints in subsequent CNS calculations. In any case,
calculations using each of three possible disulfide-bonding patterns did not affect the rest
of the structure and had a negligible effect on the target function and number of
restraints.
While the first two of the five CYANA criteria (listed in section 2.3.8.2) were met, full
satisfaction of the final three criteria appeared to be unachievable, given the extended
structure of the molecule and the complexity of the data.138
First, more than 90% of the chemical shifts should be assigned. In the case of C7-
CFF, this value was just met at 90%, i.e. a total of 1124 of a total of 1250 3H atoms
assigned in all.
Second, the cross-peak list should be a "faithful representation" of the NOESY spectra.
A large number of NOE cross-peaks (10791 in the present case) were chosen initially to
serve as a basis for the structure calculations. This apparently very large number of
potential distance restraints includes replicates, since NOEs were picked from four
different (but overlapping in data content) NOESY spectra. Moreover, attempts to
"faithfully" represent the spectra, which were of overall poorer quality than for example
the spectra collected for the CCPs, resulted in the picking of many spurious peaks.
Consequently, 1100 peaks (about 10% of total), were eliminated from the first cycle on
the grounds that they were categorised as "poor quality" according to CYANA. Poor
quality peaks are generally those that border the chemical shift tolerance limits and
whose assignments have low probability scores, as is indeed common of noise and
artifactual peaks.
The third criterion states that the average DYANA target function should be <250 A2 in
the first cycle and <10 A2 in the final of the seven cycles, with >80% of all the picked
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NOESY peaks assigned and <20% of long-range assignments eliminated from the
calculation. In the case of C7-CFF, the target function started out very high and did not
fall below 250 A until the fourth cycle. Inspection of the structures produced by the first
three cycles revealed that this was predominantly due to conformations in which CCP2
and FIMs, or CCP2 and the CCP2-FIMs linker, were closely associated. These cases
appeared to arise from a few NOEs and these could be attributed to mis-assignments due
to similarities between chemical shifts in some residues within CCP2 and other residues
in FIMs. Thus, there was not a network of NOEs to support these compact
conformations. Consequently the structures did not, overall, fit the experimental
restraints, resulting in a high target function. Also, over 10% of the peaks were
eliminated in the 1st cycle; this increased to 23% ejected peaks by the final cycle.
Therefore only 77% of the picked peaks were assigned by CYANA, just falling short of
the 80% criterion. On the other hand, and reassuringly, only 3%, compared to the
allowed 20%, of long-range assignments were eliminated over the course of the seven
cycles.
The fourth criterion is that the average backbone RMSD of the calculated structures
should be smaller than 3 A after the first cycle. CFF as a whole never meets this criterion
since (as discussed below) the linkage between the CCP and the FIMs appears to be
completely flexible. The CCP2 component alone satisfied the criterion with a backbone
RMSD of 1.5 A. However the FIMs component of CFF failed on this criterion,
producing RMSD values of 4.1 A and 4.3 A for FIM1 and FIM2, respectively.
Dissecting FIM1 into its KAZAL and FOLN subdomains yields RMSD values of 3.1 A
and 1.8 A. A similar exercise for FIM2 gave values of 3.7 A (KAZAL) and 2.4 A
(FOLN). By the second cycle all modules and subdomains had RMSDs <2.4 A. It was
decided to accept these structures despite not satisfying the fourth criterion. It was
reasoned that the CYANA criteria are in fact somewhat arbitrary and empirical in nature
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and arose out of experience with globular proteins. Their purpose is to ensure that a
misfolded structure does not become self-perpetuating. In the case of a multiple-domain
protein such as CFF with several potentially distinct folded entities it is likely to be very
difficult to eliminate chance (artifactual) encounters between domains that will be
supported by mis-assigned NOEs in the first round as described above. Provided these
are eliminated in successive cycles, and that domains with the expected (known) folds
emerge then there seems to be little danger of mis-folding. Clearly, it was important to
conduct extensive manual checks to avoid missing interdomain NOEs or the mis-
assignment of intradomain NOEs as interdomain ones.
The final criterion is that the RMSD "drift" between the mean structures of the first and
last cycle is below 3 A. For CCP2 this was easily met, at 2.0 A. For the FIMs this value
was 4.5 A and 4.1 A for FIM1 and FIM2 respectively. This is not surprising given the
high starting values that may not in fact be a matter of great concern, as discussed above.
152
CHAPTER 4: NMR STRUCTURAL STUDIES
Cycle 1 2 3 4 5 6 7 Final
Peaks:
selected 10791 10791 10791 10791 10791 10791 10791
assigned 9690 9536 9041 8870 8616 8402 8362
unassigned 1101 1255 1750 1921 2175 2389 2429
with diagonal assignment 3 3 3 3 3 3 3
Cross peaks:
with off-diagonal assignment 9687 9533 9038 8867 8613 8399 8359
with unique assignment 1825 5365 6236 6312 6661 6860 6929
with short-range assignment |i-j|<=l 5664 5622 5410 5225 5066 4947 4917
with medium-range assignment l<|i-j|<5 1474 1309 1115 1091 1022 965 963
with long-range assignment |i-j|>=5 2549 2602 2513 2551 2525 2487 2479
Upper distance limits:
total 7448 6413 5670 5360 5031 4770 4677 4737
short-range, |i-j|<=l 3641 3197 2875 2604 2430 2280 2042 2072
medium-range, l<|i-j|<5 2306 1875 919 882 803 755 748 754
long-range, |i-j|>=5 1501 1341 1876 1874 1798 1735 1887 1911
Average assignments/constraint 6.74 2.5 1.46 1.43 1.32 1.25 1 1
Target Function:
Average target function value 1527.82 673.37 837.49 225.89 101.38 46.16 49.16 17.39
RMSD (residues 625..843):
Average backbone RMSD to mean 8.88 11.55 10.13 10.53 10.8 10.56 6.72 9.1
Average heavy atom RMSD to mean 9.29 11.88 10.42 10.78 11.03 10.83 6.9 9.34
Table. 14: CYANA structure calculation cycle report for C7-CFF. Statistical tracking of NOE cross-
peaks assignment, distant-restraint deduction, target function values and RMSD values are shown (over all
CANDID cycles).
Following completion of all seven cycles, a total of 4737 unique NOE-derived restraints
was generated. These constitute 2072, 754 and 1911 upper-distance bounds
corresponding to intra-residue, medium-range (between residue i and residues (i+1 to i
+4)), and long-range (between residue i and residues i+ >4)) restraints, respectively. The
Format Converter of the CcpNmr software135 was utilised to convert the list of upper-
distance restraints generated by CYANA into a format compatible for subsequent CNS
structure calculations as was done for the CCPs. The 100 structures thus re-calculated in
CNS were ranked in order of NOE energy and in order of total energy (Fig. 58). The 13
lowest-energy structures converged well. However a slight increase in both NOE and
overall energy for the last three structures prompted a smaller selection involving just the
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ten lowest-energy structures for refinement in water solvent. The final 10, water-refined,
NMR-derived structures overlay well (although not over the whole molecule), with low
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structure ranked (according to NOE energy)
Fig. 58: Energy plot of the final, ranked 100 CNS-re-calculated C7-CFF structures. The NOE
energy is shown in red triangles and the total energy is shown in blue squares.
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Fig. 59: Backbone overlays of the ensemble of ten water-refined C7-CFF structures. (A) Backbone
overlay on CCP 2; (B) Backbone overlay on FIM1; (C) Backbone overlay for all modules. MolMol142 was
used for visualisation and calculation of the RMSD values (indicated). Domain boundaries are considered
first to last cysteines of each module.
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4.3.4 Structure description and quality analysis
Structure determination reveals that the CCP and FIMs behave as two separate globular
regions connected via a flexible linker. Both CCP2 and the FIMs of C7-CFF have the
same conformation as in the separately solved C7-CCPs and C7-FIMs respectively. The
mean structure of CCP2 in C7-CCPs and C7-CFF were compared and overlay well with
a backbone RMSD of ~1.8 A. The main differences are within loop regions at the N- and
C-terminal ends of the molecule that are involved, respectively, in interactions with the
neighbouring CCP molecule and the first few residues of the CCP2-FIMs linker. The p-
strand network of CCP2 (as predicted within the program STRIDE161) appears less
extensive in CFF (compared to CCPs), since it exhibits two shortened strands (D and F)
of the four strands identified previously (B, D, F and H). The "missing" strands B and H
are detected as single amino acid [3-bridges. Strand D is particularly short (reduced from
seven residues in CCPs to three residues in CFF), due to a backbone kink in the middle
of these residues. The canonical three-residue 3i0-helix in CCP2 was, however,
maintained. The less extensive secondary structure of CCP2 in CFF is likely a
consequence of having determined a lower resolution structure and it may or may not
reflect structural changes due to the absense of CCP1.
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Fig. 60 Comparison of CFF modules with their previously solved counterparts. (A), (C) and (D) show
respectively the backbone overlay and RMSD (MOLMOLref) of CCP2, FIM1 and FIM2 extracted from the
mean structure of CFF, with the mean structures of their NMR-derived counterparts solved previously
(CCPs and FIMs53). (B) and (E) respectively depict cartoons of CCP2 and FIMs of CFF overalaid on
cartoons of the previously solved structures, highlighting secondary structural elements. In all overlays
FIMs(alone) is in red and CFF is in blue. (F) Shows a schematic representation of this secondary structure
comparison, ^-bridges and P-sheets are shown as triangles and arrows respectively. 3i0 and a -helices are
shown in light shades and dark shades respectively. Secondary structure present in CFF is shown in black
and is typically extended and shown in red for FIMs (alone).
The FIMs pair component of CFF was found to exhibit the same two-fold rotational
pseudosymmetry as the published structure of the FIMs in isolation. As before, the two
modules are intimately associated via an extensive intermodular interface. FOLN and
KAZAL subdomains similarly comprise each individual FIM. The backbone overlay of
each individual FIM of CFF with the previously determined FIMs structures is
reasonable (backbone RMSD =~1.8 A for both modules).
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The main difference between the structucture of the FIM modules in CFF and in FIMs is
within the FOLN subdomains of both FIM1 and FIM2. In the case of FIM1 differences
in the orientation of the FOLN subdomain relative to the FIMs structure as a whole
might be genuine and could arise due to constraints induced by the attachment of the
long linker to CCP2. In the case of FIM2, the FOLN domain includes the stretch of five
residues (D783-S787), which were not assigned in either the FIMs or CFF structure
calculations, suggesting the region is conformationally promiscuous. All secondary
structural elements, as identified by STRIDE, that are present in the FIMs (alone)
structure are also present in the CFF structure, including the 2.8 turns of an a-helix in
each module. However, the secondary structure elements are generally shorter in CFF by
one residues, with the exception of the first (3-strand of the FIM2 KAZAL domain that is
longer in CFF by one residue. The orientation of the FIMs with respect to one another is
largely maintained between the FIMs (alone) and CFF structures (FIMs backbone
RMSD = 2.8A). The a-helix of FIM2, however, bends more towards FIM1 at the C-
terminal end of the helix (Fig. 60) in the CFF structure.
The WHATIF "course packing quality score" was used to analyse the C7-CFF structure
ensemble.145 WHATIF scores lower than -5.0 A are indicative of improper packing. The
average score of the ensemble was well above this value both before (-2.2) and after
(-1.7) water refinement by CNS. Subsequently, the program PROCHECK144was used to
evaluate the water-refined ensemble via establishing the energetic favourability of the (f>
and t|J angles in a Ramachandran plot (Fig. 61). A total of 95% of (J)-ijj combinations
occur in the most favoured and additionally allowed regions of the Ramachandran plot,
which is suggestive of reasonable stereochemical quality.
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Phi(degrees)
Plot statistics
Residues in most favoured regions (A.B.LJ 1200 63.5*
Residues in additional allowed regions |a.h.l.p) 600 31.7*
Residues in generously allowed regions |-a.-b.-l.~pj 60 3.2*
Residues in disallowed regions 30 1.6*
Number o! non-glycinc and non-proline residues 1890 100.0*
Number of end-residues lexcl. Gly and Pro) 20
Number of glycine residues i show n as triangles i 150
Number of proline residues 130
Total number of residues 2190
FIG 61: Ramachandran statistics (from PROCHECK144) for water-refined ensemble of the ten lowest
energy structures of C7-CFF.Each small box represents a residue and the model number, save for glycines
and prolines which are shown as triangles. Outliers are named and shown in red.
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4.3.4 Relaxation analysis
Ti and T2 relaxation time constants were collected for the [13C,15N]-CFF sample.
Incremental relaxation delays used for Ti measurements were 51.2, 301.2, 501.2, 701.2,
901.2, 1101.2, 1301.2, 51.2 ms. While for T2 they were 16.8, 33.7, 67.3, 84.2, 117.8,
134.7, 151.5 and 16.8 ms. Weak peaks, or those in overcrowded regions, were excluded
from analysis due to their associated large error values. The average Ti and T2 values for
the CCP2 component (~800 ms and ~90 ms, respectively) differed greatly to the
equivalent values for the FIMs component (1400 ms and 40 ms, respectively) of CFF
(Fig. 62). These markedly different vales are consistent with a highly flexible linker
between CCP2 and FIMs, such that each tumble quasi-independently of the other. Thus
for the purposes of the discussions below, the components were considered separately
with averages taken only within module boundaries. However, this does not mean that
the presence of the flexibly attached module would be expected to have no effect
whatsoever.
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Fig. 62: Summary of 15N relaxation parameters for CFF. (A) Ti values and associated errors at 14.1
Tesla. (B) T2 values and associated errors at 14.1 Tesla. (C) TJT2 ratio and associated errors. (D) ['H,15N]-
heteronuclear NOE values and associated errors at 14.1 Tesla . Lines for the average and +/- one standard
deviation are shown for (A), (B) and (C) calculated seperately for CCP2 and FIMs. The 0.6 ns NOE cut-off
is also shown by a line in (D). The red portion of each line highlights the linker between CCP2 and the
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As stated previously, low TJT2 values indicate backbone flexibility on the millisecond-
second timescale and represent large slow conformational changes,118while
heteronuclear NOE values <0.6 indicate flexibility on the picosecond-nanosecond
timescale, representing backbone librations and side-chain motions. The calculation of
Ti and T2 values requires that selected peaks are not overlapped and can be integrated
accurately. However, for CFF, many of the peaks (~40) were too crowded or weak, and
were therefore excluded from analysis. Also those few peaks that had not been assigned
(as described in section 4.3.1) were also not included. Ultimately, 50 of 60 residues of
CCP2, 49 of 69 of FIM1 and 48 of 70 of FIM2 were included in the analysis. It was also
recognised that the heteronuclear NOE errors in the FIMs portion of the molecule are
substantially larger than for CCP2 . This is unsurprising due to the differing xc values,
which greatly affects the efficiency of the heteronuclear NOE measurements.121
Residues displaying flexibility on either of slow or fast timescales were mapped onto the
C7-CFF structure to better visualise their spatial location and distribution (Fig. 62). The
following discussion focuses on the linker since the dynamics of the CCP2 (in CCPs)
and of the FIMs (alone) have been discussed above and elsewhere53 respectively and
(especially given the high error values in the measurements for CFF) there is little point
in reconsidering them in the CFF context.
The 13 residues between the last cysteine of CCP2 and the first cysteine of FIM1 display
a large range of flexibility on both the millisecond-second and the picosecond-
nanosecond timescales. The first two residues of the linker however (Val689 and Gin690),
are not flexible with respect to the average CCP2 NOE or Ti/T2 values. This is likely due
to side-chain interactions with the last cysteine, Cys688 and Met663 and Ser664in the
penultimate stretch (four of five) of CCP2 residues (Fig. 62) and is supported by NOEs.
Also Lys691 of the linker has the potential to make ionic interactions with the carbonyl
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group of Ser664. Interestingly, the residues surrounding the turn between strand F and the
310 helix, which contain Met663 and Ser664 was deemed flexible in the relaxation analysis
of C7-CCPs (alone). These residues are therefore stabilised by the presence of the first
three linker residues in the context of CFF. Flexibility on both timescales is present
along the rest of the length of the linker. However inspection of the TJT2 ratio reveals
that the last three residues of the linker (Val699, Pro700 and Lys701) are considered rigid
with respect to residues within the CCP2 component of CFF but flexible with respect to
the FIMs component. The decreased mobility of these residues likely stems from
hydrophobic side-chain to side-chain contacts with Leu708 of the (3-hairpin within the
FIM1 FOLN subdomain and the first residue of FIM1, Cys702 Again these interactions
are reflected by observed NOEs.
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Fig. 63: Molecular dynamics of C7-CFF (A) Residues falling within plus or minus one standard deviation
from the average values, on a module by module basis, for Tt/T2 and 'H,15N NOE are shown in green.
Residues deemed flexible, on the ns timescale, from their f'H,1:>N] NOE values are shown in yellow.
Residues deemed to have particularly low or high flexiblity, on the ms-s timescale, from their TJT2 ratios are
shown in blue and orange, respectively. Those residues, whose backone is flexible on both timescales are
shown in red. (B) Shows a close-up of the CCP2 (green) to FIMs (blue) linker (red). Linker-module
interacting residues are highlighted as sticks.
4.3.5 Analysis of the intermodular interface
4.3.5.1 CCP:FIMs
As mentioned above, in the initial rounds of the CYANA-based assignment and structure
calculation, cross-peaks matching to putative NOEs between FIMs and CCP2 were
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identified. These did not survive subsequent rounds since they were not supported by
surrounding NOEs. They may have been reassigned by CYANA, or (more worryingly)
just eliminated and not used. Therefore to be as certain as possible that no genuine
intermodular NOEs were being missed, all candidates (from early CYANA rounds) were
visually inspected. It was thus ascertained that with the exception of NOEs between
FIM1 and FIM2, no NOEs could be unambiguously assigned as intermodular.
Thus while the long flexible linker between CCP2 and the FIMs would allow for
module-module interactions to occur (and it would be very surprising if transient
contacts did not take place), the NMR data very strongly suggests that any such
interactions are short-lived on the NMR time-scale and non-specific.
On the other hand the linker (defined as the sequence of residues between the last and
first cysteines of flanking modules) is not flexible throughout its length, but only in its
middle (seven-residue) section. More insight into this aspect of C7-CFF was obtained
from the shape envelope derived from SAXS. The SAXS-based 3D model of C7-CFF
(Ab intio shape determined using DAMMIN in the PRIMUS package150) indicates that
there are indeed very likely to be some constraints on the flexion of the linker. The
model depicts a large globular region and a smaller globular protrusion. Manual fitting
of the water-refined C7-CFF structures to this model was intutitive with the larger region
being occupied by the FIMs and the smaller region by CCP2. Five of the ten water-
refined CFF structures have a relatively extended linker conformation and easily fit
within the model. However the CCP2 of any single structure is insufficient to account
for the volume of the smaller globular protrusion and the same is true with regard to the
FIMs and the larger of the two protrusions (Fig. 64A). On the other hand, an overlay of
those five NOE-derived C7-CFF structures that featured an extended linker filled the
available space very nicely suggesting that the observed shape represents a structure
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averaged over multiple conformations. The remaining five structures within the CFF
ensemble featured less elongated linkers, with the result that CCP2 and FIMs are too
close together to fit the model. Thus the SAXS-derived model indicates that there are
some constraints on the flexibility of the linker and that the NMR-based structure
calculations have under-restrained the structure rather than over-restraining it.
A
Fig. 64: Ab initio SAXS-based analysis of CFF. (A) shows the DAMMIN^0 derived SAXS model
(courtesy of Dr. Elizabeth Blackburn) overlayed with the calculated mean structure of the CFF water
ensemble. CFF is shown as a cartoon (red). (B) depicts five of the ten ensemble structures overlaid with the
SAXS-derived model with CFF residues shown as sticks.
4.3.5.7 FIM1:FIM2
The inter-FIM interface within the FIMs component of C7-CFF is supported by a
plethora of both electrostatic and hydrophobic interactions, including potentially
module-bridging hydrogen bonds, salt bridges, aromatic-to-cysteine contacts and
aromatic-to-aromatic interactions. These involve four regions of sequence in FIM1
(Arg704-Glu706; Pro723-Leu725; Val742, Cys743, Met745, and His746; and Val727, Ala729, and
Leu757) and four regions of FIM2 (Trp779; Glu799-Ile804; Glu^jGly821; and lie835).
The intermodular interfaces of FIM1 and FIM2 are nearly identical between the C7-
FIMs (alone) and C7-CFF structures (Fig. 65), with numerous NOEs "connecting" the
two modules. All but two of the residues involved in the interface make the same
contacts with the neighbouring module, Arg7b0 of FIM1 and Arg824 of FIM2. In C7-CFF,
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Arg760 points away from the interface as opposed (in FIMs) to being engaged in the
interface in hydrophobic interactions involving its H(3s with Val832 Hy1. Unfortunately,
the associated NOESY strips were overcrowded in Fourier transformed 13C-NOESY-
HSQC spectra of C7-CFF recorded in both H20 and D20. Although the maximum
entropy-processed spectra were clearer, a potential cross peak from Val832was observed
in the Arg760 strip but was noise-like and could not be picked. The corresponding 13C-
methyl-NOESY-HSQC Val832 strip had signal in the Arg760 Hp region but this was not
resolved by maximum entropy processing.
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Fig. 65: The FIM1-FIM2 modular interface. (A) shows the CFF FIMs interface. (B) shows the FIMs53
interface. In each panel FIM1 is shown on the left and FIM2 on the right with intermodular residues shown
as sticks. Hydrophobic residues are brown in FIM1 and yellow in FIM2. Basic residues are Blue in FIM1
and cyan in FIM2. Acidic residues are highlighted in red in FIM1 and pink in FIM2. Boxed residues are
those whose orientation varies significantly between the CFF and FIMs structures.
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As for Arg824, its orientation in the C7-FIMs (alone) means that it protrudes towards the
centre of the interface. In C7-CFF, although the Arg824 side-chain faces FIM1, it does not
extend so markedly towards the centre of the interface as it does in FIMs (alone).
Comparison of the NOE lists indicates that the same set of NOEs for Arg824 are used in
both calculations. What is interesting is that in both C7-FIMs and C7-CFF no
intermodular NOEs are observed for Arg824 despite it being buried in the interface in
both cases. Although the true orientation of Arg824 is unknown, it is conceivable that the
presence of an extra residue identified as being part of an a-helix in the C7-FIMs (alone)
structure, has a knock on effect with respect to the orientation of the side chain of Arg824.
However, the length and orientation of the FIM2 helix has no other observable effect on
the intermodular interface.
4.3.6 Analysis of surface properties
For both CCP2 and the FIMs of CFF, the surface electrostatics and lipophilicity have the
same characteristics as their previously solved (in isolation) counterparts. CCP2 still has
one predominantly acidic face and another predominantly basic face. With regards to the
FIMs, FIMl's solvent accessible face is predominantly basic, with Lys701, Arg704, Lys707,
Arg712, Arg733, Lys744, and Arg753 being the main contributors. Contrastingly, FIM2's
surface is predominantly acidic in nature, primarily due to several surface-exposed
glutamate side-chains, namely Glu785, Glu798, Glu799, Glu800, Glu807, Glu812, and Glu841. As
in the C7-FIMs structure Glu798, Glu799, and Glu800 form a cluster of negative charge in a
cleft in FIM2. The CCP2-FIMs linker contains two electronegative residues (E691 and
T686) that are sandwiched between four electropositive residues (Q690, K691, N693 and Q
696\
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Fig. 66: Analysis of C7-CFFs surface properties. (A) Surface-electrostatics are shown with a red (negative
charge), white (neutral charge) and blue (positive charge) colour scale. (B) Surface lipophilicity is
represented by a brown (lipophilic) to green (neutral) to blue (hydrophilic) scale. Contributing residues are
labelled in both diagrams.
The electropositive surface of FIM1 is interrupted by a patch of hydrophobicity
involving residues Met717, Tyr719, Leu748, and Tyr757 that is exposed in the FIM pair as
discussed in the FIMs structure paper.53 To assess the potential of this patch as a protein-
protein interaction site the lowest energy CFF structure was submitted for STP analysis
(Fig. 67). Indeed these residues were indicated to form a protein binding site, with the
exception of M717. Most striking, is the cleft that is lined with negative charge and runs
along the axis of symmetry between the two FIM modules. There is an extensive protein
interaction site formed between the two modules by residues W705, L725, M745, H746and
L73/ in FIM1, and I835 and R836 in FIM2. As the FIMs modules are "hinged" together at
the opposite face composed of the FIMs linker and FIM2 FOLN, it is easy to envisage an
closed-to-open transition upon binding C5-C345C, or alternatively open-up during MAC
self-assembly.
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Fig. 67: Identification of C7-CFF's ligand-binding sites using "surface triplet propensities". A surface
representation of C7-CFF with a scale going from least favourable (blue), to neutral (green), to most
favourable (red) interaction site scores. The top view shows the whole molecule, while the panel on the left
shows the backface of the FIMs (topview) and the panel on the right shows a close up of the interaction site
in the FIMs cleft.
4.4 The C7 molecular arm
4.4.1 CCP1-CCP2-FIM1-FIM2
By merging the structure of C7-CCPs and that of C7-CFF one can begin to build-up a
picture of the C-terminal "molecular arm" of C7. A simple overlay of C7-CCPs and the
water-refined ensemble of C7-CFF provide a rudimentary reconstruction of CCP1-
CCP2-FIM1-FIM2 (CCFF, Fig. 68).
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The flexible nature of the CCP2-FIM1 linker likely plays a more prominent role in FIMs
binding the C345C domain during formation of the membrane attack complex.
Moreover, in the context of CCFF, the face at the "top" of the FIMs, that has an
extensive putative protein interaction site, is distal to preceding CCP modules (Fig.68C)
and may well be exposed in the intact protein. These concepts are discussed further in
section 6.2 of the discussion chapter.
A B
Fig. 68: Structure of CCFF. Overlays were performed in MOLMOL142 between the water ensembles of C7-
CCPs and C7-CFF. (A) Shows a ribbon trace overlaid on CCP2. (B) Shows a ribbon representation of the
two lowest energy structures. (C) Shows three views of an overlay on the FIMs (ribbon), with the CCPs
shown additionally as sticks to differentiate between the module types.
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4.4.2 TSPC-CCP2 and EGF-TSPC
Purified 15N-labelled C7-TSPC-CCP2 (C7-TC) and C7-EGF-TSPC (C7-ET) samples
were produced recombinantly in E. coli and provided by our collaborator (Ron Ogata)
for initial structural analysis by NMR. 1H,15N-HSQC spectra were recorded for both
samples on 100-|iM samples (20mM phosphate buffer, pH 5.0 ) (Fig. 69A, B). In both
cases the samples produced good-quality HSQC spectra, with well-resolved amide cross
peaks covering a wide range of chemical shifts, consistent with folded modular
structures.
For C7-TC, 131 of the expected 137 peaks were resolved, while for C7-ET, 89 of 99
expected cross peaks were counted. Overlaying the two HSQC spectra with one another,
and also overlaying the HSQC spectrum of C7-TC with that of C7-CCPs was an
informative exercise (Fig. 69). The overlays indicate that the structure of each module is
relatively unchanged by the presence of neighbouring modules. This is based on the fact
that approximately half of the peaks in each comparison overlaid well.
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Fig. 69: ['H, 15N]-HSQC comparison of ET, TC and CCP module pairs. (A) shows the overlay of CCPs
(red) with ET (grey). (B) Shows the comparison of TC (red) with ET (grey). The more complex central
portion of each spectrum is blown-up for better visualisation.
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Without resonance assignment (requiring a [13C,15N]-labelled samples) confirmation of
the peaks identities was not possible. However in the case of C7-TC a 15N-HSQC-
TOCSY was recorded to better identity those peaks that overlay with peaks in the HSQC
spectrum of CCPs. Using this method, 51 of a total of 57 expected CCP-assigned cross
peaks were positively identified in the C7-TC HSQC spectrum. This confirms that the
structure of CCP1 is relatively unchanged in the presence of the TSPC domain. Such a
conclusion is consistent with the long linking sequence between them; there are 21
residues separating the (putatively) last residue of TSPC (Glu549, as identified by Pfamref)
and the first cysteine of CCP1 (Cys560).
Some CCPl-assigned peaks in the C7-TC HSQC spectrum that had moved significantly
compared to the spectrum of C7-CCPs were mapped to the C-terminal end of CCP1
(Fig. 70). This is unsurprising as C terminus-proximal residues of CCP1 obviously
interact with CCP2, and this second CCP module is absent in C7-TC. Other residues that
were affected were the N-terminal residues of CCP1. Again, this is very much as
expected since these residues are likely to interact with the first few residues of the
TSPC-CCP1 linker.
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Fig.70: Analysis of the HSQC spectrum of C7-TC and chemical shift "perturbations" arising from
absence or presence of the TSPC and CCP2 modules. (A) Shows the assignments of CCP1 cross peaks in
the 15N-HSQC spectrum of C7-TC. (B) (spheres) and (C) (sticks) highlight those residues in the CCP1
structure whose amide cross peaks had different chemical shifts in C7-TC versus C7-CCPs (orange) or could
not be found in the C7-TC spectrum (red).
There is a cysteine (Cys571) in the middle of the TSPC-CCP linking sequence. The
sequence of TSPC has only five of the six conserved cysteine residues (Fig.71), making
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Cys571 a likely candidate as a disulfide-binding partner. Nonetheless there are two other
possible binding partners. One can be found in the MACPF (Cys433, towards its C-
terminus), and the other is one residue upstream of the EGF module (Cys455, module
boundaries as outlined by EXPASY163). However, from comparison with other EGF
sequences the disulfide bonding pattern in C7-EGF is hard to distinguish and the









Fig. 71: Free cysteines in the EGF and TSPC domains and the C7-TSPC-CCP1 linker. The top panel
shows a comparison of C7-EGF domain with Coagulation factor II, for which structures are avaialable.refThe
middle panel shows a comparison of C7-TSPC with TSPC1 from human thrombospondin, for which a
structure is available.ref 'he bottom panel shows the sequence of the C7-TSP-CCP1 linker. All cysteines are
shown in red and those whose disulfide bonding partner is difficult to determine are marked with a
questionmark. Well conserved tryptophans and arganines of TSPC are also coloured blue and orange
respectively.
An intuitively attractive linkage would be from Cys433 of MACPF to Cys455 of EGF and
Cys505 of TSPC to Cys571 in the TSPC-CCP1 linker. However, a previous study164
isolated a proteolytic fragment in which Cys571 (in linker) is disulfide linked to Cys433 (in
MACPF). This arrangement would leave Cys455 (in EGF) disulfide linked to Cys505 of
TSPC. It is hard to imagine, however, that the TSPC module within the recombinant C7-
ET protein (which theoretically should contain this disulfide bond) remains relatively
unchanged relative to the TSPC within C7-TC (which it does as judged by comparison
of HSQC spectra) despite the loss of a disulfide bonding partner (if it were really linked
WSHWSPWSSCjSVT(^GDGVITRI LCNSPSPOMNGKPCEGEARETKAqKKDAC|F
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to EGF). Interestingly, initial attempts at production of the C7-ET protein resulted in
high-Mw multimers that were only observed under non-reducing conditions by SDS-
PAGE, indicative of misguided intermolecular disulphide bonds and the presence of free
cysteine(s). C7-TC production on the other hand did not share these problems, indicating
that there were no free cysteines present in this preparation.
In any case, the TSPC-CCP linker is likely to be conformationally restrained due to its
disulphide link with either the TSPC (as experience with the recombinantly produced
proteins suggest) or to the MACPF (as per Di Scippio et a/164).
By positively identifying the majority of CCP1 peaks in the C7-TC HSQC spectrum, it
can be inferred that the majority of the 79 remaining peaks (out of 82 expected i.e. 72 for
TSPC, four from the cloning artefact, and six unidentified CCP peaks) in the HSQC
spectrum belong to TSPC. The overlaid HSQC spectra of C7-ET and C7-TC (Fig. 69B)
show that the inferred TSPC-assigned peaks in the C7-TC spectrum overlay well with a
set of cross peaks presumed to be the TSPC-derived peaks in the C7-ET HSQC
spectrum. This indicates that the TSPC module structure is not greatly affected by the
presence of the EGF domain. There are 15 residues in the linker between EGF and TSPC
(Q488 to G502 as identified by Pfam162) consisting of seven small hydrophobic residues
(glycines and alanines), four bulkier hydrophobic residues (valine and leucine) and four
charged residues. Thus the majority of the linker is hydrophobic, and it is therefore
unlikely to be highly solvent exposed in the context of full-length C7. In C7-ET
however, without HSQC assignment and relaxation analysis, the flexibiltity and
structure of the linker are difficult to assess.
In conclusion all of the domains behave largely as separate entities with respect to one
another in solution, save for the CCPs and the FIMs where more extensive interactions
(particularly in the case of the FIMs) are observed between modules of the same type .
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The long linkers between EGF and TSP, TSP and CCP1, and CCP2 and FIMs, allow for
a high degree of flexibility in the C-terminus of C7. While the flexible nature of the
CCP2-FIMs linker was demonstrated experimentally by NMR, the extent of flexibility
within the other linkers is inferred. The "free" cysteine in the TSPC-CCP2 linker might
anchor it to another domain (experimental evidence suggests the MACPF domain) but




CHAPTER 5: CHEMICAL CROSS-LINKING
5.1 The cross-linking reaction
5.1.1 Strategy
The aim of this study was to investigate the use of intra-molecular chemical cross-links
as a means of assessing domain-domain contacts and thereby complementing the high-
resolution structural studies performed on selected modules of C7. As crystal structures
are available for complement C3 and its activated fragment C3b,"°"m these multiple-
domain proteins were selected as candidates for determining the utility and reliability of
the cross-linking analysis techniques under development by the group of Juri Rappsilber
(School of Biological Sciences, University of Edinburgh). The intention was to then
extend this approach to assess the tertiary structure of C7, which is currently unknown.
As described in section 2.4.3.3 representative models of TSPN, LDLRA, EGF-like and
TSPC domains (produced using the online homology modelling server PHYRE) were
used in conjunction with experimentally derived high-resolution solution structures of
CCPs and FIMs for the construction of a model of C7 architecture.
5.1.2 Optimisation and SDS-PAGE
After completion of lysine-lysine cross-linking reactions using the
Bis[Sulfosuccinimidyl] glutarate (BS2G) cross-linker (Fig. 72), performed as described
in section 2.4.3.1 on samples of C3, C3b or C7, the treated proteins were subjected to
SDS-PAGE in attempts to separate the various cross-linked oligomers from the target
monomer (Fig. 73A, B and C). A series of cross-linker:protein ratios (1:100, 1 GOO,
1:1000, 1:3000) were assessed in the case ofC3b. A ratio of 1000:1 was considered most
promising as almost no free a or P-chain remained, under reducing conditions, using this
ratio (Fig. 73A). This indicates covalent cross-linking between the chains had occurred
in the majority ofmolecules. The higher ratio of 1:3000 was not selected, as the band
corresponding to cross-linked monomeric protein band was significantly smeary and
irregular in comparison to bands obtained with the lower ratios. To maintain consistency
between analyses ofC3 and C3b, the 1:1000 protein:cross-linker ratio was used for
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cross-linking within C3, and similar results were obtained (Fig. 73B). Likewise, for C7,
a range of protein:cross-linker ratios was scrutinised (Fig. 73C). In this case, however,
there is only one chain and therefore assessment of the extent of cross-linking could not
be based on observation of inter-chain cross-linking. Analysis by SDS-PAGE, however,
indicated the success of cross-linking for all ratios on the basis of a weak band
corresponding to a dimer that was absent in the minus-cross-linker control. Therefore, a
range of cross-linking ratios were explored by MS. A ratio of 1:1000 was again selected
for further analysis as it produced the most extensive list of cross-linked peptides.
Bands (visualised by staining with Coomassie blue) corresponding to the monomer
species were cut out of the gel and in-gel trypsin digested. The tryptic peptides were then
analysed by LTQ-Orbitrap-MS/MS to allow identification of any cross-linked peptides.
The experimentally derived mass spectra were matched to all potential cross-linked
peptides by searching a protein-specific, purpose-built database and a scoring algorithm
was applied to assign a degree of confidence to the identification of candidate cross-
linked peptides.152 Furthermore, to assess the reproducibility of the cross-linking
experiment two separate cross-linking reactions were performed for all three proteins.
Determination of a dependable cross-link list was carried out by Zhuo Chen (Rappsilber
group) with only those cross-linked peptides that were reproducible, had mass-errors
within 6 ppm of the predicted peptide mass, had exceptional database search scores and
had a fully explicable mass spectrum with fragment information for both peptides, were
considered high confidence cross-links. This final set of cross-links was used for
comparison with the x-ray structures of C3 and C3b and then an equivalent set were used
to determine the relative location of domains in C7.
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BS'G-do
M W 530 35
Spacer Arm 7.7 A
BS'G d4
M W 534 38
Spacer Arm 7.7 A
Fig. 72: BS2G (Bis|Sulfosuccinimidyl] glutarate) cross-linkers. Non-deuterated (left) and deuterated
(right). Images adapted from Thermo Fischer Scientific.
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Fig. 73: SDS-PAGE analysis of C3, C3b and C7 cross-linking reactions. (A) C3b:cross-linker ratio
assessment. 1=1:100, 2=1:300, 3=1:100, 4=1:30()0, C=C3b control (no cross-linker). (B) C3 and C3b
cross-linking reaction 1:1000 ratio. 80 pg of C3/C3b was loaded in each lane. (C) C7:cross-linker
ratio assessment, 1=1:100, 2=1:300, 3=1:100, 4=1:3000, C=C7 control (no cross-linker) 50 pg of C7
was loaded in each lane.
w
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5.2 The C3 to C3b structural transition
The cross-links identified on the basis of the analysis of the MS data (Table 15 and 16)
were then evaluated by referring to the crystal structure ofC3 (2A73110, Fig. 74), the
generally accepted crystal structure of C3b (2107,111 Fig.75A)and the disputed C3b
crystal structure (2FIR0,"3 Fig.75B). Evaluation consisted of determining the distance
between cross-linked lysines in the structure and comparing this to the cross-linking
distance permitted by the 7.7-A spacer arm of the cross-linker BS2G. Given the likely
mobility ofmany lysine side chains, this distance was measured between the Ca atoms,
and the maximum inter-Ca distance compatible with cross-linking was set at 24 A (i.e.
from lysine-A Coc to lysine-B Ca).
5.2.1 C3 analysis
In the case of C3, a total of 36 cross-links were identified with high confidence (Table.
15). Many of these lie wholly within a domain - there are three in LNK, one in CUB,
two in TED, three in ANA and five in the C345C domain, all ofwhich are consistent
with the crystal structure of C3 (Fig. 74). Also compatible with the structure are a further
eight cross-links within and between domains of the MG ring.
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C3 monomer crosslinks
From (K) To (K) From domain To Domain Distance (A)
155 502 MG2 MG5 14.61
155 812 MG2 MG6 (a) 10.41
241 428 MG3 MG4 17.82
241 607 MG3 LNK 16.44
241 608 MG3 LNK 17.67
289 682 MG3 ANA 15.49
365 608 MG4 LNK 40.56
418 633 MG4 LNK 15.87
205 608 MG2 LNK 14.8
249 289 MG3 MG3 16.93
249 305 MG3 MG3 10.16
289 305 MG3 MG3 14.4
566 584 MG6 (P) LNK 5.28
607 610 LNK LNK 6.27
607 615 LNK LNK 12.35
608 615 LNK LNK 9.77
879 1526 C345C 23.78
927 1436 MG7 18.5
930 1436 MG7 13.42
959 1306 CUB CUB 14.45
1001 1436 TED 13.56
1368 1497 ANCHOR 12.11
682 692 ANA ANA 11.95
688 692 ANA ANA 8.33
685 692 ANA ANA 11.92
692 1071 ANA TED 15.63
688 1071 ANA TED 19.85
721 1071 ANA TED 19.93
1113 1139 TED TED 19.95
1203 1244 TED TED 13.85
1504 1497 ANCHOR ANCHOR 15.14
1551 1599 C345C C345C 12.86
1522 1535 C345C C345C 11.22
1526 1535 C345C C345C 13.44
1551 1595 C345C C345C 13.56
1600 1595 C345C C345C 11.01
Table. 15: C3 cross-linked peptides identified with high confidence. Domain names are colour-coded
as shown previously. Distances between cross-linked lysines that exceed the maximum of 24 A in the
crystal structure are highlighted in red.
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More structurally informative are the multiple cross-links between domains. There are
four cross-links that demonstrate the location of the LNK domain with respect to the MG
ring (Fig. 74D). While three of these four cross-links, between MG4 and LNK, fall
within the maximum cross-linking distance, another MG4-LNK cross-link connects
residues that are 40 A (Ca-Coc) apart in the crystal structure. This could well reflect
movement of the LNK domain as it is thought to be highly flexible.110 There are, in
addition, single cross-links between the MG domains and C345C (Fig. 74B), anchor
(Fig. 74B) and TED (Fig. 74C) that are consistent with the crystal structure and describe
the location of these domains with respect to the MG ring. One of the four remaining
cross-links connects the C345C with the anchor (Fig. 74B), while the final three connect
the ANA to the TED domain (Fig. 74C). As may be appreciated from Figure 74, the
experimentally derived cross-links, realistically, reflect the conformation within the two
superdomains of C3 i.e the MG-ring and CUB-TED-MG8, as well as their location with
respect to one-another and the location of the anaphylatoxin and C345C domains.
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Fig. 74: Cross-links mapped to structures of C3. All diagrams (A)-(D) are of C3 (PDB ID:2A73) in a
ribbon representation. (A) depicts the full molecule; (B), (C) and (D) are close-ups of the TED C345C
region and LNK respectively. From N to C-terminus, MG1-MG6J3 are in grey, the ANA is in purple,
MG6a in magenta, MG7 in cyan, the CUB in blue, the TED in green, MG8 in yellow, the anchor in red
and C345C in brown. All lysines Ca are shown as light-pink spheres and residues of the thioester are
shown as red spheres in the TED. In (D) LNK lysine Cot's are in dark-green, with the labelled MG domains
differentially coloured for better visualisation. Cross links are shown within 24 A are shown in black, and
those exceeding 24 A are shown in red.
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5.2.2 C3b analysis
In the case ofC3b a total of 32 cross-links were identified with confidence (Table. 16).
Seven of these lie within and between members of the MG ring and are in agreement
with both the 2107 and 2HR0 crystal structures. Similarly, non-MG intra-domain cross¬
links are found within the LNK, anchor, C345C and CUB domains. Cross-links to the
MG domain are also found for the LNK and C345C domains; these are consistent with
both the crystal structures. Thus the relative locations in the protein of the MG ring, the
LNK domain, the anchor and C345C are adequately reflected by the cross-links. While
all of these cross-links are consistent with the 2107 structure, a cross-link within CUB
corresponds to a Ca-Ca distance of ~40 A in 2HR0. Indeed, in 2HR0 the CUB domain
is structurally disorganised and lacks secondary structure. Either the cross-linker is
trapping an unusual conformation of the otherwise unfolded CUB domain, or (more
likely) 2HR0 is not an accurate reflection of the true structure.
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C3b monomer crosslinks
From (K) To (K) From domain To Domain Distance (A)-2I07 Distance (A)-2HR0
23 486 MG1 (N-term) MG5 14.22 13.85
65 1050 MG1 TED 15.03 74.99
66 1203 MG1 TED 38.34 68.03
155 812 MG2 MG6 (a) 10.19 10.81
249 289 MG3 MG3 16.67 16.82
263 891 MG3 MG 7 9.65 9.76
289 305 MG3 MG3 14.69 14.41
289 1431 MG3 MG8 17.34 15.5
359 622 LNK MG4 14.45 15.42
566 584 MG6 (P) MG6 (P) 5.32 5.3
607 610 LNK LNK 6.88 6.25
607 615 LNK LNK 14.22 12.29
608 615 LNK LNK 12.09 9.72
749 861 a-NT (a N-term) MG7 / 15.9
749 879 a-NT (a N-term) MG7 / 10.91
749 1381 a-NT (a N-term) / 21.68
749 1526 a-NT (a N-term) C345C / 24.31
749 1535 a-NT (a N-term) C345C / 23.41
749 1589 a-NT (a N-term) C345C / 19.82
879 1526 MG7 C345C 23.45 21.47
879 1535 MG7 C345C 18.56 15.52
879 1589 MG7 C345C 19.14 16.54
904 1504 M 7 ANCHOR 13.27 13.01
959 1306 CUB CUB 14.77 40.6
1071 1381 TED 140.02 140.12
1419 1431 9.63 8.01
1497 1504 ANCHOR ANCHOR 11.4 15.55
1497 1589 ANCHOR C345C 8.23 13.06
1522 1535 C345C C345C 13.07 11.2
1526 1535 C345C C345C 13.96 13.5
1551 1599 C345C C345C 8.09 7.13
1595 1600 C345C C345C 11.2 11.03
Table. 16: High confidence cross-linked peptides identified in C3b. Domain names are colour coded as
shown for C3. Additionally the a-NT is shown in orange. Distances between cross-linked lysines that
exceed the maximum of 24 A in both the 2107 and 2HR0 structure crystal structures are highlighted in red.
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Fig. 75: Cross-links mapped to structures of C3b. .Diagrams (A) and (C) are of C3b (PDB ID:2I07) and
(B) and (D) are of C3b (PDB ID:2HR0) in a ribbon representation. (A) and (B) depict the full molecule,
(C) is a close-up of the MG ring/LNK cross-links and (D) is a close-up of cross links that are absent in
2107. From N to C-terminus, MG1-MG6P are in grey, the a-NT in orange, MG6a in magenta, MG7 in
cyan, the CUB in blue, the TED in green, MG8 in yellow, the anchor in red and C345C in brown. All
lysines Ca are shown as light-pink spheres, save for the a-NT and MG8 lysines missing from 2107 and N-
terminal residue shown in orange, blue and magenta respectively. In (C) LNK lysine Ca's are in dark-
green, with the labelled MG domains and their lysines differentially coloured for better visualisation.
Cross links are shown within 24 A are shown in black, and those exceeding 24 A are in red.
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Remarkably, six cross-links were identified that highlight the use of chemical cross-
linking as a complementary technique to crystallography (Fig. 75D). These cross-links
provide for structural assessment of regions that are absent from the crystal structure.
The N-terminal end of the a-chain, the a-NT domain (residues 727-729), and a portion
ofMG8 (residues 1372-1380) is missing in the 2107 structure (although present in the
2HR0 structure). Five of these cross-links between the N-terminal residue S749 and MG7
and C345C are well within cross-linking distance in 2HR0. Moreover, the sixth S749
cross-link connects the a-NT to the portion ofMG8 that is missing in the 2107 structure.
Therefore, the cross-linking data confirms the location of the N-terminal end of the a-
chain.
There is one difficult-to-explain cross-link, that connects the "top" (MG8) and "bottom"
(TED) of the C3b molecule as seen in the crystal structure (standard view, Fig 75 A,B).
These two domains form part of the dimer interface observed in the crystal structure165 of
a C3 dimer. Therefore it is conceivable that a putative C3b dimer shares similar contacts,
which would indicate that contamination by dimeric C3b of the monomeric C3b band
has probably occurred during the SDS-PAGE gel. This is not surprising given the poor
resolution of the high-molecular weight cross-linked protein bands (see Fig. 73B).
Another explanation could be that the C3b used in the experiment is contaminated with
other forms of C3. This is conceivable considering the C3b purchased from Complement
Technology Inc was derived from pooled human plasma and claimed to be only 95%
pure by SDS-PAGE. Complement Technology Inc confirmed that there were trace
amounts of antibodies, C5 and complement factors in the sample, however the presence
of other forms of C3 was not ascertained. It could similarly be argued that this cross-link
is physiologically relevant and that the CUB-TED-MG8 superdomain permits movement
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of the TED towards the MG8 domain. So far however, no C3b conformation has been
identified that would support this cross-link. Attempts were made by collaborators to
purify C3/C3b monomers by chromatographic methods, however they were
unsuccessful. Of particular interest are two TED-MG1 cross-links. One of these (Lys65
-Lys1050) satisfies the 2107 structure with a cross-linking distance of 15 A. However, in
2HR0 this distance was measured at ~75 A, far exceeding the maximum cross-linking
distance, and can not be explained without a significant movement of the CUB-TED-
MG8 superdomain in solution. The second TED-MGl cross-link (Lys65-Lys1203) is
inconsistent with the distance in the structure (it is 38 A) but this could be explained
simply by a rotation of the TED with respect to the CUB, via the two six-residue long
linkers that pass between them.
The 2107 structure is consistent with cross-links within the CUB domain that is located
between the translocated (with respect to C3) TED and MG1. Conversely, these CUB-
CUB and TED-MG1 cross-links are not consistent with the 2HR0 structure. At first
glance the cross-linking data supports the 2107 over 2HR0 with respect to the TED
domains location in solution. The 2HR0 conformation brings many lysines of the CUB
within cross-linking distance to lysines of the TED. Yet no cross-links were observed
between the CUB and TED. In communications114'115 discussing 2107 versus 2HR0, it
was argued that the 2HR0 structure depicts C3b in a more open conformation that might
be physiologically relevant. EM studies83 indicate that in C3b the CUB-TED-MG8 arm
swings between different conformations. When the 2HR0 and 2107 structures were
overlaid with models representing the two main classes of C3b conformations observed
by EM, 2107 was deemed to be in the class I conformation and 2HR0 is somewhere
between the two. As no cross-links were identified to support the CUB-TED-MG8
conformation of 2HR0, it would have to be the case that this structure represents a short-
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lived intermediate in solution that crystallises but that cannot be "captured" by cross-
linking.
Thus this study of C3 and C3b has shown that a combination of cross linking and mass
spectrometry provides a powerful means of observing domain rearrangements, and of
differentiating between various molecular architectures, in big multiple domain proteins.
Thus, this strategy was next applied to C7.
5. 3 C7 architecture
In a sample of full-length C7 (Complement Technologies Inc.), 19 high-confidence
cross-links were identified. Three main groups of cross-links may be considered: those
within the MACPF domain (eight), those between MACPF and the smaller modules
(eight) and those between the smaller modules (three) (Table. 17). The eight MACPF-
MACPF cross-links are all within cross-linking distance in a model of the C7-MACPF
built by homology with a crystal structure of the C8a-MACPF (Fig. 76). The presence of
these cross-links thus cross-validates the model ofC7-MACPF. One of these cross-links
connects the dl region and the dl/d3 (3-sheet core, while the remaining seven cross-links
are located in the d3 helical cluster region. On the other hand, the MACPF-module
cross-links are all located in the dl region of the MACPF, which, combined with the
cross-links between smaller modules (TSPC-CCP1, FIM1-LDL and FIM1-CCP2), and
an absence ofMACPF-MACPF cross-links in this region, indicates that the smaller N
and C-terminal modules are predominantly packed around the dl region of the MACPF
(Fig. 76).
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From (K) To (K) From (domain) To (domain) Distance (A)
221 420 MACPF MACPF 9.81
244 323 MACPF MACPF 16.49
323 354 MACPF MACPF 17.31
323 361 MACPF MACPF 17.27
325 354 MACPF MACPF 17.98
325 361 MACPF MACPF 18.05
338 354 MACPF MACPF 10.72
338 400 MACPF MACPF 10.1
99 159 MACPF /
167 684 MACPF CCP2 /
159 706 MACPF FIM1 /
167 735 MACPF FIM1 /
167 706 MACPF FIM1 /
167 735 MACPF FIM1 /
167 771 MACPF FIM1- linker /
167 788 MACPF FIM2 /
99 735 FIM1 /
517 593 TSPC CCP1 /
684 706 CCP2 FIM1 /
691 706 CCP2 FIM1 /
Table. 17: High confidence cross-linked peptides from CI. Domain names are colour coded as shown
previously. Distances shown are for MACPF-MACPF cross-links distances in the C8 a-MACPF
homology model.
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C433
Fig. 76: C7-MACPF inter and intra-modular cross links. C7-MACPF model is shown with dl region
in orange, central P-sheet in red and helical clusters in brown. Schematic representations of the modules
are coloured as shown previously: purple, yellow, red, magenta, dark-green, green, blue and cyan for
TSPN, LDLRA, EGF-like, TSPC, CCP1, CCP2, FIM1 and FIM2 (from N to C-terminus) respectively.
Key MACPF-module cross-linked lysines Ca's are shown as spheres (mahenta), MACPF intramodular
cross-linked lysines Ca's are blue spheres. Cross-links are shown as black arrows or lines, peptide-links
are shown as blue arrows and potential cysteine-links are shown as red-dotted lines.
Of the eight identified MACPF-smaller module cross-links, six link the MACPF to
FIM1, FIM2 and the linker between them. The cross-links map to one face of the FIMs
with FIM1 cross-linked lysines located in both the FOLN and KAZAL sub-domains
while in FIM2 they are located in the KAZAL domain only (Fig. 77). Five of the six
cross-links involve the same residue (Lys167) in the MACPF. Attempts to orient the FIMs
domain with respect to the MACPF (by re-orientating the independent modules in
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PYMOL and assessing cross-linking distances using the measurement wizard) were
successful (Fig. 77). However, if all cross-link inferred distances were to be satisfied
simultaneously, the FlMs would occupy a fixed position with respect to the MACPF.
The cross-linked lysines are primarily situated around the cleft between domains, thus
confirming this region as a site for protein-protein interactions. Although the cross-
linking-inferred distance restraints are satisfied by a model in which the FlMs remain
compactly folded and pack snugly against the relevant portion of MACPF, there are
other explanations. For example, the FIMs may be flexibly attached, with cross-linking
capturing a range of different conformations. Or the FIMs could adopt an opened up
conformation in this setting, and thus wrapped around the N-terminal end of the
MACPF, they could more easily satisfy all of the distance restraints. A flexible or open
attachment is more probable, as the FIMs in the 'fixed orientation (Fig. 77) do not allow
incorporation of LDL-FIMs and CCP2-FIMs cross-links (Fig. 78 and 80) into the model.
To do so requires a rotation of the FIMs and the violation of one or more of the cross¬
link-derived (MACPF-FIMs) distances.
Fig. 77: Cross-linking inferred location of C7-FIIVIs with respect to the C7-MACPF. (A) The MACPF
colour coded as in Fig. 76. Cross-linked lysine Cas between FIM1 (blue), FIM2 (cyan), and the FIM1 -
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FIM2 linker (green) and the MACPF are shown as spheres (magenta). A close-up view is shown in (B).
The solitary MACPF-CCP2 cross-link also locates CCP2 (Lys684 - Lys167) on the
MACPF. The same residue in CCP2 also has a link connecting this module to FIM1
(Lys706) which also has a cross-link to Lys'67. Thus, despite the long flexible linker
described by the NMR structural analysis ofC7-CFF (see section 4.3.4), in the context
of full-length non-complexed C7, the CCPs and the FIMs can be found relatively close
in space as can be seen in Fig. 78. No cross-links that involved Lys691 and Lys701 in the
CCP-FIMs linker were observed. Therefore whether the linker is found close to the main
body of the molecule or remains loose is undetermined. Although no cross-links linked
CCP1 to the MACPF, the rigidity of the CCP pair as determined by NMR (see section
4.2.4) is likely to restrict the CCP modules movement with respect to one another. An
attractive option is that the concave face formed by the 84° bend between the CCP
modules allows the modules to wrap around the MACPF (Fig. 78C). Thus they act as a
bridge between FIMs located at the N terminus of the MACPF in the dl region, to the C-
terminal end of the MACPF from which the EGF-like domain and TSPC protrude (Fig
78).
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Fig. 78: Cross-linking inferred location of C7-CCPs with respect to the C7-MACPF and C7-FIMs.
(A) The MACPF colour coded as previously shown, with cross-linked lysine Cas shown in yellow.
Arrows indicate that the CCP1 location is not restrained by cross-links. (B) a close-up view of the cross¬
links. A top or 'birds-eye-view' of (A) is shown in (C).
Looking further towards the N-terminal end of the molecular arm, neither TSPC nor
EGF-like undergo cross-linking to the MACPF. Note, there are two neighbouring lysines
(Lys516 and Lys517) in TSP-C. Highlighting these residues on a model of TSP-C (Fig. 79)
reveals their proximity to the C-terminus of the module. As Lys517 is found within cross-
linking distance ofCCP1 (despite the 23 residues between the last cysteine of TSPC and
the first of CCP1), these lysines may be within cross-linking distance of lysines on
MACPF but be unable nonetheless to form cross-links. This could be for a number of
reasons. For example, there may be incompatible Lys-Lys side-chain orientations or the
CCP module may simply obstruct bridging by the cross-linker as shown in Figure 79C.
In this theoretical representation of TSPC, the long TSPC-CCP2 linking sequence can
198
CHAPTER 5: CHEMICAL CROSS-LINKING
easily accommodate a disulfide bond, while maintaining the TSPC and CCP1 in cross-
linking range. By extension, this would locate the EGF-like module close to the free
cysteine of the MACPF for disulfide bonding, and the EGF-like domain would therefore
not be packed against the putative TMFIs (see below). Alternatively, if the cysteine in
the TSPC-CCP1 linking sequence were disulfide bonded to the MACPF (as suggested
by Di ScippioREF) the TSPC would be have to be sandwiched between the MACPF and
the CCP1 in order to keep the TSPC and the CCP1 within cross-linking range.
Fig. 79: Cross-linking inferred location of TSPC with respect to CCP1. (A) An extended N to C-
terminal view of TSPC (magenta), linker (grey), CCP1 (dark-green) and CCP2 (green). Free cysteines are
shown as yellow spheres, disulfides as sticks, cross-linked lysines as cyan spheres and the 'free' lysine of
TSPC as a blue sphere. In (B) the MACPF is coloured entirely in orange for simplicity and a 'birds-eye-
view' is shown in (C).
The EGF-like module on the other hand contains only one lysine, and in the homology
model this is located at the C-terminal end of the module. However, EGF-like domains
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are hard to model due to the existence ofmany similar but different sub-types and so the
fold of the module and the true location of its lysine cannot be ascertained reliably.
Furthermore, given that we have detected no cross-links for this lysine, there is no
reason to assume its location is restricted to the dl region ofMACPF. Instead it may
occupy the position relative to the MACPF domain that resembles its equivalent in
perforin (Fig. 81). In perforin the EGF-like domain is packed against the TMH regions
of the MACPF. The aforementioned variable nature of EGF-like domains however
makes modelling the C7 EGF-like domain on perforin difficult; the six conserved
cysteines are in different positions (and there is an additional cysteine in perforin's EGF-
like domain, Fig. 80). If the EGF in C7 were packed against the TMHs, the free EGF
cysteine would be too far from the MACPF's free cysteine to form a disulfide bond. In
this instance the TSPC and the TSPC-CCP1 linker would have to span the TMHs and the
free cysteine of the MACPF to form a full set of disulfides.
C7-EGF-like CHC-458-RPCQNGGLATVEGTHCLCHCKPYT F-482-GAACE
RPC+ +G + + C C C+
Perforin-EGF-like CS-379-RPCRSGQHKSSHDS -CQCECQDSKV-401-TNQDCC
Fig. 80:C7-EGF-like and Perforin-EGF-like sequence alignment using BLAST2P.166 Highlighted in
bold is the section of the sequences that were selected by BLASTP for alignment.
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Fig. 81: The MACPF-EGF pair modelled on the perforin IMACPF-EGF pair. (A) shows C7-MACPF-
EGF in the arrangement found in perforin.79 MACPFs are coloured with the dl in orange, the dl/d3 f-
sheet in pink and the TMHs in brown. The EGF-like module is in red and the EGF-MACPF linker is in
grey. The free cysteines ofEGF's and MACPF are shown as yellow spheres in A. The MACPF-EGF
disulfide link of perforin is similarly depicted in (B).
Considering the N-terminal modules; the compact 39-aa LDLRA domain is peptide
linked to the N-terminal end of the MACPF with a relatively short five residue-long
linker. The MACPF N-terminus is located in the dl region according to the homology
model, and therefore the LDLRA domain is likely to be located directly adjacent to the
putative FIMs:MACPF interface. This juxtaposition is consistent with the detection of a
cross-link between the LDL and FIM1 , and this provides additional evidence for the
location of the FlMs (Fig. 82). The location of the N-terminal module TSPN, that
immediately precedes LDLRA in the sequence, remains to be established since there are
no cross-links involving lysines in this domain. The relatively short linker between
TSPN and LDLRA (five residues from consensus cysteine to consensus cysteine)
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implies that these two modules will be close in space.
Fig. 82: Cross-linking inferred location of LDLRA with respect to MACPF and FIMs. (A) The
MACPF is colour coded as previously shown (Fig. 76), TSPN is in purple, the LDLRA is in yellow and
FIM1 and FIM2 in blue and cyan respectively. Cross-linked lysine Cots are shown as green spheres.
Arrows indicate that the location of the TSPN module is not restrained by cross-links. (B) shows a 'birds-
eye-view' ofA, without TSPN.
In summary, although no cross-links were observed for the EGF-like domain and TSPN
the relative location of the other C-terminal and N-terminal domains is likely to be close
to the dl region, on the basis of either direct MACPF-module cross-links or from
inspection of module-module cross-links. Models of each module (along with the NMR-
derived solution structures of the CCPs and FIMs) were used to create a model
representation of the tertiary structure of C7 (Fig. 83). Although the EGF-like module is
shown in close proximity to the MACPF's dl region, it similarly could adopt a different
location as discussed previously. The implications of this "top-heavy" domain
organisation is discussed further in section 6.2.
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Fig. 83: Model of C7 Architecture. (A) A schematic representation of C7 to better visualise the colour
scheme. (B) Four cross-link indicated orientations of C7 modules and the MACPF with linkers between
modules (linkers created via Modellerrct). (C) Schematic representation of tertiary structure as in (B).









6.1 Critique of techniques employed in this study
6.1.1 Protein production and purification
6.1.1.1 The pET15b/OriaamiB pLvsS expression system
The use of the pETl 5b/OrigamiB pLysS expression system for the production of the
disulfide-rich protein modules from E. coli used in the current study made a strong
contribution to the overall success of this project since it provided the C7-CCPs, C7-ET
and C7-TC samples used for NMR data collection. Even employing this tailor-made
system, however, half or more of the protein produced was incorrectly folded and
packaged into inclusion bodies; this occurred for all of the pET15b constructs. Although
there are many established protocols for refolding disulphide-rich proteins from
inclusion bodies667 - some ofwhich have been applied to CCP modules - the precise
conditions that give efficient refolding differ between protein sequences and thus there is
a requirement for the sampling of a variety of conditions, with no guarantee of eventual
success. In any case, the very large number of disulfides in, for example, C7-CFF (11)
would be likely to pose a challenge even to the Origami system, while re-folding such a
protein might well be unfeasible.
6.1.1.2 The pPICzaBIP.pastoris expression system
Recloning into pGAP/pPIC vectors and subsequent protein production and purification
from P. pastoris, was a reasonable alternative that was explored in the current project
and deployed successfully for the triple-module construct C7-CFF that was eventually
used in the structural studies. This system has proved suitable (in the Barlow group and
elsewhere) for producing numerous disulfide-rich proteins, notably intact complement
factor H with 40 disulfides.'68While P. pastoris growths are much slower than E. coli
ones and the genetic manipulation required is more involved, the yeast system has
advantages in that the folded protein is secreted into the medium, cell densities can be




The positive results obtained for all the re-cloned constructs in "miniscale" protein
production trials indicates that production in P. pastoris of the MAC protein truncations
really was a viable alternative to production in E. coli. Other higher eukaryotic
expression hosts, such as mammalian and insect cells, have the ability to perform
complex post-translational modifications that are more similar to the human processes.
However stably over-expressing genes in these cells is a more demanding task, and
generally results in the production ofmuch smaller quantities of protein.169 170
Furthermore, isotopic enrichment is problematic in such cells that require complex
media for culture. Thus P. pastoris represents an excellent compromise between
mammalian/insect cells and prokaryotic cell lines. In the case ofC7-CFF production,
fully folded protein was obtained in sufficiently high quantities for NMR-derived
structure determination using double-labelled samples.
6.1.1.3 CCPs purification
With regards to CCPs (produced in E. coli) and its purification, the incorporation of
DNA encoding the His-tag into the vector allowed standard metal-affinity batch
purification. This allowed a relatively straightforward and standardised route to purified
protein: metal chelate affinity chromatography coupled with thrombin cleavage of the
His-tag, with the requirement of only one final 'polishing' step (size-exclusion
chromatography) to remove any impurities (as visualised by SDS-PAGE). Isotopic
labelling was acheived in minimal growth media, which consequently reduces cell
growth and produces less protein relative to rich medium.'7' The labelling protocols used
however, sufficiently overcame these issues, by using the commercially available
isotopically labelled ISOGRO growth (Sigma-Aldrich Co.) supplements in M9 minimal
media. The resultant sample contained highly purified and fully folded protein, of the




The purification protocol used for C7-CFF was typical ofmethods used to isolate
proteins from P. pastoris. The secreted nature of the recombinant proteins provides a
major advantage in this respect since there are generally only a few other secreted
proteins present in the medium. Thus the target protein is normally, and was in the case
of C7-CFF, the strongest band on an SDS-PAGE gel and this eases identification and
purification. Fortuitously the pi ofC7-CFF (=6.4) permitted cation-exchange
chromatography (at a buffer pH of 4.0) as the initial harvesting and purification step.
This is the preferred method of choice when resolving recombinant proteins from P.
pastoris-native ones because using anion-exchange chromatography results in co-
purification of the recombinant protein with various P. pastoris proteins. It is also
important to include such a rapid first step in the protocol since any ruptured P. pastoris
cells in the medium are a notorious source of proteases, meaning that storage of medium
can be problematic and that protease inhibitors should be used as a preventative
measure. One of the post-translational modifications performed by P. pastoris is
glycosylation. The KM71H stain of P. pastoris used, however, is not engineered to
incorporate mammalian-type glycans (although in recent years such strains have become
available'72). Rather it will yield glycoproteins that are hyper-mannosylated. As a result,
the glycosylated C7-CFF, that contains a single consensus site for N-glycosylation, must
be deglycosylated leaving an N-acetyl glucosamine "stub" on Asn724 as detected by MS.
Thus a limitation of our approach was that we were unable to investigate the potential
biological role of the native glycan. Only one further, final purification step (size-
exclusion chromatography) was needed to produce samples of a sufficient purity for
structural determination by NMR.
6.1.2 NMR analysis of C7
6.1.2.1 CCPs
The purpose of studying the C7-CCPs was to ask the question: do these modules form a
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rigid spacer arm and if so, how long is it? While it would obviously be most informative
to study CCPs in the context of full-length C7 or at least the entire C-terminal arm, a
divide-and-conquer strategy was adopted here based on the likely difficulties of
producing recombinantly, purifying and crystallizing these larger constructs with their
many domains and mutiple disulpfide linkages.
CCPs have been extensively studied by NMR (over 60 solution-NMR structures
currently deposited in the PDB). They are excellent candidates for NMR due to their
relatively small size (-60 aa) and compact fold based around a conserved hydrophobic
core and two invariant disulfides. The C7-CCPs proved not to be an exception as even
the most complex experiment recorded on this protein (the ljC-NOESY-HSQC)
produced high-quality spectra with well-resolved peaks. The excellent quality of the
acquired NMR data was reflected in the ease of CYANA and CNS-based assignment and
structure calculations, as indicated by the ease with which the CYANA -associated
criteria for a reliable NMR-derived structure were satisfied, the excellent convergence of
structures following simulated annealing in CNS (-40/100) and the very low RMSDs for
the backbone overlay of the final NMR ensemble of 20 model structures (CCP1 = 0.4 A,
CCP2 = 0.5 A and both = 0.8 A).
The two CCPs had a relatively small (by the standards of specific protein-protein
interactions) interface (440A2 buried surface area) that nonetheless seems to rigidify the
junction between the domains. Residual dipolar coupling constants could be recorded in
order to more thoroughly establish intermodular angles. This is not necessarily trivial,
though, since it requires partial alignment of the sample (see below). The number of
intermodular and module-to-linker NOEs observed in C7-CCPs (and the small RMSD
value for the overlaid structures) do provide a degree of confidence in these structures




The structure determination of C7-CFF was required to address two principal
unanswered questions. Is the closed conformation of the FIM modules (with respect to
one another), which lie at the very C terminus ofC7, altered by the presence of the
attached CCP? More generally, what is the extent of the interactions between all three
modules?
For this study we would have ideally used a C7-CCFF four-module construct, but at
30kDa this would have represented a serious challenge to standard NMR methods,
particularly if it had turned to have an elongated structure (associated with anisotropic
tumbling and rapid 77 relaxation). Even the recombinant C7-CFF (-24 kDa) used in this
study was on the large side for NMR-derived structure calculation without resorting to
expensive and time-consuming protocols for deuteration or selective labeling.'73 In the
current work [l3C-15N]-labelling proved sufficient (although only marginally) for
structure determination based on recording the standard suite ofNMR experiments on an
800-MHz spectrometer for nuclear assignment and NOE-based structure calculation.
Analysis of 15N relaxation rates highlighted the conformational freedom in CFF (see
below). This very likely improved the quality of the spectra and therefore the feasibility
of our strategy. If the two module types (CCP2 and FIMs) had shared a large buried
surface area then more exotic labeling would almost certainly have been necessary.
The NMR spectra ofCFF were indeed hard to interpret due to the large number of cross-
peaks in the spectrum and low 15N 77 values (expecially for the residues in FIMs) that
caused line broadening and overlap. Within the HCCH-TOCSY spectrum, for example,
strips pertaining to the FIMs component of CFF were of poor quality due to inefficient
TOCSY transfer and their assignment was a tasking procedure. Maximum entropy
processing allowed the deconvolution ofmerged resonance that was essential in picking
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peaks in the 13C-NOESY-HSQC spectra. A drawback, however, to using maximum
entropy processing is that it can distort relative peak intensities and thus the inferred
distance restraints.
The NOESY peaks submitted for automated assignment by the CYANA program were
abstracted from a total of four processed NMR spectra. This was necessary because
although some NOESY strips were clearer in the maximum entropy-processed spectra,
some peaks were lost by this method and some strips were plagued with artifacts; hence
spectra that had been processed with and without maximum entropy were used. The high
spectral overlap within the l3C-NOESY-HSQC experiment is likely to have prevented
the picking ofmany lower-strength peaks that were crowded by stronger peaks. This
reduces the number of restraints available and will have a consequence for convergence
during simulated annealing in CNS.
Overall, the poorer quality data for CFF (compared, for example, to CCPs) is reflected in
the failure to meet all of the CYANA criteria (particularly with regard to the RMSD
values obtained after the first round) and in the smaller proportion of low-energy, well-
converged structures within the final ensemble. The non-globular and multiple-domain
nature of CFF probably also contributed to the failure to meet some of the initial
CYANA criteria.
Despite this, the resultant CNS-calculated water -refined ensemble had low backbone
RMSD values when overlaying on residues within individual modules (CCP2 in
particular, but also, FIM1 and FIM2), good coarse-quality packing scores (a check of the
normality of the local environment of individual residues) and satisfactory
Ramachandran plot statistics. Moreover, comparison with structures of FIMs and CCPs
solved previously indicated that the expected fold had been calculated for each of the
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three domains in CFF, albeit at a lower resolution. Given that CCP2 is properly folded,
it seems high unlikely that the inclusion of CCP1 in this construct (avoided due to the
NMR size-limit) would have had any effect on the interaction between CCP2 and the
FIMs, This vindicates the decision to work with the smaller construct (note that a CCF
construct would be unlikely to be of much use on the basis that the FIMs form an
intimate interface with one another and it is doubtful that F1M1 would be properly
folded in the absence ofFIM2).
The structure of C7-CFF (or C7-CCFF) could alternatively have been studied by X-ray
crystallography. The highly flexible nature of the CCP2-FIM1 linker may, however, have
proved problematic during crystalization trials. Even in the event of good quality crystal
formation, X-ray techniques would not have allowed for the determination of the
flexibility of the linker since it is genuinely mobile as confirmed by the l5N-relaxation
studies. Moreover, it is possible to selectively 'freeze' out one conformation under
crystallography conditions that are normally high in salt. Indeed crystallographic
conditions could also disrupt key interactions or, as seems more likely, induce closer
packing of the CCP and FIMs.
Residual dipolar coupling (RDC) measurements provide information on the global
folding of a protein or protein complex and long-range distance structural information
that illuminates orientational restraints (as opposed to short-range distance restraints
derived from NOEs). RDC's are recorded by partially restraining the orietentation of a
protein in liquid crystal alignment media (e.g. bicelles, fillamentous phage, cellulose
crystallites). The RDC values can in principal determine the relative orientation of two
bond vectors even if they are at opposite ends of the molecule. However there are
technical complexities encountered when using RDC for the study of a protein that
exhibits reciprocal conformational freedom as in C7-CFF.174 Thus measured RDCs may
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not in any case have been sufficient to describe the orientation of the FIMs with respect
to CCP2.
RDC's measurements can also provide a more extensive dynamics analysis than TJTi
values and heteronuclear NOE measurements, because they additionally include time-
scales close to the overall correlation time of the protein in question. This degree of
dynamic analysis could in theory allow a much more useful characterisation of the
amplitude of motion between the module types. However, dynamics analysis via RDC's
requires that measurements are taken in at least five distinct alignment media. This is
inevitably a time-consuming process that involves testing the success of alignment in a
variety ofmedia, and therefore requires larger amounts of labelled protein than were
produced in the current study.
Recording SAXS data on the other hand, is far less time-consuming and can be
performed on unlabelled protein. It proved an ideal method to assess the orientation of
modules within CFF. With the FIMs together being much larger and bulkier than an
individual CCP module, fitting of the NMR-derived structures to the SAXS-derived
shape envelope was easily achieved and did not require the use of specialised software to
obtain a good fit. The SAXS-derived shape envelope was only compatible with half of
the ensemble of selected C7-CFF structures from NMR. This implies that the SAXS
data could have been used as a valuable restraint in the simulated annealing, NOE-based
structure calculation. There are straightforward algorithms available for doing this and it
would certainly have been worthwhile if time had allowed.
In conclusion, despite the fact that the structure of C7-CFF is of poorer quality than the
structures ofC7-CCPs and ofC7-FIMs, it is nonetheless good enough to address the
questions we set out to answer.
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6.1.3 Protein architecture analysis by chemical cross-linking
The study of proteins and protein-protein interactions by chemical cross-linking coupled
with mass spectrometry is a low resolution, structural analysis technique that has become
more widely used in current years.98"105 This technique (as opposed to higher resolution
methods such as NMR and X-ray crystallography) has, theoretically, no limit with
regards to the size of the protein or protein complex to be studied. This is because the
proteins are subjected to enzymatic digestion prior to MS/MS, creating peptides, which
are more easily analysed. This makes cross-linking an ideal technique to study the
architecture of full-length C7, which has so far evaded detailed tertiary structural
analysis. Moreover, with the increasing repertoire of cross-linkers and continued
advances in methodology for mass spectrometric analysis of cross-linked peptides,
cross-linking has the potential to generate extensive lists of various intermolecular or
intramolecular upper distance bounds, thus enhancing other kinds of structural analysis.
In its current state of development however, such applications have not been routinely
implemented. There may be several reasons for this, such as the requirement for
specialized reagents, the necessity of access to, and expertise in the use of, high-end
tandem mass-spectrometers and, in particular, the need for sophisticated tailored
software that can find and identify cross-linked peptides in a very highly populated mass
spectrum.103
6.1.3.1 C3 to C3b structural transition
The cross-linking analysis of test proteins C3 and C3b (for both ofwhich high-resolution
3-D structures are available), proved reasonably accurate and informative with regards to
the organisation of domains. The findings are largely consistent with the crystal
structures, proving the reliability of the hybrid cross-linking:mass spectrometry method.
Furthermore the cross-linking data sheds light on the dramatic conformational changes
that accompany the C3 to C3b transition. Moreover, two polpeptide segments that were
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absent from the 2107 structure - (the N terminus of the a-chain and a portion ofMG8
(that was present in 2HR0) - were involved in inter-domain cross-links. This highlights
cross-linking use as a tool to augment (as well as confirm) structural analysis by X-ray
crystallography.
6.1.3.1 C7 Architecture
Unlike in the case of C3 and C3b, no crystal structure of C7 has been determined to date.
Thus C7 presents an interesting challenge for reconstruction of the tertiary structure of a
mutiple-module protein using cross-linking derived distance restraints, in combination
with computational models or atomic structures of the individual protein modules.
Initial attempts were made using scripts written for the program CNS to generate a low-
resolution model of C7 that was consistent with all of the cross-linking data. It soon
became clear, however, that the number and coverage of cross-link derived distance
restraints was too small to allow convergence on a consensus structure. For example,
there were no detectable cross-links involving lysine residues in TSPN or EGF despite
the likely proximity of EGF to MACPF. This limitation could possible have been
overcome using cross-linkers with different functional groups and spacer-arm lengths
possibly coupled with the use of proteases with different cleavage sites. Indeed, "zero-
length" A-hydroxysuccinimide ester-based cross-linking was carried out on C7, as was
protease digestion using GluC (as opposed to trypsin). However, the in-house software
for identifying cross-linked peptides is still under development.
Despite the lack of a complete 3-D structural model of C7, the cross-linking studies
proved very useful in two respects. First, numerous intra-domain cross-links confirmed
the homology-based model of the C7-MACPF. Second, the pattern of intermodular
cross-links, while inadequate to define an absolute configuration, clearly showed that
most of the C-terminal arm ofC7 wraps around the "top" of the MACPF domain, away
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from what is likely (by analogy with the CDCs and perforin) to be the region that
initially docks onto a membrane surface, The implications of these findings discussed in
the following section.
6.2 Structure based model of MAC formation
6.2.1 Modules of the molecular arm
This structural investigation of the C-terminal modules (EGF, TSPC, CCP1, CCP2,
FIM1 and FIM2) ofC7 provides insights that help to elaborate current hypotheses based
around the existence of a molecular arm that articulates during the remarkable, enzyme-
free, process of MAC self assembly.
We propose that the CCPs form the rigid part of an arm that hinges on one or both of the
EGF and TSPC modules to deliver the C-terminal FIMs pair to their binding site on C5-
C345C. Displacement of the arm (or "safety catch") from its original position on C7 (in
response to binding of C5b6) would, according to the hypothesis, allow the triggering of
a major structural rearrangement of the MACPF domain that alters its characteristics
from those of a soluble protein to those of a membrane-associated one. The activated C7
protein thus develops an affinity for the membrane and the nascent C5bC6C7 complex
then acts as landing pad for C8, thus promoting further steps on the irreversible path to
MAC assembly. Activation of C7, by analogy with the CDCs, may involve immediate
release of its cryptic and potentially membrane penetrating (^-hairpins; alternatively this
may occur after C7 has docked onto the membrane surface. Something similar
presumably occurs in C6 that has the same domain structure as C7.
Based on observations of other proteins that carry domains similar to the FIMs, it was
speculated that the two F1M modules open up to provide a large specific surface area for
the C5-C345C interaction.^ Thus the putative swinging arms of C6 and C7 are
fundamental to both driving self-assembly forward, but they are equally important as
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"safety catches" on the MACPF domains ofC6 and C7, ensuring they do not become
activated inappropriately. The current work thus set out to test various predictions of this
hypothesis.
6.2.1.1 FIMs
The solution structure of the FIMs module pair (alone) was solved previously. But this
work did not reveal whether or not the closed conformation ofFIMs (involving intimate
mutual association of the two modules) is affected in any way by the presence of the
neighbouring CCPs. This is important because the FIMs form the C-terminus ofC7 and
hence their only neighbour (within the sequence) is CCP2 so there is a good chance that
the structure ofFIMs in the context ofC7-CFF (or C7-CCFF - too big for NMR, see
above) will recapitulate their structure in the freely swinging arm of intact C7.
The solution structure ofCFF, in conjuction with relaxation studies and SAXS analysis,
confirm that the FIMs have indeed adopted their closed conformation in the context of
C7-CFF. Moreover, it was ascertained that the seven-residue central section of the linker
between CCP2 and FIM1 is highly flexible or indeed disordered in the context ofCI, on
several timescales. Thus the FIMs and CCP2 ofC7-CFF behave largely as separate
modules in solution. In the context of C7 the linker may be packed alongside the
MACPF but the current findings are consistent with the idea that once released from
MACPF (if indeed this happens) the arm would have a flexible joint between the
"forearm" (CCPs) and the "fist", i.e. the FIMs, which may become an open "hand" when
binding C5-C345C. Note that the C345C domain is likewise flexibly attached to the
body of C3 (or C5). This makes sense in terms of an induced fit mechanism whereby the
initial encounter between the C345C domain and the FIMs is followed by an adjustment




The structure of CCPs, on the other hand, reveals a rigid, bent rod-like structure that is
6.6nm in length (directly measured from N-terminus to C-terminus). A significant
amount of energy would appear to be required to articulate around such a joint.
Therefore, the structural data bears out the notion of rigidity in the arm. This is a
requirement of our model because a completely flexible arm would presumably be less
good (it would incur more entropic costs) at direct delivery ofFlMs from their site of
residence on C7 to their binding site at the top ofC5. The CCPs would thus act as rigid
spacers, providing the arm with the reach needed to carry out its goal.
6.2.1.3 EGF-TSPC
Initial l5N-HSQC based NMR investigations into TSPC-CCP1 (C7-TC) reveal that very
few cross peaks of CCP1 are perturbed by attachment of TSPC its N-terminus. Thus
TSPC and CCP1 are unlikely to be in physical contact with each other. Furthermore the
structure of CCP1 is not modulated in any way by the presence of TSPC. Thus, as with
the CCPs and FIMs, we may infer from looking at the sequence alignment, that TSPC
and CCP1 are joined by a long, potentially flexible, linking sequence. This is in
agreement with most simplistic notions of the swinging molecular arm that would
require a pivot point at either end of the rigid CCP-CCP section, analogous with the
"elbow" and the "wrist" of a real-life arm. Although the extent and location of chemical
shift changes induced in TSPC by the presence of EGF (in the ET HSQC spectrum)
could not be ascertained directly due to the absence of any resonance assignments, it is
clear that the structure of TSPC is largely unperturbed by attachment to the EGF domain.
Again, a flexible linker is implied. However this cannot be unambiguously determined
without further structural analysis.
6.2.1.4 Summary
Thus in summary (Fig. 84), one can describe the FIMs as the 'hand' of the molecular arm
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that is closed like a fist in the C7-CFF context and hence is very likely to be closed also
when these modules are part of C7. The FIMs may open-up, however, on binding the
C345C domain of C5 but we have no evidence for that suggestion. Continuing with the
arm analogy, the CCP2-F1M1 linker is the flexible 'wrist' that joins the FIMs to the rigid
'forearm' formed by the CCP pair. The CCP pair is connected to the 'upper arm' or TSPC
via another, presumably flexible, linker between them, corresponding to the 'elbow'. And
the TSPC links to the EGF domain via a "shoulder" joint.
Finally the EGF domain may be fused to the MACPF domain in an analogous fashion to
that seen in the experimentally determined structure of perforin79 (where a MACPF
domain is also followed immediately next to an EGF domain). These observations relate
to the free arm since they are based purely on a dissect-and-rebuild approach to the C-
terminal domains performed in the absence of the rest of the C7 molecule. To shed light




Fig. 84: C7 structural transition. The cartoon image on the left is a schematic representation ofC7 in the
"arm-folded" conformation; the image on the right depicts C7 in the "open-arm" conformation. Modules
are labelled with the parts of an arm in an analogical manner and coloured as previously. Dotted black
lines show potential disulfide links to the MACPF. Solid red lines denote linkers between modules.
Extents of conformational freedom that are currently unknown are shown with double-headed arrows.
6.2.2 C7's molecular arm
The cross-linking data give an indication as to the location of the C-terminal "molecular
arm" with respect to the MACPF domain. The arm appears to fold around or embrace
the "upper" portion of the MACPF domain as observed in the standard view with the
membrane proximal regions at the bottom. This part of the C7-MACPF domain is known
as the dl region by analogy with CDCs.74The N-terminal modules LDLRA and TSPN




Early electron microcopy studies have provided some very low-resolution images of the
C7 molecule. Note that the staining methods used to record the EM image dehydrate the
molecule and can result in exposure of hydrophobic regions and molecular distortions.
Nonetheless, negatively stained images of single molecules can be very useful as
emerged in studies ofC3, C3b and C3(H20).83 In the case ofC7 it is worth remembering
in this respect that C7 is proposed to undergo conformational changes (upon opening out
of the C-terminal molecular arm in our models) that exposes hydrophobic regions for
binding to the target membrane. Thus it is concievable that the EM staining methods
have forced the molecular arm into an open configuration (or more precisely, trap a rare
conformation of C7 in which the arm is dissociated). To better visualise this a
comparison of the EM image and the C7 reconstruction is shown in a similar
conformation (Fig. 85). One can see from the compatibility of dimensions that the
globular region is clearly the MACPF, and the molecular arm in the EM images is of a
length that can accommodate the C-terminal modules (and is too long to be formed by
the two N-terminal modules). Thus the EM images do not conflict with our C7





Fig. 85: Structural comparison of C7 model with its EM image. (A) shows the C7 reconstruction in a
conformation representative of the EM image"6 in (B). Distances were measured for equivalent dimensions
as in (B) from the two furthest separated points and are as shown. Colors for C7 modules are as shown
previously. The cysteine of TSPC-linker and of the MACPF are brought into close-proximity in this
representation and are therefore shown as yellow spheres.
Thus the cross-linking data indicate that in solution and prior to incorporation into the
nascent MAC complex the molecular arm is a "folded" one. The degree of flexibility
between modules in this context is difficult to ascertain, however the occurrence of
TSPC-CCP2 and CCP2-FIM1 cross-links indicate that the modules are in a closer
proximity than we observe in our dissect-and-rebuild strategy. It would not be at all
surprising if interactions between individual modules and MACPF restrain the potential
for flexibility in the molecular arm, especially considering the MACPF is disulfide
linked to either the EGF-like domain, TSPC or the TSPC-CCP1 linker. None of these
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observations are inconsistent with our model (Fig. 86) in which "release" of the
molecular arm from the C7-MACPF upon binding the C5b6 complex reveals faces of the
modules that were previously in close contact with the MACPF. The wide spread of
cross-links in the FIMs modules, locating to one region of the MACPF indicate that the
FIMs still display some flexibility with respect to the MACPF. Moreover the MACPF
cross-links in the FIMs modules span the cleft between the two FIMs that form a
potential protein binding site. It may result that an interaction of the cleft residues with
the MACPF is replaced by their interaction with C5-C345C in the formation of the
MAC. One can envisage a dynamic equilibrium between open and closed forms {i.e.
forms in which the arm is free versus forms in which the arm is folded up around the top
of the MACPF). The binding ofC5b and provision of the C345C as an alternative tight
binder for FIMs presumably then stabilizes the open form sufficiently for the C7 helices
in dl (that are equivalent to the helical clusters of the CDCs, C8 and perforin) to
rearrange themselves, perhaps (by analogy with these homologues) into (3-hairpins that
have affinity for membranes.
It is also important to consider that C5 binds C7 in the pre-activation complex discussed
in the Introduction (see section 1.2.3.2). In our model, the location of the FIMs and the
flexible wrist could allow for an interaction between the FIMs and C345C without a
gross movement of the molecular arm. Not until a complementary surface in C5b6 (as
opposed to C5) is displayed for binding the MACPF/molecular arm modules would the
energetic cost of the molecular arm unfurling be compensated for.
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Fig. 86: Model of MAC assembly. MAC proteins are shown as schematic representations. C5 is in
teal w ith the top circle representing C5-C345C and the lower circle representing C5d; C6 is in magenta;
C7 is colour-coded, module by module, as shown previously; C8a-y is in purple; C8p is in blue and C9 is
in grey.
6.3 Future Work
6.3.1 High resolution structural analyses of C7
6.3.1.1 EGF-TSPC
The next logical step in our dissect-and-rebuild strategy would be to devote more study
to the TSPC and the EGF-like domain. Initial l5N-HSQC based structural studies reveal
that C7-TSPC-CCP and C7-EGF-TSPC constructs produced by our collaborators (Ogata
et al) have structures that should be solved with relative ease by NMR. Their sizes
(ET=~10 kDa and TC=~15 kDa) are well within limits to solve their structures using the
standard suite of experiments employed to solve the structures ofC7-CCPs and C7-CFF.
The sensitivity and spectral complexity issues encountered during the structural
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determination of C7-CFF should not arise.
Flowever, prior to solving these new module-pair structures, it would be worthwhile to
determine the disulfide bonding pattern of C7. This is intrinsically difficult for proteins
such as C7 that have clusters of cysteine residues. In traditional enzymatic
cleavage/mass spectrometry techniques even the most non-specific proteases cannot
easily cleave between cysteine residues that are very close neighbours.'7:> The plethora of
disulphide bonds (28 for C7 in total) and their clustering in relatively small disulphide
rich protein modules will make disulfide mapping difficult as already found for C7-
FIMsf 'The contemporary literature contains several mass spectrometry based methods
that may overcome such problems.175'176 Following the establishment of as much
disulphide bonding information as possible for C7, it will be possible to check whether
these same linkages exist in the recombinantly produced ET and TC protein module
pairs.
6.3.1.2 MACPF
The high quality C7-MACPF model (Whatlf score -1.65) indicates that the C7-MACPF
contains the same three subdomains (d 1 ,d2 and d3) as the C8a-MACPF. How the EGF
domain interacts with the MACPF remains to be seen. It may be that the EGF is
elongated, flexible and packs against the TMHs as in perforin or it may be that C7-EGF
has a different location with respect to the MACPF and/or has a structure that is more
highly ordered with more secondary structural elements like the EGF-like domain of
Heregulin-a.177 Atomic resolution structural analysis ofMACPF-EGF would identify any
structural differences with C8a-MACPF and determine the true fold of the EGF domain.
Due to the size of such a protein (~41 kDa) solving the structure would be very
challenging and therefore crystallization would likely be the method of choice.
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6.3.2 Chemical cross-linking and complement
6.3.2.1 C7 Architecture
A more exhaustive cross-linking analysis of full-length C7 may provide insights into the
MACPF-EGF arrangement and, of course, a more detailed description of C7 as a whole.
Achievement of a more extensive list of cross-link lists can be achieved via the use of
different proteases to produce a larger variety of peptide fragments, and to identify cross-
linked peptides whose trypsin-digested counterparts did not "fly" in the mass
spectrometer. As mentioned earlier, different cross-linkers could also be used. The
expanding repertoire of available cross-linkers incorporates various combinations of
functionalities e.g. for binding to amine, sulfhydryl, carboxyl, and carbohydrate groups,
and non-specific photoreactive cross-linkers. Careful selection of cross-linkers could
allow resolution of regions were there was previously a dearth of cross-links.
An exhaustive set of cross-link derived distances combined with solving the atomic
structures of the individual modules and module pairs should allow a simulated
annealing (e.g using CNS) or rigid-body docking (e.g. in HADDOCK'78) type approach
to structure calculation for C7. There are likely to be localized structural differences
between modules solved separately and the same modules in the context of C7, but any
gross changes in structure should be highlighted by intra-modular cross-linking
distances.
However, the tertiary structure model produced would require validation by another,
orthogonal, low-resolution solution-based structural technique such as SAXS.
6.3.2.2 MAC
The structural transition suggested to occur in the formation of C5b from C5 could also
be investigated (by analogy with the successful work done on C3b). Taking cross-linking
in the membrane attack complex to the next level and looking to the future and more
advanced software and hardware, it would be exciting to establish the relative location of
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domains with respect to one another for C6, C8 and C9 both as individual proteins but
also in the various complexes that can readily be isolated: C5b6, C5b67 etc. Moreover,
such work need not be limited to isolated complexes. Quantitative techniques allow
meaningful cross-linking:mass spectrometry studies to be done in mixtures and even in
plasma.
Carbohydrate/lipid-protein (target membrane to MAC) cross-linking ofMAC complexes
bound to either living cell membranes or artificial micelles should also be considered as
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Pair-wise CCP module structural comparisons of C7-CCP1 and C7-CCP2.
Protein~module number (PDB C7~01 C7~02
code RMSD in A (alignment length, RMSD in A (alignment length,
gaps included) Gaps included
C7-01 2.76 (59)
C7-02 2.76 (59)
Clr~01 (1GPZ) 2.46 (59) 2.24 (58)
Clr~02 (1GPZ) 2.21 (34) 2.43 (35)
Cls-02 (1ELV) 2.30 (49) 2.54 (61)
C2-01 (3ERB) 2.89 (51) 2.79 (47)
C2-02 (3ERB) 3.06 (60) 2.46 (60)
C2-03 (3ERB) 2.57 (58) 2.34 (58)
C4BPa~01 (2A55) 2.99 (58) 3.58 (58)
C4BPcc~02 (2A55) 2.24 (59) 2.44 (58)
CR1~15 (1GKN) 2.35 (58) 3.25 (58)
CR1~16 (1GKN) 2.41 (59) 2.35 (59)
CR1~17 (1GKG) 1.88 (57) 2.49 (57)
CR2-01 (1LY2) 2.37 (60) 2.57 (60)
CR2~02 (1LY2) 2.23 (59) 2.47 (59)
DAF-01 (10K3) 1.62 (60) 3.11 (59)
DAF-02 (10K3) 1.88 (59) 3.01 (58)
DAF-03 (1H03) 2.49 (56) 2.52 (59)
DAF-04 (1H03) 1.81 (59) 2.44 (59)
FB~01 (20K5) 3.14 (57) 3.43 (58)
FB-02 (20K5) 2.85 (60) 2.32 (60)
FB-03 (20K5) 2.55 (58) 2.43 (58)
FH-01 (2RLP) 2.16 (57) 3.25 (58)
FH-02 (2RLQ) 2.40 (57) 2.84 (58)
FH-03 (2RLQ) 2.46 (58) 2.24 (58)
FH-04 (2WII) 2.52 (57) 2.35 (50)
FH~05 (not deposited) 2.69 (56) 2.58 (56)
FH-06 (2UWN) 2.85 (54) 3.66 (56)
FH-07 (2UWN) 2.96 (49) 2.84 (56)
FH-08 (2UWN) 2.24 (55) 2.64 (56)
FH-12 (2KMS) 2.18 (58) 2.64 (57)
FH-13 (2KMS) 3.25 (57) 3.20 (49)
FH-15 (1HFH) 2.01 (58) 3.28 (58)
FH~16 (1HFH) 2.56 (56) 3.18 (46)
FH~19 (2G7I) 2.19 (58) 2.49 (57)
FH-20 (2G7I) 2.72 (56) 2.98 (57)
MASP1-01 (3GOV) 2.48 (60) 2.37 (60)

































Table 1: Pair-wise CCP module structural comparisons of C7~01 and C7~02. Comparison of individual
lowest energy structures of C7~01 and C7~02 versus all other individual CCPs of known structure within the
complement system based upon C„ RMSD values using structural alignment program CE. For each CCP,
inclusive module boundaries were one residue before Cys1 and the third residue after Cys"1. In cases where
structures have been solved by both NMR and X-ray diffraction, the higher resolution X-ray structure was
used for comparison. Where both liganded and unliganded structures were available, the highest resolution
unliganded X-ray or NMR structure was used. A few residues were missing in the crystal structure of
Clr~02, and hence in this case, the structure with the most determined residues was employed for both
modules. Colour key used in table: Blue: 0 - 1.99 A; Green: 2.00 - 2.99 A; Red: 3.00 - 3.99 A; Brown:
Alignment lengths < 40 amino acids. Abbreviations used in Table: C4BPa = C4b-binding protein a-chain;
CR = complement receptor; DAF = decay-accelerating factor; FB = factor B; FH = factor H; MASP1 / 2 =
mannan-binding lectin-associated serine proteases 1 / 2; MCP = membrane cofactor protein; VCP = Vaccinia
virus complement control protein. Some residues were not present (solved) in the electron density map for
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